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AMPAR α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
ATP Adenosine triphosphate 
C-terminal Carboxy-terminal 
cKO Conditional knockout 
DAPI 2-(4-amidinophenyl)-1H-indole-6-carboxamidine 
dcKO Double conditional knockout 
DIV Day in vitro 
dKD Double knock-down 
dKO Double knockout 
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HA Hemagglutinin 
HECT Homologous to E6-AP C-terminus 
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KAR Kainic acid receptor 
KD Knock-down 
KO Knockout 
LTP Long term potentiation 
miRNA microRNA 
N-terminal Amino-terminal 
Nedd4 Neural precursor cell expressed developmentally down-regulated 4 
NMDAR N-methyl-D-aspartate receptor 
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PSD Postsynaptic density 
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Development of neurons begins in the middle of embryogenesis after closure of the neural 
tube. In the process of neurogenesis, neural stem cells generate nerve cells by asymmetric 
cell divisions at the ventricular zone of the brain. Immature neurons embark for their 
destination and start projecting axons and dendrites during migration. Growing axons are 
guided across the embryo towards their target neurons, and upon synaptogenesis and synapse 
elimination create complex architecture of the neural networks. Emerging evidence unveils 
that posttranslational modification by protein ubiquitylation and posttranscriptional 
regulation of gene expression by microRNAs are of particular importance for the nerve cell 
development. In this study, we demonstrate the roles of HECT-type ubiquitin ligases in 
newborn and mature nerve cells. Additionally, we characterize intronic microRNA and its 
host gene encoding for HECT-type ubiquitin ligase in developing nerve cells. Our work 
provides novel molecular insights for nerve cell development and contributes to present 





Our emotions, memories ability to speak and hear all rely on uninterrupted neuronal 
connectivity [1,2]. Our brain is made up of 100 billion nerve cells, connected through 
synapses in circuits. Uncompromised functioning of neuronal networks depends on 
morphology of individual nerve cells [3,4]. Generation of mature neurons is a complex 
process that include molecular and cytological rearrangements controlled by multifarious 
cell signaling pathways. 
 
1.1.Development of cortical neurons in vivo 
 
Neural stem and progenitor cells give rise to neurons in the process of neurogenesis. Upon 
neurogenesis, newly born nerve cells migrate, differentiate, form axons and dendrites, and 
establish neuronal connectivity during synapse formation and elimination (Fig. 1A). 
Generation of astrocytes and oligodendrocytes (gliogenesis), myelination, angiogenesis, and 
blood-brain barrier formation accompany neuronal development in shaping the mature brain 
[5]. 
 
1.1.1. Neuroepithelial cells 
 
During development, neuroepithelial cells in the neural tube undergo a series of symmetrical 
proliferative divisions to then switch to asymmetrical mitoses, which result in self-renewal 
and generation of more lineage-restricted precursor cells (non-stem-cell progenitors termed 
basal progenitors), or differentiated neurons. Basal progenitors divide symmetrically, giving 
rise to two terminally differentiated postmitotic nerve cells [6-8].  
The neural plate and neural tube is comprised of epithelial cells just before the onset of 
neurogenesis. Radial neuroepithelium spans the entire thickness of the neural tube. The 
nuclei of neuroepithelial cells perform characteristic alternate movement along the apico-
basal axis, a phenomenon known as interkinetic nuclear migration. Since the cell cycle of 
neuroepithelial cells is not synchronized, the epithelium acquires a characteristic 
pseudostratified outlook. Interestingly, highly polarized neural stem cells present features 




1.1.2. Radial glial cells 
 
As development proceeds, the neuroepithelium lining the ventricular wall converts into a 
layered tissue with most of the neuronal progenitors. This region is collectively termed as 
ventricular zone. At E9-E10 in mice, the neurogenesis begins and neuroepithelial cells 
undergo several major cytological changes, which include downregulation of epithelial 
features and their differentiation status. Fundamentally, neuroepithelial cells undergo 
differentiative divisions giving rise to radial glial cells (RGCs), more fate-restricted 
progenitors. In contrast to neuroepithelial cells, murine RGCs are devoid of functional tight 
junctions at the apical end of the plasma membrane, but display adherens junctions 
associated with Zona Occludens-1 (ZO-1). [11-13]. Notably, progenitor cells induce the 
expression of astroglial markers, such as intermediate filament nestin [14]. 
RGCs maintain a characteristic bipolar shape of neuroepithelial cells with the long basal 
process reaching the pial surface, and shorter apical process, reaching out to the ventricular 
lumen [15]. Successively, RGCs replace neuroepithelial cells and directly or indirectly give 
rise to the majority of cortical neurons [16]. RGCs retain some features of neuroepithelial 
progenitors, such as apico-basal polarity of membrane protein distribution (e.g. apical 
expression of prominin-1, partitioning defective kinase-3, Par3/Par6/aPKC, atypical protein 
kinase C), contact with basal lamina, and interkinetic nuclear migration [11,17,18]. 
However, the nuclei of RGCs remain restricted to apical cytoplasm of the somata defining 
the ventricular zone. The last mitosis of RGCs takes place between E12 and E16 in mice, 
however, some of the apical progenitors preserve the radial glia characteristics until late 
postnatal stages and may function in adult neurogenesis [19]. 
Generation and maintenance of RGCs is dependent on numerous signaling cascades. Those 
include Notch/Delta-1, or neuregulin-1, Nrg-1, and ErbB2 tyrosine kinase receptor. 
Importantly, neurogenesis is controlled by transcription factors, such as sine-oculis related 
homeobox-3, Six3, empty spiracles homolog-2, Emx2, or paired box gene 6, Pax6 
transcription factors [20-25].  
 
1.1.3. Basal progenitors 
 
Besides RGCs, another progenitor cells appear at the onset of neurogenesis, namely basal 
progenitors. These cells originate after mitoses of neuroepithelial cells and RGCs at the 
apical site of ventricular zone. During later stages of neurogenesis, basal progenitors define 
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subventricular zone in the mammalian telencephalon [26,27]. Basal progenitors display yet 
another mode of cell division, paralleled by retraction of their apical process towards the 
ventricular surface. Notably, these cells specifically express non-coding RNA subventricular 
expressed transcript-1, Svet1, and transcription factors, such as eomesodermin homolog 
Eomes, also known as Tbr2, and cut-like homeobox-1 and -2, Cux1 and Cux2 [23,28,29]. 
Basal progenitors undergo symmetrical cell division, in which two daughter cells are 
generated, therefore subventricular progenitors function to increase the pool of neurons 
generated from ventricular precursors [30].  
 
1.2.Neuronal migration in the developing brain 
 
Newly born pyramidal neurons at ventricular zone embark for their future destination in the 
cortex in the process of radial migration, utilizing RGCs processes, that span the entire 
thickness of developing cortical plate. Tangential migration does not rely on interaction with 
RGCs and concerns GABAergic nerve cells, originating from the ganglionic eminence [31]. 
 
1.2.1. Initiation of radial migration and acquisition of cell polarity in vivo 
 
Radially migrating neurons form specialized connections with RGC processes, known as 
junctional domains, critical for maintenance of the translocation towards pia [32]. The 
adhesion of migrating newborn neuron to the glial process specifies its leading process, 
facing towards the direction of translocation, and a trailing process, reaching out towards the 
ventricle. At this stage of development, newborn neurons display a characteristic bipolar 
morphology [33].  
Importantly, newborn neurons inherit their axon-dendrite polarity from the apico-basal 
polarity of their progenitors. Consequently, the leading process acquires the dendritic fate, 
and the trailing one extends as an axon. Neurons specify an axon already during migration 








1.2.2. Maintenance of migration 
 
Interactions between molecules at the junctional domains, depend on the integrity of 
microtubules, which generate the force during the migratory movement. In line with this, 
significant migratory defects are observed upon mutations in genes critical for regulation of 
microtubule stability. X-linked lissencephaly in humans is caused by mutations in gene 
encoding for a protein doublecortin, Dcx. Dcx binds to microtubules and triggers their 
polymerization [35-37]. Another severe form of lissencephaly, Miller – Dieker syndrome, is 
caused by mutations in gene encoding another microtubule-associated protein, 
lissencephaly-1 protein, Lis1 (also known as platelet-activating factor acetylhydrolase 
isoform 1b, Pafah1b). Mutations in Lis1 result in slower migration of newborn neurons and 
disorganized cortical plate [38,39]. 
 
1.2.3. Radial migration termination 
 
Radial movement of neurons abruptly terminates on the border between cortical plate and 
marginal zone, where nerve cells detach from RGCs and distribute within cortical layers. 
Early born neurons accumulate in deeper layers, and later-born nerve cells invade superficial 
cortical regions. Reeler mutant mouse shows inverted cortical layering, with early-born 
neurons distributing superficially in the cortex, and later-generated nerve cells in deeper 
layers [40]. The reeler locus encodes for a large protein, reelin secreted from Cajal-Retzius 
cells of the marginal zone, the outmost layer of developing cortex [41,42]. Cortical 
lamination is controlled by reelin, disabled-1, Dab1, apolipoprotein E receptor-2, ApoER2, 
and very low density lipoprotein receptor, VLDLR. ApoER2 and VLDLR bind reelin and 
this leads to phosphorylation of Dab1, a cytoplasmic adapter. Phosphorylated Dab-1 
transduces an intracellular signal to induce rearrangements of actin cytoskeleton and 
modulate surface expression of integrins, which affects cellular adhesion. All four molecules 




Fig. 1. Development of mammalian neurons. (A) Key steps of neuronal development in 
mammals. (1) After the closure of the neural tube neuroepithelial cells proliferate and give 
rise to radial glial cells (RGCs). (2) Symmetrical divisions of RGCs produce intermediate 
progenitors (IP). Asymmetrical divisions of RGCs give rise to immature neurons, which 
migrate along RGCs processes. (3) After receiving a stop signal from Cajal-Retzius cells, 
newborn neurons detach from RGCs (i), and distribute horizontally in an appropriate cortical 
layer to further differentiate. Neurons born later, migrate towards superficial cortical layers 
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(ii). (4) Nerve cells establish their polarity by specification of neurites to dendrites and axons. 
(5) In the process of synaptogenesis and synapse elimination, axons establish contacts with 
their postsynaptic targets to organize nerve cells into circuits. (6) Soon after neurogenesis is 
complete, RGCs generate glia. (B) Postsynaptic spine and molecular signaling pathways for 
actin stabilization in the spine. Binding of Ephrin B to its receptor EphB2 recruits FAK and 
SRC kinases to activate p130 Crk associated substrate (p130CAS), adaptor molecule CRK, 
dedicator of cytokinesis protein 1 DOCK1 complex, and relay the activation signal to small 
GTPase, RAC1. RAC1 releases the WAVE regulatory complex (WRC) from WASP family 
verprolin-homologous protein-1, WAVE1, which in turn activates actin related protein 2/3 
(ARP2/3) to initialize new actin branch, and promote spine remodeling. Integrin α3β1 
activates tyrosine kinase ARG (Abl2) leading to its association with cortactin, which 
activates ARP2/3 and stabilizes newly formed actin branch. Myristoilated alanine-rich C 
kinase substrate (MARCKS) mediates association of actin filaments with the membrane. 
Upon depolarization, brain derived growth factor, BDNF associates with its receptor TRKB 
and recruits RAC1 to promote p21-activated kinase 1, PAK1 and LIM-domain containing 
protein kinase, LIMK1 inhibition of cofilin which hampers its actin-destabilizing activity. 
(A) After [5] with permission of Nature Publishing Group (license number 3693560392918). 




1.3.Neuronal development in vitro 
 
Cultured primary hippocampal neurons progress through developmental stages that 
recapitulate those observed for postmitotic neurons in vivo. 12-24 hours after plating, 
neurons adhere to the substrate and display numerous lamellipodia and protruding filopodia 
(Stage 1), which follows with emergence of multiple neurites (Stage 2). Stage 3 represents 
a specification of neuronal polarity, during which one of the immature neurites extends 
rapidly as axon, while remainder neurites acquire dendritic fate. Next, neurites undergo rapid 
outgrowth (Stage 4) to establish synapses and functional circuits with other differentiated 
neurons characterized by dendritic spines and axon initial segment (Stage 5) [47]. 
 
1.3.1. Axon formation 
 
Distribution of cellular organelles and cytoskeleton organization differ in dendrites and 
axon. Orientation of Golgi complex, mitochondria, and endosomes seem to correlate with 
the neurite acquiring axonal fate. In the developing hippocampal neurons, Golgi apparatus 
is deployed into an apical process that acquires dendritic identity [48]. 
Moreover, axons display a uniform microtubule organization, with the plus ends directed 
away from the soma. Dendritic microtubules display rather complex array of microtubule 
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orientation. Arrangement of microtubules determines microtubule-dependent transport 
through kinesins and dyneins, characteristic for axons. Both type of neurites also present an 
intricate set of microtubule associated proteins, MAPs. MAP1B and Tau are specifically 
found in an axon, whereas MAP2a-c are dendritic proteins [49-52].  
Moreover, disruption of actin polymerization leads to aberrant distribution of dendritic 
proteins into an axon. Actin cytoskeleton is critical for a polarized transport of organelles 
and proteins. Unique axonal F-actin organization appears critical for specification of axon 
initial segment and clustering of voltage gated sodium channels [53-55]. 
Not surprisingly, altering stability of cytoskeleton have dramatic consequences for the fate 
of the neurites. Taxol-induced stabilization of microtubules triggers neurons to project 
multiple axons. Moreover, local disruption of actin cytoskeleton at tips of the minor neurites 
turns them into axons [56,57].  
 
1.4.Dendritic spines and structural basis of synaptic transmission 
 
Over the course of development, cortical neurons extend axons and dendrites to establish 
neural networks in synapse formation and elimination. Dendritic spines harbor majority of 
glutamatergic postsynapses in the mammalian brain. Morphology of individual spines 
distinguish several spine classes, i.e. stubby, filopodia, thin, mushroom, and bifurcated type. 
Dendritic spines are rich in F-actin that defines their shape and allows for activity-dependent 
shape remodeling. High-frequency synaptic stimulation promotes actin polymerization and 
consequently results in spine enlargement. Conversely, low-frequency stimulation leads to 
actin depolymerization and results in shrinkage of dendritic spines [58-60]. 
 
1.4.1. Structural plasticity of dendritic spines 
 
Actin dynamics within the spine distinguishes a spine shell with fast actin turnover, and a 
spine core, characterized by more stable actin. Due to a rather stable actin core, spines keep 
their positions on the dendritic shafts, however, display dynamic morphological changes of 
the outer shell [46]. 
Actin binding proteins, altering stability of actin are therefore critical in maintaining 
structural plasticity of spines (Fig. 1B). Actin-related protein 2/3 complex (Arp2/3) nucleates 
new actin branches on existing actin filament, allowing for spine shape remodeling. Loss of 
Arp2/3 in neurons results in loss of glutamatergic synapses of hippocampal and cortical 
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nerve cells, and reduction of synaptic transmission. On the whole, long term maintenance of 
dendritic spines relies of molecular machinery controlling actin stability in response to 
extracellular signals [61,62].  
 
1.4.2. Synaptic transmission and circuit formation 
 
Majority of glutamatergic presynaptic inputs converge on postsynaptic dendritic spines. 
Basal neurotransmission in the central nervous system is mediated by AMPA-type and 
kainate glutamate receptors (AMPARs and KARs, respectively). Activation of NMDA 
receptors (NMDARs) elicits structural and functional plasticity, which underlies the basis of 
long-term potentiation (LTP). Scaffolding proteins, such as postsynaptic density-95, PSD-
95, or membrane associated guanylate kinase, WW, and PDZ containing 2, Magi-2 (also 
known as S-SCAM) anchor and cluster neurotransmitter receptors at the synapses. 
Deficiencies in postsynaptic scaffold follow with dramatic consequences for synaptic 
plasticity, resulting in compromised activity of neuronal circuits. That in turn may lead to 
disturbances of cognitive abilities and alteration of behavioral traits. 
 
1.5.In utero electroporation in studies of neuronal development 
 
In utero electroporation constitutes a powerful method to study of different aspects of 
neuronal development, from cell fate determination to spine morphology of nerve cells. 
DNA of interest is injected to the lateral ventricles of the embryo and electroporated to 
neuronal progenitors of the ventricular zone. In utero transfection of neocortical 
neuroepithelium, ammonic neuroepithelium, lateroventral pallial neuroepithelium, 
ganglionic eminence, or optic vesicle allows to study neurons of different brain regions they 
give rise to, such as cerebral cortex, hippocampus, piriform cortex and amygdala, 




Fig. 2. In utero electroporation (IUE). (A) The procedure of IUE. Under deep anesthesia, 
the uterus of a pregnant mouse is exposed, DNA is injected into the lateral ventricles of the 
embryonic brains and electroporated to neuronal progenitors by application of electric 
current. (B) Depending on the age of the embryo and positioning of the electrodes depicted 
on the scheme, precursors of different brain regions are transfected. (C) Overview of DAPI 
staining and Venus fluorescence in P21 coronal brain section after in utero electroporation 
at E14.5. Neuronal precursors in cortical and ammonic neuroepithelium were transfected 
with plasmid encoding Venus. Note transfected neurons in the cerebral cortex, cingulate 
cortex, and CA1 – CA3 fields of hippocampus. Scale bar, 1 mm.  
(A) After [72] with permission of Nature Publishing Group (under a Creative Commons 




Maturation of neurons, from newly born RGC daughter cells to a nerve cell harboring 
dendritic spines, structurally and functionally integrated into neuronal networks is precisely 
controlled at each step through numerous signaling cascades. Effector proteins responsible 




1.6.Posttranslational control of gene expression: biology of ubiquitylation 
 
Posttranslational modifications of proteins by ubiquitylation involves conjugation of 10 kDa 
globular ubiquitin (Ub) to a target proteins in cascade enzymatic reaction. First, E1 
activating enzyme catalyzes conjugation of Ub with AMP through a high energy bond. Ub-
AMP complex is covalently bound to the cysteine residue of E1. Ub activated in such a 
manner is subsequently shuttled onto E2 Ub conjugating enzyme and further onto the target 
protein with assistance of E3 ubiquitin ligase. Ultimately, protein ubiquitylation comprises 
of a formation of an isopeptide bond between ε-amino group of a lysine moiety in a substrate 
protein and the carboxyl rest of glycine at the C-terminus of Ub molecule (Fig. 3A). There 
is an evolutionary divergence considering the amount of genes encoding for enzymes 
mediating ubiquitylation reaction. One or two E1, about thirty E2, and around six hundred 
E3 are encoded in the human genome, but E3 ligases mediate specific protein-protein 
interaction and confer the specificity of ubiquitylation. Importantly, ubiquitylation can be 
reversed in a reaction catalyzed by proteases collectively named deubiquitinases (DUBs). 
Ub can be either cleaved off from its substrate, or ubiquitin chains can undergo enzymatic 
trimming [74-80]. 
Proteins can be coupled to a single Ub moiety, or can be decorated with Ub chains. Chain 
formation employs one or several lysine groups (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, 
and Lys63) of Ub. Ub-multimers can acquire forms of homotypic linkages to forked 
conformations. Importantly, the lysine utilized for chain formation specifies the functional 
consequence of conjugation of the Ub-chain to the substrate protein. Polyubiquitin chains 
comprised of Lysine-48 Ub moieties have been thought to serve as the main species of 
ubiquitin modification [81,82]. As discovered in the early 1980s, conjugation of Lys-48-
linked Ub chain destines substrate proteins for proteasomal degradation. Nonetheless, recent 
data illustrates that Lys-11 and Lys-63 alongside Lys-48 chains serve as the major ubiquitin 
modifications in the rat brain [83]. Functional consequences of Lys-63 polyubiquitylation 
include control over genomic stability [84] and regulation of transmembrane proteins 
[85,86], whereas Lys-11 linked poly-Ub chains control cell cycle progression [87] and are 
involved in endoplasmic reticulum-associated degradation pathway [88]. 
E3 ubiquitin ligases fall into two major families based on their biochemistry of 
ubiquitylation. Really Interesting New Gene (RING) ligases do not act as Ub acceptor 
themselves, but bring the E2 bound to Ub and the substrate protein in the molecular vicinity 
to facilitate Ub transfer. Homologous to E6-AP C-terminus (HECT)-type ligases covalently 
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conjugate Ub moiety to a cysteine residue in their catalytic domain and thereupon transfer 
Ub onto their target proteins. While RING-type enzymes are the preponderant E3 ligases, 
only 28 of HECT-type have been identified to date [89,90]. 
The HECT domain is homologous between the members of HECT-type ligases and 
comprised of N-terminal, E2-enzyme-binding lobe, and C-terminal lobe, harboring a 
catalytic cysteine residue. Juxtapositioning of catalytic centers of E2 and E3 enzymes during 
Ub transfer is facilitated by flexible hinge region, bridging both lobes. [91]. Based on the 
domain organization and homology of N-termini, HECT-type ligases are further grouped 
into three subfamilies: Nedd4 family, HERC family, and other HECT-type ligases [92-94] 
(Fig. 3B). 
 
1.6.1. Nedd4 family ubiquitin ligases of HECT type  
 
Nedd4 family ligases represent a unique group among HECT-type ligases due to their 
distinct domain organization (Fig. 3C). To date nine members of Nedd4 ligases have been 
identified in the human genome and majority of them have been implicated in different 
aspects of neuronal development [92].  
Nedd4 ligases share a C-terminus calcium binding C2 domain, several WW-domains, 
critical for substrate-ligase interactions, and C-terminus catalytic HECT domain. 
Homologous domain organization implicates a uniform activation of Nedd4 ligases, e.g. by 
calcium, or through phosphorylation by up-stream activators [95]. 
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Fig. 3. HECT Type E3 ubiquitin ligases. (A) Mode of action of HECT type ligases. 
Ubiquitin is conjugated to E1 ubiquitin activating enzyme at the expense of ATP hydrolysis. 
Thereupon, ubiquitin is shuttled to E2 ubiquitin conjugating enzyme and associates with E3 
ubiquitin ligase, which catalyzes ubiquitin transfer onto a substrate protein. (B) HECT-type 
ligases family. Based on the architecture of the N-termini and domain homology, HECT 
ligases are further subdivided into HERC family, Nedd4 family, and other ligases. Note 
ubiquitin ligase 3B, UBE3B and ubiquitin ligase 3C, UBE3C with N-terminal IQ motif. (C) 
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HECT ligases of Nedd4 family. N-terminal C2 domains, depicted as green rectangles, bind 
calcium and mediate association with lipid rafts. WW domains, represented as red 
rectangles, are responsible for substrate recognition and binding of proline rich stretches in 
proteins. C-terminal HECT domain, shown as a blue rectangle, catalyzes ubiquitin 
conjugation. 




1.6.1.1. Nedd4 ligases in neuritogenesis 
 
Nedd4 ligases are essential regulators of neuronal morphology. Neural precursor cell 
expressed, developmentally downregulated Nedd4-1 and SMAD ubiquitination regulatory 
factor 1 Smurf1 are critical for proper neuritogenesis. Upon phosphorylation, Smurf1 
shuttles from partitioning defective 6, Par 6 to a small GTPase RhoA at the tip of axons. 
Smurf1 mediates proteasomal degradation of RhoA, critical regulator of cytoskeleton 
stability in neurons. Overexpression of Smurf1 mutant that mimics its phosphorylation 
results in specification of multiple axons, while Smurf1 KD abrogates axon specification in 
neurons [96]. 
Interestingly, HECT-type ligases control neuritogenesis also by non-proteasomal 
degradation of their target proteins. Nedd4-1 monoubiquitylates a small GTPase Rap2. This 
prevents Rap2 interaction with downstream Traf2 and NCK-interacting protein, Tnik. GTP-
bound Rap2A-Tnik complex abrogates outgrowth of neurites. Monoubiquitylation of Rap2 
by Nedd4-1 results in dissociation of Rap2A-Tnik complex and promotes neurite growth 
and branching. Consequently, Nedd4-1 deletion from neurons results in reduction of the 
dendritic tree complexity and neurite outgrowth [97]. Moreover, recent data uncovers the 
role of Nedd4-1 and Nedd4-2 in facilitating axon growth and branching, which in contrast 
to previously published reports, seems to depend on Pten-mediated regulation of Nedd4-1 
mRNA translation [98]. 
 
1.6.1.2.The role of Nedd4 ligases in regulation of neurotransmitter receptors, ion 
channels and transporters 
 
Dynamic regulation of synaptic proteins is essential for synaptic plasticity. By regulating the 
abundance, expression, subcellular localization, and function of neurotransmitter receptors, 
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ion channels, or transporters, ubiquitylation contributes to structural and functional plasticity 
of synapses and activity of neuronal networks. 
Homologous Ca2+-binding C2 domain, essential for association of Nedd4 ligases with lipid 
rafts is of particular importance for neuronal functions [95]. Recent data demonstrate that 
upon activation of AMPARs, Nedd4-1 translocates into dendritic spines of hippocampal 
neurons. This subcellular activation-induced compartmentalization appears to depend on C2 
domain, considering the fact that Nedd4-1 mutants devoid of N-terminus fail to exhibit 
translocation [99]. C2 domain is essential for Nedd4-1 association with GluA1 containing 
AMPARs. Upon AMPAR agonist treatment, or bicucculine-mediated GABARA blockade, 
Nedd4-1 catalyzes Lys-63 linked polyubiquitin of a lysine cluster in the C-terminal loop of 
GluA1 and GluA2, inducing the removal of AMPARs from synaptic surface and their 
endosomal trafficking [100]. Moreover, Nedd4-1 mutants deficient for C2 domain are 
unable to reduce AMPAR-mediated synaptic transmission [99]. 
Nedd4-1-mediated AMPAR internalization and degradation depends on activation of 
voltage gated calcium channels and kinases, e.g. calcium-calmodulin kinase II, CaMKII, or 
serum-, and glucocorticoid regulated kinase 1, Sgk1. Upon stress, Sgk1 phosphorylates 
Nedd4-1, which enhances its ubiquitylation and resultant degradation of GluA1 in medial 
prefrontal cortex of rats [101]. Overexpression of Nedd4-1 results in decreased miniature 
excitatory postsynaptic currents (mEPSCs), and alters the ratio of NMDAR to AMPAR 
current, which corroborates Nedd4-1-mediated decreased surface expression of AMPARs 
[102].  
Close homolog of Nedd4-1, Nedd4-2 has been reported to ubiquitylate and regulate 
membrane abundance of voltage gated potassium and sodium channels. In line with these 
studies, Nedd4-2 is essential for sodium channel function and pain processing. Genetic 
deletion of Nedd4-2 from dorsal root ganglion neurons in mice results in thermal 
hypersensitivity and allodynia [103-107]. 
Nedd4-2 mediates protein kinase C-induced ubiquitylation of dopamine transporter. 
Additionally, Nedd4-2-mediated ubiquitylation regulates surface expression of excitatory 
amino acid transporter 2, EAAT2, essential for regulating extracellular glutamate 
concentration [108-110]. Nonetheless, cell autonomous effects of Nedd4-2 on synaptic 




1.6.2. Molecular basis of Angelman syndrome and the role of Ube3a in developing 
and mature neurons 
 
Among well characterized ubiquitin ligases in terms of neuronal development and 
homeostasis is the founding member of HECT type ligase family, E6-associated protein, 
E6AP, or ubiquitin protein ligase E3A. The gene of Ube3a is subjected to genomic 
imprinting is mice and humans resulting in silencing of paternal Ube3a allele [111]. 
Molecular determinants of this silencing seem to involve attenuating of the sense Ube3a 
transcript by a long non-coding RNA, however, the details of this interaction remain to be 
elucidated [112]. 
Mutations in maternal Ube3a allele in humans are causative of Angelman syndrome, a 
debilitating neurodevelopmental disorder. Patients with Angelman syndrome exhibit severe 
developmental delay with intellectual disability, speech impairment, characteristic 
tremulous motor disturbances, particular behavioral features such as excitable personality, 
and happy demeanor. Frequently, patients diagnosed with Angelman syndrome display 
microcephaly, seizures, and abnormal EEG with large amplitude slow-spike waves [113-
116]. 
Interestingly, behavioral analyses of mice deficient of maternal Ube3a, which constitutes a 
model of Angelman syndrome reveal striking resemblance to feature of Angelman syndrome 
patients. Mice devoid of maternal allele of Ube3a (Ube3a KO) exhibit seizures, motor 
deficiencies, aberrant spatial, and contextual learning. Hippocampal activity of Ube3a KO 
mice monitored by electroencephalography is characterized by abnormal spikes, sharp 
waves, and spike-wave discharges [117,118]. On the molecular level, Ube3a KO neurons 
display increased phosphorylation of CaMKII, resulting in its lower activity, and lower 
levels of CamKII associated with postsynaptic densities [119]. Consequently, high 
frequency stimulation in CA1 subfield of hippocampus in the Ube3a KO hippocampus 
results in a very transient potentiation, indicative of ineffective LTP. 
In mice, Ube3a is critical for polarized morphology of developing neurons. Knock-down of 
isoform 2 of Ube3a abrogates growth of apical dendrites in CA1 pyramidal neurons. 
Consequently, maternal Ube3a-deficient mice, mouse model of Angelman syndrome, 
exhibit stunted and less branched apical dendrites projected by cortical neurons of layer II/III 
or CA1 subfield of hippocampus [120]. 
Ube3a seems to localize to pre- and postsynaptic terminals of hippocampal neurons, to 
regulate spine morphology, and synaptic transmission [121]. Pyramidal neurons of layer 
 16 
II/III in visual cortex of Ube3a KO mice exhibit reduced density of dendritic spines 
concomitant with impairments of LTP and LTD, which represents an activity-dependent 
reduction in synaptic transmission. Interestingly, loss of plasticity and altered spine 
morphology observed in Ube3a KO neurons seem to rely on external stimuli. Described 
phenotypical changes are present in animals exposed to visual inputs, and not the ones reared 
in darkness [122]. 
At the molecular level, depletion of Ube3a decreases glutamatergic transmission, which is 
in line with observed decreased spine density and shrinkage of spine heads. Ube3a KO 
neurons exhibit reduced frequency of mEPSCs, indicative of decreased synapses specified 
on individual neurons. Interestingly, sh-RNA mediated downregulation of activity-regulated 
cytoskeleton-associated protein, Arc, restores AMPAR-positive synapses [123]. Arc induces 
endosomal recycling of AMPARs and its expression level is increased in Ube3a KO 
neurons. Although Ube3a ubiquitylates Arc in in vitro assays, if Arc represents Ube3a 
substrate remains controversial [124].  
Ube3a catalyzes ubiquitylation of phosphorylated ephexin-5 (E5), which acts as a Rho 
guanine nucleotide exchange factor and negatively regulates spine numbers in rat 
hippocampal neurons. Aberrant spine number and morphology might be attributable to 
increased neuronal levels of E5 reported in Ube3a KO mice [125].  
Recent report describes that de novo missense mutation in autistic patients abrogates 
phosphorylation of UBE3A by protein kinase A, PKA, essential for inhibition of UBE3A 
enzymatic activity. Excessive UBE3A-mediated ubiquitylation results in abnormal 
excessive spine formation on primary basal dendrites of layer II/III neurons [126].  
 
1.6.3. HECT ligases in intellectual disability syndromes 
 
Disturbances in ubiquitin signaling comprise the molecular basis of numerous human 
diseases, such as cancer, multisystem autoimmune disease, and various brain disorders [127-
129]. Strikingly, malfunction HECT-type ligases has been reported for syndromes 
characterized with intellectual disabilities. HUWE1, located on chromosome X in humans, 
is causative for Brown-Wisniewski-Brooks syndrome, also called X-linked mental 
retardation [130-132]. UBE3A comprises a well characterized gene mutated in patients with 
Angelman syndrome, who suffer from mental retardation [133]. Interestingly, a genetic 
screen of sporadic mutations in patients with autism spectrum disorder reveals point 
mutations in UBE3C, a gene for ubiquitin ligase E3C whose role in neurons has been 
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uncharted [134]. Interestingly, UBE3C has been reported to associate with human 
postsynaptic densities [135].  
Additionally, recent reports identify truncating mutations in human UBE3B gene, encoding 
for ubiquitin ligase E3B, as causative for Kaufman oculocerebrofacial syndrome [136-139]. 
 
1.6.3.1.Clinical symptoms of Kaufman oculocerebrofacial syndrome 
 
In 1971, Robert Kaufman described a peculiar pathology in four of seven siblings, he 
examined in Genetics Clinic at St. Louis City Hospital in Washington D.C. All of four 
patients exhibited severe mental retardation with absent speech, mild up-slanting of 
palpebral fissures, characteristic facial dysmorphisms with blepharophimosis, aberrances of 
the eye, ectodermal anomalies, and micrognathia, a disorder known today as 
oculocerebrofacial syndrome [140].  
Since then, about 50 cases of Kaufman oculocerebrofacial syndrome (KOS) have been 
reported worldwide (OMIM #244450). Main features of the disease include distinctive face 
and eye anomalies, microcephaly, severe psychomotor retardation, and growth arrest. 
Additionally, serum analyses unveil hypocholesterolemia, implicating defects in cholesterol 
metabolism. Neurological aberrances include hypoplasia of corpus callosum, and anterior 
commissure, Chiari type I malformation, smaller pituitary gland, and in some cases seizures. 
Notably, all KOS patients exhibit severe mental retardation [136-138].  
The presence of blepharophimosis and mental retardation makes the KOS diagnosis 
challenging for physicians, as both phenotypes have been reported for other syndromes, such 
as Dubowitz syndrome (OMIM #223370), Toriello-Carey syndrome (OMIM #217980), 
Marden-Walker syndrome (OMIM #248700), Ohdo syndrome (OMIM #249620), or Smith-
Lemli-Optiz syndrome (OMIM #270400).  
Recently the groups of Guntram Borck at University of Ulm and of Giuseppe Zampino at 
Universitá Cattolica del Sacro Cuore in Rome have revealed mutations in UBE3B, which 
inherited in autosomal recessive manner, are causative for KOS, a distinct intellectual 







1.6.3.2. UBE3B gene discovery 
 
UBE3B gene was discovered in 1996 by the group of Margaret Lomax at the University of 
Michigan Medical School [141]. Differential mRNA expression study, to reveal genes up-
regulated after acoustic trauma in the chick basal papilla, lead to identification of cDNA 
which exhibited 84% of identity of uncharacterized human cDNA. Interestingly, its 
expression dramatically increased in the regions of damaged chick inner ear upon noise-
induced trauma. In 2003, human and mouse UBE3B gene was cloned and characterized by 
its discoverers [142]. Degree of homology of HECT domains between UBE3B and UBE3C 
is higher than between other member of HECT type, implicating a distinct biochemical 
properties and ubiquitylation patterns catalyzed by both ligases. For this reason, UBE3B and 
UBE3C represent a separate family of HECT-type ligases.  
 
1.6.3.3.Mutations in UBE3B identified in KOS 
 
Pathological mutations in UBE3B in KOS patients appear to affect the enzymatic activity of 
the ligase. Majority of reported mutations result in frame shift, leading to loss of catalytic 
function of UBE3B Interestingly, substitution mutations have been reported as well. All 
reported point mutations affect amino acids of HECT domain, implicating conformational 
restrictions hampering UBE3B-mediated ubiquitylation. In fact, three dimensional modeling 
of UBE3B HECT domain illustrates that Q727P substitution, identified in one of KOS 
patients may affect substrate binding and positioning towards catalytic cysteine, essential 
for efficient ubiquitylation [136,138,139,143].  
Although UBE3B contribution to human disease has been reported by at least four 
independent research groups, its molecular function still remains uncharted. 
 
1.7.Posttranscriptional regulation of gene expression: biology of microRNAs 
 
Precise control over gene expression is critical for uncompromised neuronal development. 
Small non-coding RNAs, microRNAs (miRNAs) are key regulators of gene expression. 
miRNAs, expressed in the majority of Eucaryota, mediate sequence-specific 
posttranscriptional gene regulation. As discovered by Victor Ambros and Gary Ruvkun in 
December 1993, miRNA-mediated regulatory mechanism involves binding to 
complementary RNA sequences, usually located in the 3’ untranslated regions of messenger 
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RNAs (mRNA) [144,145]. Intriguingly, most coding genes seem to be regulated by miRNAs 
[146].  
 
1.7.1. miRNA gene transcription and initial processing of miRNA precursors 
 
Transcription of miRNA gene locus is majorly carried out by RNA-polymerase II and yields 
an approximately 1 kb long, primary miRNA transcript, pri-miRNA with local hairpin-loop 
structures. Microprocessor complex including RNase III, Drosha and its cofactor DiGeorge 
syndrome Critical Region gene 8 protein (DGCR8) cleaves pri-miRNA into 60-70 
nucleotide-long precursors (pre-miRNA) [147]. Drosha processing of pri-miRNA is critical 
for mature miRNA specificity, because it defines the terminal nucleotides of each miRNA 
strand. The resultant pre-miRNA contains a two nucleotide-long overhang on its 3’ terminus, 
essential for its further processing by Dicer [148-150]. Drosha determines miRNA 
abundance, therefore, mechanisms controlling Drosha expression, stability, or activity 
control the levels of miRNAs. Processing of pri-miRNAs is regulated by RNA-binding 
proteins, which affect recruitment of Drosha to the terminal loops of miRNA precursor, 
containing numerous cis-regulatory sequences [151,152].  
 
1.7.2. Nucleus-cytoplasm shuttle of pre-miRNAs 
 
Initial processing of the miRNA precursors is restricted to nucleus. Upon exportin-5-
mediated nuclear transport, pre-miRNAs are further processed in the cytoplasm by RNase 
III Dicer and its cofactor TAR RNA-binding protein 2 (TRBP2). Exportin-5 forms a 
complex with the pre-miRNA and Ran-GTP, a nuclear GTPase. Upon translocation through 
the nuclear pore, GTP is hydrolyzed, and pre-miRNAs are released to the cytosol [153]. 
Transport of non-canonical miRNAs, like pre-mir-320, which contains 5’ 7-methylguanylate 









1.7.3. Cytosolic pre-miRNA processing 
 
Dicer processing removes the terminal loop of the pre-miRNA to liberate a miRNA duplex 
composed of two complementary strands: -5p and -3p. Dicer binds to pre-miRNA with the 
two-nucleotide overhangs, generated previously by Drosha [150]. Dicer domains critical for 
its RNase III activity are positioned so, that the cleavage of pre-miRNA liberates the mature 
miRNA strands of a 21-25 nucleotides in length, depending on the Dicer isoform. Therefore, 
the distance between those domains functions as a ‘molecular ruler’ in miRNA processing 
[155]. 
 
1.7.4. Formation of RNA-induced silencing complex 
 
Generally, after Dicer processing, miRNA duplex associates with Argonaute (Ago) to form 
a RNA-induced silencing complex (RISC). RISC is able to regulate translation of a target 
mRNA in a sequence-specific manner [156,157]. Small miRNA duplexes are loaded into 
RISC in ATP-dependent manner [158], mediated by conformational changes of Dicer 
induced by heat shock cognate 70, HSC70, and heat shock protein 90, HSP90 chaperones 
[159]. Mismatches in the center of the duplex prevent the endonucleolytic activity of Ago 
proteins and are essential for duplex unwinding, which releases passenger strand and 
biologically active guide strand [160]. Release of passenger strand from miRNA duplex is 
ATP-independent [161].  
 
1.7.5. Strand selection and target mRNA recognition 
 
Determination of the guide and passenger strand relies on the thermodynamic stability of the 
two termini of miRNA duplex [162]. Strand with more unstable 5’ end is typically specified 
as the guide strand. Interestingly, arm switching, a process of alternative strand selection has 
been described for some miRNA duplexes[163]. 
Main determinants of miRNA-mRNA binding include perfect complementarity between 
mRNA and miRNA nucleotides 2 to 8, so called miRNA seed. Complementarity between 3’ 
terminus of a passenger strand and mRNA is critical for stabilization of miRNA-mRNA 
hybrid [164,165]. Although the canonical miRNA-mediated gene regulation leads to 
translational arrest, under certain cellular contexts, miRNAs are known to enhance gene 
expression [166].  
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1.7.6. Molecular mechanisms of mRNA silencing 
 
Generally, the consequences of miRNA-RISC-mRNA interaction affect the initiation and 
efficiency of transcription, but also alter the stability of mRNA. Perfect complementarity 
between miRNA and its binding site on a target mRNA induces its Ago2-mediated 
endonucleolytic cleavage and destabilization. Core protein components of RISC, Ago and 
trinucleotide repeat containing 6a, also known as GW182 are essential for miRNA-induced 
gene repression.  
Generally, miRNA-dependent translation regulation requires mismatches in the central 
region of miRNA-mRNA hybrid [165]. miRNA-RISC recruit decapping enzymes (e.g. 
decapping protein 1, DCP1), deadenylases (e.g. CCR-associated factor 1-carbon catabolite 
repression 4 protein-negative on TATA-less, CAF1-CCR4-NOT complex), or nucleases, all 
resulting in mRNA destabilization and decay [167]. Moreover, Argonaute molecules 
compete with cap-binding proteins and eukaryotic translation initiation factor 4E for binding 
of 5’ mRNA cap and hamper ribosome recruitment to the cap [168]. Association of Ago 
with mRNA cap prevents circularization of mRNA, essential for translation initiation [169]. 
Post-initiation mechanisms of miRNA-mediated gene regulation include RISC-induced 
premature mRNA-ribosome dissociation [170], or competition of Ago with elongation 




Fig. 4. Processing and posttranscriptional regulation of gene expression by miRNAs. 
(A) Processing of miRNA precursors. Upon RNA-polymerase II transcription, precursors of 
miRNA (pri-miRNA) are either excised by Drosha and its cofactor DiGeorge syndrome 
critical region gene 8 (DGCR8) in canonical processing pathway, or processed in pre-mRNA 
splicing (mirtrons) by debranching and trimming enzymes in non-canonical pathway. 
Resultant pre-miRNAs are exported to the cytoplasm by exportin-5, where they are further 
cleaved by Dicer, unwound by Argonaute (Ago) proteins and undergo TAR RNA-binding 
protein, TRBP-dependent loading onto RNA-induced silencing complex (RISC). RISC 
mediates the posttranscriptional gene silencing. Transport of RISC loading complex, RLC 
to different neuronal compartments, e.g. axons or dendrites, enables local regulation of 
translation. (B) Three mechanisms of miRNA-mediated gene regulation. (a) Repression of 
translation initiation. RISC prevents circularization of mRNA critical for translation 
initiation. Argonaute-2, Ago2; trinucleotide repeat containing 6a, GW182; poly-A binding 
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protein, PABP. (b) miRNA-mediated inhibition of elongation. RISC induced premature 
drop-off of ribosome from mRNA and binding of elongation factors critical for active 
translation. (c) Destabilization of target mRNA by miRNAs. RISC recruits decapping 
enzymes 1 and 2 (Dcp1 and DCP2), that hydrolyze 5’cap, and deadenylases that mediate 
destruction of polyA tail, and recruit exonucleases. (C) Schematic of Wwp2 gene locus. 
Intron 16 of Wwp2 harbors miR-140 gene. SRY-box containing gene 9, Sox9 transcription 
factor binding sites are located upstream of Wwp2 exon 1 and within intron 16, upstream of 
miR-140. Upon Sox9-mediated transcription, translation and posttranscriptional processing, 
Wwp2 locus simultaneously generates a ubiquitin ligase and miR-140 [172].  
(A) After [173] with permissions of Nature Publishing Group (license number 




1.7.7. The role of Dicer in developing and mature neurons 
 
The crucial importance of miRNAs during neuronal development is illustrated by studies on 
Dicer KO mice. Dicer-mediated processing represents essential step of miRNA biogenesis. 
Conditional neuron- and glia-specific, Emx1-Cre driven knock-out (cKO) of Dicer results in 
defects of gross morphology on the brain including ventricular dilatation and reduction in 
cortical thickness from E13.5 onwards [175]. 
In postmitotic neurons, Dicer ablation leads to abnormal neuronal migration resulting in 
reduction of upper cortical layers thickness and lack of deep cortical layers. Conditional 
deletion of Dicer impedes radial migration and disrupts polarity formation in newborn 
neurons. Dicer KO results in emergence of multipolar cells throughout cortical plate, while 
migrating control neurons mostly acquire bipolar morphology [176,177]. Additionally, 
Dicer-deficient pyramidal neurons of the hippocampus exhibit reduced dendrite complexity 
and increased dendritic spine length [178]. 
Pathological changes in morphology of Dicer-deficient neurons are paralleled by 
pathological behavioral outcomes. CaMKII-driven Dicer cKO mice display ataxia, motility-
induced tremors and early postnatal death [178]. Deletion of Dicer from the dopaminergic 
neurons of basal ganglia using dopamine receptor-1-Cre results in front and hind limb 
clasping in mice, indicative of motor impairments and neurological pathology [179].  
Collectively, genetic ablation of Dicer and resultant reduction of mature miRNA levels lead 
to dramatic morphological and physiological consequences, indicating that Dicer-mediated 




1.7.8. Biology of intragenic miRNAs 
 
Interestingly, about half of murine miRNA loci are located within introns of protein-coding 
genes, thereby linking miRNA gene transcription to host gene promoters [180]. However, 
35% of known intronic miRNAs have upstream regulatory elements, such as RNA-
polymerase start sites, compatible with promoter function. This indicates that transcription 
of intronic miRNA can either employ the promoter sequences of their host genes, or exploits 
its own intron-embedded promoters [181]. 
Intronic miRNAs (sometimes described as mirtrons) can be generated during pre-mRNA 
splicing and bypass Drosha processing [182]. Interestingly, it has been proposed, that 
intronic miRNAs function to fine-tune the activity of proteins encoded by their host genes 
[183]. Interestingly, 20% of intronic miRNAs are predicted to regulate the expression of 
their host [184]. 
 
1.7.9. Interplay of Wwp2 ubiquitin ligase and intragenic miR-140 in control of 
gene expression  
 
Intron 16 of Wwp2, a murine gene encoding for WW domain containing E3 ubiquitin protein 
ligase 2 harbors a locus of miR-140 (Fig. 4C). Wwp2 is a HECT-type ubiquitin ligase of 
Nedd4 family with well characterized roles in cancer and embryonic stem cells [185-189]. 
Notably, intronic miR-140 has been reported as a tumor suppressor [190-195]. Acting 
antagonistically to the host Wwp2, miR-140 represses SMA and mothers against 
decapentaplegic 2, Smad2, limiting invasive potential of colorectal cancer [196].  
The biology of miR-140 has been extensively studied in cartilage. Genetic deletion of miR-
140 in mice leads to dramatic proteoglycan loss, fibrillation of articular cartilage and 
osteoarthritis-like changes [197].  
Induction of expression of C-terminal isoform of Wwp2 and miR-140 is critical for 
maintenance of proliferative activity of chondroprogenitor cells [172]. This implicates 
synergistic activities of Wwp2 and miR-140 in cartilage biology. Moreover, promoters of 
genes encoding both molecules are major targets of SRY-box containing protein-9, Sox9 in 
cartilage [198] (Fig. 4C). Although the role of Wwp ubiquitin ligases in mature neurons 
remain unexplored, during neuronal development Wwp2 and its close homolog Wwp1 
regulate axon acquisition in primary hippocampal neurons, polarity formation of cortical 
pyramidal neurons and distribution of layer II/III pyramidal nerve cells [199]. Expression of 
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miR-140 in the brain has been reported [200], however, its function in neurons has never 




In this study, we characterized miR-140 and Wwp2 duo in developing neurons. We 
corroborate that Wwp1 and Wwp2 are indispensable for axon acquisition in developing 
hippocampal neurons and neuronal polarity of cortical neurons, and that knock-down of 
Wwp1 and Wwp2 in cortical progenitors results in aberrant distribution of pyramidal 
neurons. Moreover, we present that miR-140 exerts synergistic effects towards Wwp1 and 
Wwp2 activities during neuronal development. Genetic deletion of miR-140 results in 
disturbances of axon acquisition and dramatic defects in polarity formation in cortical 
neurons. Moreover, we demonstrate that acute knock-down of miR-140-3p in neurons 
phenocopies knock-down of Wwp1 and Wwp2 concerning neuronal development. Finally, 
for the first time, we identify Sox9 as a transcription factor essential for neuronal polarity 
and neuronal distribution of postmitotic pyramidal neurons, implicating Sox9-Wwp1/2-
miR-140 axis in control of neuronal development. 
We characterize the roles of other HECT-type ubiquitin ligases in developing and mature 
neurons. We demonstrate, that genetic deletion of Nedd4-2, and Wwp1 and Wwp2 
conditionally in neurons leads to alterations of dendritic spine morphology and/or number, 
which implies that enzymes of Nedd4 family are critical for uncompromised function of 
mature neurons. 
For the first time, we characterize murine Ube3b in neurons. We generated a conventional 
and neuron- and glia-specific Ube3b KO mouse lines, both recapitulating symptoms 
described for KOS patients. We demonstrate that Ube3b is essential for developing and 
mature neurons. Primary hippocampal neurons deleterious for Ube3b exhibit reduced 
dendritic branching, which is reversible by overexpression of human UBE3B, but not by 
UBE3B with point substitution mutations identified in KOS patients. Moreover, Ube3b loss 
from pyramidal hippocampal neurons leads to increased density of dendritic spines, which 
exhibit defectful morphology. Consistently, we show that conditional Ube3b deletion from 
neurons leads to increased mEPSC frequency and alters NMDAR to AMPAR ratio, 
indicative of increased synapse number and composition of glutamate receptors specified by 
neurons deleterious for Ube3b. In line with our cell biological and electrophysiological 
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findings, we demonstrate that neuron- and glia-specific Ube3b cKO animals display 
impairment in spatial learning and aberrant social interactions. 
Altogether, this study corroborates essential role of HECT-type ligases in neurons and 








Colonies of wild type mice has been maintained in the animal facility of Max Planck Institute 
of Experimental Medicine (MPIem) and all used in this study unless stated otherwise were 
of C57BL/6N strain. Wwp1f/f; Wwp2f/f and Nedd4-2f/f mouse lines were generated by Dr. 
Hiroshi Kawabe and Prof. Nils Brose. Prof. Tatsuya Kobayashi kindly provided the miR-
140-/- line [201], NEX1-Cre mouse line was from Dr. Sandra Goebbels and Prof. Klaus-
Armin Nave [202], and Emx1-Cre was kindly shared by Dr. Yuqing Li [203]. Sox9f/f mice 
were originally generated by Prof. Haruhiko Akiyama’s group, and PFA-fixed brains of 
Sox9f/f after in utero electroporation were provided by Dr. Mikio Hoshino. Ube3b mutant 
ES cells were purchased from The European Conditional Mouse Mutagenesis Program 
(EUCOMM), and Ube3b-/-, and Ube3bf/f; Emx1-Cre lines were established during this study. 
All animal experiments have been performed in compliance with welfare guidelines issued 
by the state of Lower Saxony. Corresponding permits for animal experiments have been 
granted (33.9-42502-04-13/1359, and 33.19-42502-04-13/1052). 
 
2.2.Bacterial and yeast strains  
 
Table 1. Bacteria and yeast used during this study. 
E. coli XL-1 Blue competent cells Stratagene 
E. coli Electro10-Blue competent cells Stratagene 
E. coli JM109 competent cells Promega 
E. coli TOP10 competent cells Invitrogen 











Table 2. cDNA libraries used in this study. 
Mouse brain prey library (in pGAD-GL) Provided by Dr. Hiroshi Kawabe 
Rat brain prey library (in pVP16-3) Provided by Prof. Nils Brose 
P0 mouse cortex library Generated in this study 
 
Table 3. Vector plasmids used in this study. 
ENV Provided by Prof. Pavel Osten 
L21 Provided by Prof. Pavel Osten 
PACK Provided by Prof. Pavel Osten 
pcDNA-3.2-GW/EmGFP Invitrogen 
pcDNA-3.2-GW/EmGFP-miR-140 Generated in this study 
pcDNA-3.2-GW/EmGFP-miR-140 Generated in this study 
pcDNA-3.2-GW/EmGFP-Scramble Invitrogen 
pcDNA3-HA-hUbe3b 
Provided by Rüstem Yilmaz and Prof. Guntram 
Borck 
pcDNA3-HA-hUbe3b G779R 
Provided by Rüstem Yilmaz and Prof. Guntram 
Borck 
pcDNA3-HA-hUbe3b R997P 
Provided by Rüstem Yilmaz and Prof. Guntram 
Borck 
pCIG Provided by Dr. Evangelos Pavlakis 
pCIG-2XmiR-140 Generated in this study 
pCR2.1-HECT-Nedd4-2 Generated in this study 
pCR2.1-HECT-Ube3b Generated in this study 
pCR2.1-IQ-Ube3b Generated in this study 
pCR2.1-IQ-Ube3b Generated in this study 
pCR2.1-SB-3’Ube3b Generated in this study 
pCR2.1-TOPO Invitrogen 
pCR2.1-Ube3b (WT, full length) Generated in this study 
pCR2.1-Ube3b C1038S Generated in this study 
pCR2.1-Wwp2/miR-140 Generated in this study 
pCX::myrVenus Provided by Dr. Anna-Katerina Hadjantonakis 
pFUGW Provided by Dr. Inder Verma 
pFUGWiCre Provided by Dr. Richard Huganir 
pGAD424-HA Clontech 
pGBD-C2 Provided by Dr. Philip James 
pGBD-IQ-Ube3b Provided by Dr. Hiroshi Kawabe 
pLKO.1-Scramble Thermo Scientific 
pLKO.1-sh-mSox9-2  Addgene, gift of Bob Weinberg, [204] 
pLKO.1-sh-mWwp1 Thermo Scientific 
pLKO.1-sh-mWwp2 Thermo Scientific 
pLKO.1-Venus-Scramble Provided by Dr. Hiroshi Kawabe 
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pLKO.1-Venus-sh-mSOX9 Generated in this study 
pLKO.1-Venus-sh-mWwp1 Provided by Dr. Hiroshi Kawabe 
pLKO.1-Venus-sh-mWwp2 Provided by Dr. Hiroshi Kawabe 
pCAG Provided by Dr. Jun-ichi Miyazaki 
pCAG-CTR-Sponge Generated in this study 
pCAG-miR-140-3p-Sponge Generated in this study 
pCAG-miR-140-5p-Sponge Generated in this study 
pCAG-myc-1 Provided by Dr. Hiroshi Kawabe 
pCAG-myc-IQ-Ube3b Generated in this study 
pCAG-myc-Ube3b Generated in this study 
pCAG-myc-Ube3b C1038S Generated in this study 
pVP-16-3 Provided by Prof. Nils Brose 





Oligonucleotides used in this study are listed below. All of them were synthetized in MPIem 
DNA Core Facility. Reaction sites employed for molecular cloning are underlined. 
 
Table 4. Oligonucleotides used in this study (Nb, number; RS, restriction site). 
Nb Sequence (5'-3') RS 
89 5’-TGTAAAACGACGGCCAGT -3’  - 
91 5’-AACAGCTATGACCATGATTACG -3’  - 
2409 5'-CCGCATAACCAGTGAAACAG -3'  - 
8546 5'-GCCTGCATTACCGGTCGATG -3'  - 
10908 5'-AGAGGCAAGAGAATGGCGTCAAG -3'  - 
10909 5'-CAGAAACAGTGATCTACAAGTCTAAATG -3'  - 
12804 5'-CTCCCCACTGCAGTTCCTACC -3'  - 
12806 5'-AGCTGCTCAGGCTGAATCACC -3'  - 
12809 5'-CCATCATGAACTTCAGCCTC -3'  - 
12812 5'-GATGGTTGTGAGCCACTTACTTC -3'  - 
14539 5'-CAATGAATACGGCTACAGCAAC -3'  - 
14540 5'-TTACTCCTTGGAGGCCATGT -3'  - 
18637 5'-GTTTCTGGTCCTCACATTGTCTA -3'  - 
18638 5'-ATTTCCGGTTATTCAACTTGCAC -3'  - 
19902 5'-GCCTGAGGGCAGTAAGGAC -3'  - 
19903 5'-GGAGTAGGGCGGCTCTGT -3'  - 
25252 5'-ATGCCCAGAAGGTACCCCAT -3'  - 












25939 5'-CAGAGCACTGTGTTACCTTCACCC -3'  - 
25940 5'-CCTAACCCAGATTTGGATCCATTTAT -3'  - 
26082 5'-GACTGGAGCTCCAGAGCACTGTGTTACCTTCACCC -3' SacI 










26327 5'-CTCCTCGAGTTATTAGGAGAGCTCAAAGCCCGTGTT -3' XhoI 











27678 5'-TTAGTGTGGCTTTTCAGCCTTAA -3'  - 
27679 5'-TGGAGCCGTTAGGTCATTTCA -3'  - 
27879 5'-GGGGGCGTGGCCAGAGAAT -3'  - 
27880 5'-CACGTCGACATCACCAAGGCC -3'  - 
27883 5'-CGGATGTTGGAGGACGGCTA -3'  - 
27884 5'-CTTGATGATGGAACGGAAGCC -3'  - 
28441 5'-CCACAACGGGTTCTTCTGTTAG -3'  - 
28741 5'-GTGAGAGGCACAAGTTGGC -3'  - 
28742 5'-CTCTGTGTAGGATCTTCAATC -3'  - 
28745 5'-CTTGGTGGGCATCTGGTGTGGCTC -3'  - 
28746 5'-GAGCTAAACAATTGGGGAACAATC -3'  - 
29127 5'-GTATCTTATCATGTCTGGATCCGGGGG -3'  - 
29156 5'-ATGCTGGCAGACTTTGCACTCTTTACTCTC -3'  - 
29244 5'-TCGGGTGTTTACTTGGATAACTCT -3'  - 
29245 5'-TGTGCTTTGGTTCCTTATCTGTC -3'  - 
31998 5'-CTGGGAAGTGTGCCTAATGG -3'  - 
31999 5'-GCAGTCCCACTGGATTCTCT -3'  - 
32140 5'-GTTGCTGCCAGACCCAAA -3'  - 
32141 5'-TAGGACAGATGATGATTCTCCATTA -3'  - 
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32142 5'-GTACCCGCATCTGCACAAC -3'  - 




Table 5. Primary antibodies used for Western blotting and immuoblotting used in this study 
(order on the list according to emergence of figures) 
Recognized protein 
(clone number) 
Host species Developer 
Usage and dilution 
WB ICC IHC 
SMI312 Mouse Millipore - 1:2000 - 
MAP2 Chicken Novus - 1:1000 - 
GFP Rabbit MBL - - 1:2000 
Wwp1 (0221) Rabbit SySy 1:500 - - 
Wwp2 (7425A) Rabbit SySy 1:500 - - 
α-actin (AC40) Mouse Sigma 1:2000 - - 
Cux1 (M-222) Rabbit SCBT - - 1:500 
PSD-95 Mouse NeuroMab 1:1000 - - 
RabGDI Rabbit SySy 1:1000 - - 
NFM 150 Rabbit Chemicon 1:1000 - - 
Fyn (15) Mouse SCBT 1:500 - - 
Sox9 (5535) Rabbit Millipore 1:2000 1:500 1:500 
Ctip2 (25B6) Rat Abcam - - 1:500 
Cre Rabbit SySy - - 1:1000 
Ube3b (339003) Rabbit SySy 1:1000 - - 
Myc (9E19) Mouse Sigma - 1:500 - 
HA Mouse Covance - 1:1000 - 
NeuN Mouse Millipore - - 1:400 
GFAP Mouse SySy - - 1:1000 
Iba1 Rabbit SySy - - 1:2000 
MAC3 Rat Abcam - - 1:1000 



















Mouse Goat HRP Bio-Rad 1:10000 
Rabbit Goat HRP Bio-Rad 1:10000 
Mouse Goat IR-Dye-680/800 Rockland 1:8000 
Rabbit Goat IR-Dye-680/800 Rockland 1:8000 
Chicken Donkey AlexaFluor-633 Invitrogen 1:1000 










2.6. Molecular biology methods 
 
2.6.1. Electroporation of plasmid DNA into competent bacteria 
 
An aliquot of electro-competent bacteria of a given E. coli strain was thawn on ice, 
transferred to pre-cooled electroporation cuvette (0.1 cm, Bio-Rad) and 10 ng of DNA or 
0.8 μL of ligation reaction was added, mixed, and incubated for 1 minute prior to 
electroporation. Next, an electric pulse of 1.8 kV was administered (Electro-Pulser, Bio-
Rad) and electroporated cells retrieved from the cuvette with 250 μL of pre-warmed (37°C) 
SOC medium and incubated with moderate shaking for 1 hour at 37°C allowing for the 
expression of resistance genes. Bacterial cells were then plated on appropriate selection agar 
plates. 
LB medium: 25 g Luria Broth (LB, Invitrogen) dissolved in 1 L ddH2O and autoclaved. 
SOC medium (reagents in final concentration): 2% (w/v) tryptone (DIFCO), 0.5% (w/v) 
yeast extract (DIFCO), 10 mM NaCl, 2.5 mM KCl, 20 mM MgCl2 in ddH2O, autoclaved. 
Before usage add glucose (filtered, 0.22 μm, Corning) to 20 mM. 
LB agar: 15 g Bacto-agar (DIFCO) dissolved in 1 L of LB medium, autoclaved. For selection 
of transformed E. coli, ampicillin or kanamycin was added after autoclaving at the 




2.6.2. Plasmid DNA purification 
 
Purification of plasmid DNA from bacteria was carried out following manufacturer’s 
protocols using PureLink Quick Plasmid kits, Mini-, Midi- or Maxi-Prep (Invitrogen) or 
Endo-free Plasmid Maxi Kit (Qiagen). Air-dried plasmid DNA was resuspended in TE 
buffer or endotoxin free TE buffer. 
TE buffer: 10 mM Tris-HCl pH 7.4 (Sigma-Aldrich), 1 mM EDTA (Sigma-Aldrich). 
 
2.6.3. Determination of DNA concentration 
 
Absorption measurement at 260 and 280 nm wavelength by a UltraSpec 3100pro 
(Amersham) was used to determine the concentration of DNA in aqueous solutions with the 
formula dsDNA concentration=OD260 X 50 μg/mL X dilution factor. Solutions with 
OD260/OD280 ratio within the range 1.8-2.0 were treated as pure preparations, relatively free 
from protein and RNA contaminants.  
 
2.6.4. DNA Sequencing 
 
Sequence analysis of DNA was performed by DNA Core Facility of MPIem using Applied 
Biosystems 373 DNA Sequencer. 
 
2.6.5. DNA digestion with endonucleases 
 
Digestion of DNA prior to further subcloning steps was carried out with a specific restriction 
endonuclease and appropriate buffer following the New England Biolabs (NEB) manual. 
For molecular cloning, the digestion reaction was performed using 20 U of restriction 
endonuclease per μg plasmid DNA for 3 hours at a temperature required for a given enzyme.  
 
2.6.6. DNA ligation 
 
For ligation reactions, digested destination plasmid and digested DNA insert with 
compatible ends were mixed at 1:5, 3:3, and 5:1 ratios, each reaction then supplemented with 
T4 DNA ligase (NEB), its buffer, and molecular biology (MB) grade water (MB-H2O) to 
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the final volume of 20 μL. The ligation reaction was carried out in ice bucket/water, which 
allowed for little temperature increments from 4°C to room temperature for 16-20 hours. 
 
2.6.7. DNA precipitation method 
 
20 μL DNA solution was supplemented with 2 μL of 3 M potassium acetate (Sigma-
Aldrich), and 44 μL of ice-cold ethanol, and incubated at -80°C for 30 minutes. After 
centrifugation at 16 krpm for 30 minutes, DNA pellet was washed with 70% ethanol, air 
dried, and resuspended in 5 μL of TE buffer. 
 
2.6.8. Isolation of plasmid DNA with phenol/chloroform 
 
Pellets of E. coli transformed with appropriate plasmids and grown for 16-20 hours at 37°C 
were resuspended in 300 μL buffer P1, and 300 μL of buffer P2 was added to the bacterial 
slurry. Tube was inverted five times and incubated at room temperature for 5 minutes, upon 
which 300 μL of buffer P3 at 4°C was added. Mixture was incubated on ice for 5 minutes, 
centrifuged at 4°C and 14 krpm for 10 minutes, and supernatant was transferred to 500 μL 
of PCA. Mixture was then centrifuged at 14 krpm for 5 minutes, and 800 μL of the aqueous 
phase was transferred to 560 μL of isopropanol (Merck), mixed by inversion, and spun at 14 
krpm for 15 minutes at 4°C. DNA pellet was subsequently washed with 70% ethanol, air 
dried, and resuspended in 20 μL of TE buffer. 
 
Buffer P1: 8% (w/v) sucrose (Merck), 5% (v/v) Triton X-100 (Roche), 50 mM Tris-HCl, pH 
8.0, 10 mM EDTA, 100 μg/ μL RNaseA (Invitrogen). 
Buffer P2: 200 mM NaOH (Merck), 1% (w/v) SDS (Gerbu). 
Buffer P3: 3.0 M potassium acetate, pH 5.5. 









2.6.9. Isolation of genomic DNA from mouse tail biopsies 
 
Genomic DNA for the purpose of genotyping was isolated with Genomic DNA Isolation Kit 
for Tissue and Cells (Nexttec) according to manufacturer’s protocol.  
 
2.6.10. Agarose gel electrophoresis 
 
Digested DNA, isolated RNA or PCR products, were subjected to electrophoresis in 1-2.5% 
agarose (UltraPure, Invitrogen) gel containing 0.1% GelRed (Biotium). Negatively charged 
DNA fragments were separated in TBE buffer at 100 V and then visualized by UV-light 
(Intas). The appropriate DNA size was estimated with Gene Ruler DNA Ladder Mix 
(Fermentas), included on the gel.  
TBE buffer: 50 mM Tris-HCl (Sigma-Aldrich), 50 mM boric acid (Sigma-Aldrich), 2 mM 
EDTA (Sigma-Aldrich), pH 8.0. 
DNA Loading Dye: 10 mM Tris-HCl pH 7.6, 0.03% (w/v) bromophenol blue (Sigma-
Aldrich), 0.03% (w/v) xylene cyanol FF (Sigma-Aldrich), 60% (v/v) glycerol (Merck), 60 
mM EDTA. 
 
2.6.11. Agarose gel extraction 
 
DNA of interest was excised with a surgical scalpel from the agarose gel and purified with 
PureLink Gel Extraction Kit (Invitrogen), following manufacturer’s protocol.  
 
2.6.12. Polymerase Chain Reaction (PCR) 
 
DNA amplification in vitro was performed in PCR [205]. The reaction included template 
double stranded DNA, dNTPs (GE Healthcare), oligonucleotide primers, DNA polymerase, 
and the supplied buffer. High-fidelity Pfu polymerase was used for cloning applications and 
Red-Taq DNA polymerase was applied for genotyping or diagnostic purposes. All reactions 
were carried out on Peltier Thermal Cycler PTC-225 (MJ Research, Bio-Rad) with the 
following conditions: 
 
Step 1: 94°C for 2 minutes, 
Step 2: 94°C for 30 seconds, 
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Step 3: annealing temperature for 30 seconds, 
Step 4: 72°C for extension time (500 bp per 1 kb of DNA) (30 cycles from Step 2 to 4) 
Step 5: 72°C for 10 minutes.  
 
Annealing temperature was always 5°C lower than the mean of estimated melting 
temperatures of primers in reaction.  
 
2.6.13. Long-Range PCR 
 
Amplification of long genomic DNA sequences (i.e. for validation of correct recombination 
of targeting vector to genomic DNA, Fig. 26E) was performed using Pfu-AD polymerase 
(kindly provide by Steffan Frey, MPIbpc) in Phusion-HF buffer (NEB) in the presence of 1 
M betaine (Sigma-Aldrich), and oligonucleotides 29127 and 29156 with the following 
parameters: 
Step 1: 99°C for 3 minutes, 
Step 2: 99°C for 30 seconds, 
Step 3: 60°C for 30 seconds, 
Step 4: 72°C for 90 seconds (30 cycles from Step 2 to 4) 
Step 5: 72°C for 2 minutes. 
 
2.6.14. 3’loxP diagnosis 
 
Multiplex PCR to detect 3’loxP site (Fig. 26F) was performed with standard parameters 
using oligonucleotide primers: 29244, 29245, 28441. 
 
2.6.15. Mutant mouse genotyping 
 
Genotyping for all mutant mouse lines was performed in DNA Core Facility (MPIem, 
Göttingen) by PCR using oligonucleotide primers listed below (wt, wild type allele; Cre, 
knock-in allele with Cre; ko, knockout allele; floxed, allele with loxP site). PCR for SRY 





Table 7. Genotyping summary of mouse lines used in this study. 
Mouse line Primers PCR product size 
Emx1-Cre 8546/25252/25253 
wt – 234 bp 
Cre – 321 bp 
NEX1-Cre 2409/18637/18638 
wt – 236 bp 
Cre – 356 bp 
miR-140 28745/28746 
wt – 233 
ko – 256 bp (After [201]) 
Wwp1f/f;Wwp2f/f 10908/10909/12812/12809 
Wwp1 wt – 182 bp 
Wwp1 floxed – 304 bp 
Wwp2 wt – 349 bp 
Wwp2 floxed – 368 bp 
Nedd4-2f/f 12804/12806 
wt – 224 bp 
floxed – 322 bp 
Ube3bf/f 29244/29245/28441 
wt – 197 bp 
floxed – 345 bp 
SRY 28742/28741 
male – 150 bp 
female – no band (After 
[206]) 
 
All genotyping PCR were performed with the following parameters: 
Step 1: 96°C for 3 minutes, 
Step 2: 94°C for 30 seconds, 
Step 3: 64°C for 1 minute, 
Step 4: 72°C for 1 minute (32 cycles from Step2 to 4), 
Step 5: 72°C for 7 minutes. 
 
2.6.16. TOPO-TA subcloning 
 
Subcloning of PCR products was performed with TOPO-TA cloning kits (Invitrogen) in 









2.6.17. Cloning strategies for constructs generated in this study 
 
pCR2.1-Wwp2/miR-140 
Intronic sequence of Wwp2 gene was amplified by PCR using primers 25939/25940, and 
subcloned to pCR2.1-TOPO. The constructed plasmid was used for further cloning (pCIG-
2XmiR-140), and for RNA-probe synthesis used in in situ hybridization.  
 
pcDNA-3.2-GW/EmGFP-miR-140 
To generate pre-miR-140, oligos 25831/25832 were mixed at the ratio 1:1, and incubated at 
95°C for 10 minutes. The thermoblock was then switched off, and the duplex was let anneal 
for 10 hours. Next, precursor sequence of miR-140 was cloned into pcDNA-3.2-
GW/EmGFP following manufacturer’s protocol (Invitrogen). 
 
pCAG-CTR-Sponge 
CTR sponge was synthetized as a tandem of 16 DNA repeats: 5’-
AAGTTTTCAGTTTGCTAACA-3’ by Life Technologies. The 5’ site was additionally 
equipped with restriction sites for XhoI, BglII, and BspEI restriction nuclease, and 3’ was 
with EcoRI, SalI, and KpnI. In the downstream of the 5’ restriction sites, three stop codons 
were added. Synthesized double strand DNA was digested with XhoI, and SalI, and shuttled 
to pRaichu-205X, opened with the corresponding restriction enzymes. pRaichu-205X was 
constructed by Dr. Michiyuki Matsuda’s group from pCAGGS vector originally developed 
by Dr. Jun-ichi Miyazaki, Osaka University Medical School. 
 
pCAG-miR-140-3p-Sponge 
miR-140-3p sponge was synthetized as a tandem of 16 DNA repeats: 5’ 
AACTGGTTCCGAACTGTGGTA-3’, and shuttled to pCAG-205X with the same 
combination of restriction enzymes as for construction of CTR sponge. 
 
pCAG-miR-140-5p-Sponge 
miR-140-5p sponge was synthetized as a tandem of 16 DNA repeats: 5’-
CTAGCATAGGAGCCAACCACTG-3’, and shuttled to pCAG-205X with the same 





Precursor sequence of miR-140 (pri-miR-140) in pCR2.1-Wwp2/miR-140 were amplified 
by PCR with primer pairs of 26082/26084, and 26083/26084. PCR products were subcloned 
into pCR2.1-TOPO to verify the sequence. Next, both vectors were digested with a pair of 
restriction enzymes, XhoI/SacI or SacI/EcoRI, to clone a tandem repeat of pri-miR-140 to 
pCIG plasmid opened with XhoI/EcoRI. 
 
pLKO.1-Venus-sh-mSOX9 
For usage in cell culture experiments and in utero electroporation, pCX::myrVenus was 
digested with BamHI/KpnI, and the Venus expression cassette was cloned into pLKO-sh-
mSox9-2 opened with the same restriction enzymes.  
 
pCR2.1-HECT-Nedd4-2 
DNA sequence encoding for Nedd4-2 HECT domain was amplified by PCR using 
27879/27880 primers and P0 cortex cDNA library generated by reverse transcription of total 
RNA isolated from wild type P0 cortex, subcloned into pCR2.1-TOPO, and used for RNA 
probe synthesis.  
 
pCR2.1-SB-3’Ube3b 
To generate Southern blot probe for validation of the correct recombination of Ube3b 
targeting vector, primers 27678/27679 were used for PCR using DNA isolated from wild 
type ES cells as a template. Amplified DNA was subcloned into pCR2.1-TOPO. 
 
pCR2.1-HECT-Ube3b 
To generate a template for in situ hybridization probe, primers 27883/27884 were used in 
PCR to amplify cDNA encoding for Ube3b HECT domain using P0 cortex cDNA library as 
a template. Amplified DNA was subcloned into pCR2.1-TOPO 
 
pCR2.1-Ube3b (WT, full length) 
cDNA NM_054093.2 encoding full length Ube3b (1070 aa) was amplified with primers 
26326/26327, introducing 5’EcoRI and 3’XhoI restriction sites using pYX-Asc-Ube3b as a 





pCR2.1-Ube3b was digested with EcoRI and XhoI, and ligated with pCAG-myc-1 opened 
with the same restriction enzymes.  
 
pCR2.1-Ube3b C1038S 
Primers 26703/26704 were used for site-directed mutagenesis to generate pCR2.1-Ube3b 
C/S introducing point C1038S mutation into pCR2.1-Ube3b WT.  
 
pCAG-myc-Ube3b C1038S 
pCR2.1-Ube3b C1038S was digested with EcoRI and XhoI, and ligated to pCAG-myc-1 
opened with the same restriction enzymes.  
 
pCR2.1-IQ-Ube3b 
Primers 26326/26395 were used on pCR2.1-Ube3b wt template for PCR amplification of 
729 bp long DNA fragment encoding for 243 amino acid-long N-terminal fragment of 
Ube3b including the IQ motif. Amplified DNA was then subcloned into pCR2.1-TOPO, and 
that plasmid was used to generate pGBD-IQ-Ube3b for in Yeast Two-Hybrid screening. 
 
pCAG-myc-IQ-Ube3b 
pCR2.1-IQ-Ube3b was digested with EcoRI and XhoI, and ligated into pCAG-myc-1 
opened with the same restriction enzymes.  
 
2.6.18. Isolation of RNA 
 
All tools used for RNA work was thoroughly cleaned with 70% ethanol (Sigma) and rinsed 
with RNA-Zap (Thermo Fisher) before the beginning of the procedure. Brain tissue was 
isolated from mice and flash-frozen in liquid nitrogen until the purification procedure. The 
tissue was homogenized in appropriate volume of Trizol [207] (Thermo Fisher) - 1 mL for 
embryonic cortex, 2 mL per adult cortex - with Ultra Turrax homogenizer (IKA Labtechnik) 
for 1 minute, and incubated at room temperature for 5 minutes. For every 1 mL of 
homogenate, 200 μL of chloroform (Merck) was added, mixed well using vortex (Bender 
and Hobein), incubated at room temperature for 2-3 minutes, and centrifuged 15 minutes at 
13 krpm. The aqueous phase was transferred to new tubes (Eppendorf), mixed with one 
volume of 70% ethanol (Sigma-Aldrich), and the solution was applied onto RNeasy columns 
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(RNeasy Mini Kit, Qiagen). For purification of miRNA fraction, miRNeasy purification Kit 
(Qiagen) was used. Further steps were performed according to the manufacturer’s protocols. 
RNA was eluted from the silica membranes using 30 μL of MB-H2O.  
 
2.6.19. Quality validation of RNA preparation 
 
After purification of RNA, the quality was verified by agarose gel electrophoresis, and 
quality check and concentration estimation was performed using 2100 Bioanalyzer 
(Agilent).  
 
2.6.20. First-Strand cDNA synthesis 
 
Reverse transcription of purified RNA was carried out with SuperScript III First-Strand 
Synthesis System (Invitrogen) following manufacturer’s manual. For each reaction, 3μg of 
total RNA was used in the final volume of 20 μL. After terminating of the reaction by 
incubation at 85°C for 5 minutes, the mixture was cooled on ice for 5 minutes, and 1 μL of 
RNaseH (Invitrogen) was added. Reaction was held for 20 minutes at 37°C. Thereafter, 21 
μL reaction was supplemented with 63 μL of MB-H2O, and stored at -20°C until further 
processing.  
 
2.6.21. Real Time PCR (RT-PCR) for mRNA detection and quantification 
 
The RT-PCR was performed in 384 well plates (Roche). For each analyzed gene, master mix 
including 5 μL of SYBR Green (Invitrogen), 0.1 μL of each RT-primer, and 1 μL MB-H2O 
per reaction was prepared. Next, 4 μL of cDNA solution was pipetted to each well followed 
by 6 μL of master mix. Pipetting was performed on ice, and the plate covered from light. 









Table 8. The parameters of Real Time PCR in this study. 
Temperature Duration Ramp Rate (°C/s) Number of cycles 
Pre-incubation 
50°C 2 min 4.8 
1 
95°C 10 min 4.8 
Amplification (Quantification) 
95°C 15 s 4.8 
45 
60°C 1 min 2.5 
Melting Curve 
95°C 10 sec 4.8 
1 (acquisition per 5 °C) 65°C 1 min 2.5 
95°C Continuous 0.11 
Cooling 
40°C 10 sec 2 1 
 
Before each gene analysis by RT-PCR, a standard curve using different concentration of 
cDNA was plotted, and the input amount of cDNA was calculated, enabling the 
quantification of mRNA levels in the linear range of the input template. Level of transcripts 
of each analyzed gene: Wwp1 (detected with qRT-PCR primers 32140/32141), Wwp2 
(31998/31999), and Sox9 (32142/32143) was then normalized to the average level of mRNA 
of housekeeping genes: Gapdh (14539/14540), and Oaz1 (19902/19903). Primers for the 
reaction were designed with Roche Assay Design Center.  
 
2.6.22. Detection of miRNA by qRT-PCR 
 
For detection of miRNAs, cDNA was synthetized with miScript II RT system (Qiagen) using 
3 μg of total RNA. Quantitative Real Time PCR (qRT-PCR) was carried out with miScript 
(Qiagen) primers for miR-140-3p, miR-140-5p, and RNU6B (miRScript Primer Assay) 
using miScript SYBR Green PCR Kit (Qiagen). Each step of miRNA detection (including 
duration and temperatures of RT-PCR) was performed in collaboration with Dr. Xin Zhang 
(GZMB, Molecular Oncology, Göttingen) according to manufacturer’s protocol. Level of 






2.6.23. Isolation of the genomic DNA from Embryonic Stem Cells (ES Cells) 
 
The ES cells were grown in 6-well plates (Greiner) until confluency, carefully washed with 
PBS, and incubated with 1 mL of lysis buffer for 16-20 hours at 37°C. Next, cell lysate was 
collected to 2 mL reaction tubes (Eppendorf), and supplemented with 700 μL isopropanol 
(Merck). The mixture was inverted several times, and centrifuged for 15 minutes at 4°C at 
13 krpm. Resulting DNA pellets were subsequently washed with 70% ethanol (Sigma-
Aldrich), air dried, and resuspended in 100 μL of TE Buffer. DNA solutions were kept at 
4°C until further processing.  
 
PBS buffer: 8g NaCl, 0.2g KCl, 1.44g Na2HPO4, 0.24g KH2PO4 (all reagents from Merck) 
in 1L ddH2O, pH 7.4. 
Lysis Buffer: 100 mM Tris, pH 7.5, 5 mM EDTA, 0.5% (w/v) SDS (Gerbu), 200 mM NaCl, 
100 μg/mL Proteinase K (Roche). 
 
2.6.24. Southern blotting 
 
The method was modified after previously published work [208]. Restriction digest of 10 μg 
of genomic DNA isolated from ES cells was held using 10U of SapI restriction enzyme 
(NEB) in 37°C for 16 hours. Next, digested genomic DNA was resolved in 0.7% agarose 
gel in 500 mL TAE buffer supplied with 40 μL of 1% ethidium bromide (Carl Roth) at 30V 
for 16-20 hours. After gel documentation in UV (Intas), agarose gel was incubated in 0.25 
M HCl (Merck) for 10 minutes, and subsequently in 0.4 M NaOH (Merck) for 10 minutes. 
Upward capillary transfer of DNA onto a nylon membrane (Hybond N+, GE Healthcare) 
was performed in 0.4 M NaOH for 16-20 hours. Next, the membrane was incubated in 
2XSSC until neutralized, and air dried on chromatography paper (Whatman). DNA was 
further UV-crosslinked with energy density of 1.00J/cm2 (FluoLink, Biometra), and the 
membranes were pre-hybridized in Rapid Hyb-Buffer (GE Healthcare, Amersham) 1 hour 
at 65°C. Radioactive probes were synthetized with Prime-It II Random Primer Labeling Kit 
(Agilent) using 25 ng of EcoRI-digested pCR2.1-SB-3’Ube3b and α-32P-labeled dCTP 
(Perkin-Elmer) following manufacturer’s protocol. After termination of probe synthesis, the 
sample was diluted with MB-H2O to final volume of 100 μL, passed through 
chromatography columns to remove unincorporated dCTP with Bio-Spin size exclusion 
column (Bio-Rad). 25 μL of the eluate was diluted with 5 mL of pre-warmed (65°C) 
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hybridization buffer, and incubated with DNA crosslinked on the nylon membrane. 
Hybridization was held at 65°C for 2 hours, followed by extensive washing with 2XSSC 
buffer with 0.1% SDS (sodium dodecyl sulfate, Gerbu) for 15 minutes in room temperature, 
and subsequently with 1XSSC buffer with 0.1% SDS for 7 minutes at 65°C. Radioactivity 
of the membrane was then monitored with Geiger-Müller counter, and the washing was 
continued until the scintillator reported approximately 100 counts. Membrane was then 
exposed to photographic film (Kodak) for 16-20 hours at -80°C, and developed. 
 
TAE buffer: 40 mM Tris-base (Sigma-Aldrich), 20 mM acetic acid (Sigma-Aldrich), 1mM 
EDTA (Sigma-Aldrich). 
1XSSC buffer: 150 mM NaCl (Merck), 15 mM sodium citrate (Merck), pH 7.0. 
 
2.6.25. Yeast Two-Hybrid (Y2H) screening 
 
Screening of Ube3b binding partners using PJ69-4A yeast strain was performed with pGBD-
IQ-Ube3b bait vector and two cDNA libraries: mouse embryo (in pGAD-GL plasmid) and 
rat brain (pVP16-3) according to modified previously published protocol [209].  
 
2.6.25.1. Media, buffers and stock solutions for Y2H 
 
Yeast complete and selective media were prepared using ddH2O, and autoclaved. For 
preparation of culture plates, 2% agar (w/v) was added to media before autoclaving. All 
recipes are per 1 L, unless specified otherwise. 
 
YPAD 
10 g yeast extract, 20 g bacto-peptone, 0.4 g adenine, 20 g glucose. 
 
SC-W 
6.7 g yeast nitrogen base without amino acids, 20 g glucose, 5 g casamino acids, 0.2 g 
adenine, 0.2 g uracil. 
 
SC-WL 




6.7 g yeast nitrogen base without amino acids, 20 g glucose, 50 mL 20X-WLH mix. 
 
SC-WLH plus 3AT 
100 mL of SC-WLH before autoclaving was supplied with 1 mL of 1 M 3-amino-1,2,4-
triazol (3AT), earlier passed through 0.22 μm filter. 
 
SC-WLA 
6.7 g yeast nitrogen base without amino acids, 20 g glucose, 50 mL 20X-WLA mix. 
 
20X Complete Amino Acid Mix 
0.4 g adenine, uracil, L-tryptophan, histidine HCl, L-arginine, L-methionine, 0.6 g L-
tyrosine, L-isoleucine, lysine HCl, 1.2 g phenylalanine, 0.6 g leucine. 
 
20X-WL 
As above, but without L-tryptophan, and L-leucine. 
 
20X-WLH 
As above, but without L-tryptophan, L-leucine, and L-histidine HCl.  
 
20X-WLA 
As above, but without L-tryptophan, L-leucine, and adenine. 
 
20X-LA 
As above, but without L-leucine, and adenine. 
 
Buffers: 
LiAc: 10.2 g lithium acetate (Sigma-Aldrich) in 100 mL ddH2O, pH 7.5 with diluted acetic 
acid (Merck).  
 
Yeast lysis buffer: 1% (w/v) SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 
2% (v/v) Trtion X-100.  
 
10XTE: 100 mM Tris-HCl, pH 7.4, 10 mM EDTA. 
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2.6.25.2.  Transformation of DNA into yeast 
 
PJ69-4A yeast was transformed with the bait vector (pGBD-IQ-Ube3b) with heat shock. 5 
mL of YPAD medium was inoculated with a single yeast colony, and incubated for 16-20 
hours at 30°C. Next, 200 μL of the preculture was transferred to 10 mL of fresh YPAD, and 
incubated for 3 hours at 30°C. Yeast were harvested by centrifugation at 3 krpm for 5 
minutes at room temperature, resuspended in 1 mL of 1XTE/LiAc, pelleted again, and 
resuspended in 0.5 mL of 1XTE/LiAc. 100 μL of cell slurry was supplied with 1 μg of 
plasmid DNA, 5 μL of salmon testis DNA (10 mg/mL, Roche), 600 μL of 
40%PEG/100mMLiAc/TE (PEG 3350, Sigma-Aldrich), and incubated for 30 minutes at 
30°C with moderate shaking. Next, to each reaction tube, 70 μL DMSO (Roche) was added, 
the cells were incubated at 42°C for 15 minutes, transferred on ice for 1 minute, harvested 
by centrifugation at 7 krpm for 1 minute, and resuspended in 1 mL of YPAD to recover for 
1 hour at 30°C. Then, yeast cells were washed with ddH2O cultured for 16-20 hours in 
appropriate medium, and streaked on selection plate. An aliquot of yeast was streaked on 
YPAD plate to determine the transformation efficiency. 
 
2.6.25.3. Bait construct autoactivity check  
 
For autoactivity check of the bait construct, yeast cells were transformed as described with 
the following DNA: pGBD-IQ-Ube3b alone, pGBD-IQ-Ube3b, and pVP-16-3, and pGBD-
IQ-Ube3b, and pGAD424-HA, and streaked on SC-WL, SC-WLH+3AT, and SC-WLA 




Upon validation of no autoactivity of the bait vector, yeast cells were transformed with 1 μg 
of mouse embryo or rat brain cDNA library. After overnight culturing in SC-WL medium, 
yeast cells were streaked onto SC-WLH+3AT (10mM) plates, and incubated for 3 nights at 
30°C. Colonies were subsequently transferred onto SC-WLA plate. Yeast colonies formed 





2.6.25.5. Isolation of yeast DNA 
 
The positive yeast clones were resuspended in 200 μL of ddH2O, and supplied with 0.3 g of 
glass beads, spun down at 3 krpm for 5 minutes, and suspended in 200 μL of yeast lysis 
buffer. Next, the tube was supplied with 200 μL of phenol/chloroform mixture, closed, and 
shaken for 20 minutes at room temperature. Extracted yeast DNA was further collected as 
an aqueous phase upon centrifugation at 15 krpm for 5 minutes in room temperature, and 
concentrated by ethanol precipitation method. 
 
2.6.25.6. Identification of binding partners 
 
Yeast DNA was further transformed to E. coli Electro10 or XL1-Blue strain, and seeded on 
appropriate selection plates. Single colonies were then incubated with 5 mL of LB medium 
with selection antibiotics for 16-20 hours at 37°C, and plasmid DNA was then isolated with 
phenol/chloroform DNA isolation method, and sequenced. Binding partners were identified 
with Basic Local Alignment Search Tool software (BLAST). 
 
2.6.26. In situ hybridization (ISH) 
 
For DNA-RNA in situ hybridization [210], digoxigenin-labeled RNA (DIG-RNA) probes 
were used.  
 
2.6.26.1. Probe synthesis  
 
To determine the orientation of the subcloned DNA sequences, we performed diagnostic 
PCR with primers specific to T7 and Sp6 promoters of pCR2.1 (89/91) and to the insert. For 
all RNA-probe templates, Sp6 RNA polymerase yields the generation of DIG-labeled 
antisense probe, and T7 RNA polymerase generates sense control probe. To generate 
linearized templates for in-vitro transcription, 7 μg pCR2.1 plasmids were linearized by 
restriction digestion with XhoI for antisense probe synthesis, and with HindIII or BamHI 
(for Nedd4-2) for sense probe transcription. Digested DNA was subjected to electrophoresis 
in agarose gel, and isolated with gel extraction kit (Invitrogen). Further the amount of 
template DNA was estimated by agarose gel electrophoresis using GeneRuler 1 kB ladder 
(Fermentas) as a standard. Next, DIG-labeled RNA probes were synthetized in an in vitro 
 48 
transcription using digoxigenin-11-dUTP (Roche) with SP6/T7 MAXIscript Transcription 
Kit (Thermo Fisher Scientific) following manufacturer’s protocols. The quality of RNA 
upon in vitro transcription was further analyzed by non-denaturing agarose gel 
electrophoresis, and ethidium bromide staining.  
 
2.6.26.2. Tissue preparation 
 
For in situ hybridization, C57BL/6N mice at E16 and P21 were used. Embryos, and brains 
were isolated from deeply anaesthetized mice, washed with ice-cold PBS, flash-frozen in the 
isopentane bath at -38 to -40°C, embedded in OCT Tissue Tec (Sakura), and cryosectioned. 
Sagittal sections of 20 μm for the embryos, and 14 μm for the adult brain were collected on 
Superfrost slides (Thermo Scientific), and air-dried for 10 minutes at room temperature 




All solutions for processing of sections before the hybridization were treated with 
diethylpyrocarbonate (DEPC, Sigma-Aldrich) at a final concentration of 0.1% or prepared 
using DEPC-treated ddH2O. 
Sections were subsequently fixed at room temperature with 4% (w/v) paraformaldehyde 
(PFA) for 20 minutes in PB buffer, washed 3 times in PBS, dehydrated with methanol (JT 
Baker)/PBS series, and incubated in 100% methanol at -20°C for 20 minutes. Further, 
sections were rehydrated through reverse methanol/PBS series, beginning with 80% 
methanol with 6% hydrogen peroxide (Merck) in H2O for 1 hour. Next, sections were 
washed with PBST buffer, and treated with 10 μg/mL proteinase K for 10 minutes. Upon 
washing 3 times with PBST, sections were post-fixed with 4% PFA/PB for 5 minutes, again 
washed 3 times with PBST, rinsed with 0.85% (w/v) NaCl solution, incubated in 70% 
ethanol prepared in 0.85% NaCl solution, and further dehydrated with 95% ethanol. Sections 
on slides were air dried for 10 minutes. DIG-probes were denatured by heating at 80°C for 
5 minutes, and diluted with hybridization buffer to the final concentration of 750 ng/mL. 
Hybridization was held in chamber humidified with 50% formamide (Sigma-
Aldrich)/5XSSC buffer at 37°C for 48 hours.  
 
5XSSC Buffer: 750 mM NaCl (Merck), 75 mM sodium citrate (Merck), pH 7.0. 
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2.6.26.4. Post-hybridization washes and antibody application 
 
The sections were subsequently washed with 50% formamide/5XSSC for 3 times, followed 
by washes in salt gradient (5X-0.2XSSC, each time for 30 minutes), and 3 times in MBST 
buffer. Next, section underwent blocking with 20% heat inactivated sheep serum (HISS), 
(PAA) in MBST for 1 hour at room temperature, followed by incubation with the anti-DIG 
antibody conjugated with alkaline phosphatase (Roche) diluted 1:1000 in 2% HISS in MBST 
at 4°C for 16-20 hours. 
 
2.6.26.5. Color Developing 
 
Next, sections were washed 3 times with MBST, and incubated in the developing buffer 
(NTMT) for 10 minutes at room temperature. Then, developer solution was added to each 
slide (NBT/BCIP in NTMT, Roche), the color development was observed and terminated 
by washing with PBS. Further, coverslips were mounted on slides with Immu-Mount 
medium (Shandon, Thermo Scientific). 
 
2.6.26.6. Image acquisition 
 
Apochromatic Leica MZ16F steromicroscope was used to visualize the color signal after in 
situ hybridization,.  
 
4% paraformaldehyde: 4 g paraformaldehyde (PFA) was added to 40 mL of ddH2O heated 
to 50°C, and supplied with 38 μL of 10 M NaOH. The solution was stirred until PFA was 
completely dissolved, cooled down on ice, filled with 50 mL PB Buffer, and completed with 
ddH2O up to 100 mL. pH within the range 7.0-8.0 was verified using pH-strip indicators 
(Merck).  
PB Buffer: 0.1 M phosphate buffer (sodium phosphate dibasic, sodium phosphate 
monobasic, pH 7.2, Merck). 
PBST Buffer: PBS with 0.1% (w/v) Tween-20 (Sigma-Aldrich). 
Hybridization Buffer: 10 mM Tris-HCl, pH 7.5, 600 mM NaCl, 1 mM EDTA pH 8.0, 0.25% 
(w/v) SDS, 10% (w/v) dextran sulfate (Sigma-Aldrich), Denhardt’s 1:50 (Thermo Fisher), 
200 μg/mL yeast tRNA (Thermo Fisher), 50% (v/v) formamide, deionized (Sigma-Aldrich).  
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MBST Buffer: 100 mM maleic acid (Sigma-Aldrich), 150 mM NaCl, pH 7.5, 0.1% (w/v) 
Tween-20. 
NTMT Buffer: 100 mM NaCl, 100 mM Tris-HCl, pH 9.5, 50 mM MgCl2 (Sigma-Aldrich), 
0.1% (w/v) Tween-20. 
 
2.6.27. LNA-based in situ detection of miRNA 
 
In situ hybridization to detect mature miRNAs was performed in collaboration with Dr. 
Tamara Rabe and Prof. Ahmed Mansouri (MPIbpc, Göttingen). Wild-type hippocampal 
neurons grown on poly-L-lysine-coated coverslips at DIV7 were fixed with 4% PFA, and 
washed with PBS. Cells on coverslips were then incubated with acetylation solution, and 
upon 5 minute-long proteinase K (5 μg/mL PBS) treatment underwent pre-hybridization at 
room temperature for 4-8 hours, followed by hybridization at 55°C for 16-20 hours. For each 
coverslip, 1 pM of LNA-DIG labeled probe purchased from Exiqon diluted with 
hybridization buffer was used. Coverslips were subsequently washed in 5XSSC (pH 4.5) at 
60°C for 5 minutes, and with 0.2XSSC at 60°C for 1 hour. Coverslips were incubated for 10 
minutes at room temperature with solution B1 followed by application of an anti-DIG 
antibody coupled with alkaline phosphatase diluted 1:2000 in blocking solution. After 16-
20 hours incubation at 4°C, coverslips were washed in B3 solution 3 times for 10 minutes, 
and Developer solution was applied. Color development was stopped with PBS. 
 
Acetylation solution: 0.015% (v/v) Triethanoloamine (Sigma-Aldrich), 0.02% (v/v) HCl 
(Merck). 
Hybridization solution: 50% deionized (v/v) formamide, 5XSSC, 5 mM EDTA, 0.1% (v/v) 
Tween-20, 0.1% (w/v) 3-((-3-cholamidopropyl)-dimethyloammonio)-1-propanesulfonate 
(CHAPS, Biomol), 0.1 mg/mL heparin (Sigma-Aldrich), 1 mg/mL yeats tRNA. 
Solution B1: 0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl. 
Blocking solution: 10% (v/v) fetal bovine serum (FBS, Gibco), 0.5% (v/v) Tween-20 in 
solution B1. 
Soultion B3: 0.1M Tris-HCl, pH 9.5, 0.1 M NaCl, 50 mM MgCl2, 0.1 % (v/v) Tween-20, 20 
μM levamisole-HCl (Sigma Aldrich) passed through 0.45 μm filter (Nalgene). 






2.7.1. Protein concentration measurements 
 
Protein concentration was estimated with BCA kit (Thermo, Pierce) following 
manufacturer’s protocol The absorbance of protein complexes was measured with Plate 
Reader (Bio-Rad). Protein concentration in sample was calculated based on the absorbance 
value for BSA standards (Thermo, Pierce). 
 
2.7.2. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Proteins were separated under denaturing conditions using SDS-PAGE [211]. Protein 
samples were dissolved in Sample buffer [212], and incubated at 65°C for 15 minutes, loaded 
on two-layered acrylamide gel, and subjected to electrophoresis with Running buffer (Bio-
Rad) at 90 V for the stacking gel, and 120 V for the separating gel. Protein gel, made of 
stacking, and separating gels was casted according to Bio-Rad Protean II system.  
 
Sample buffer: 10% (v/v) glycerol, 50 mM Tris-HCl, pH6.8, 2% (w/v) SDS, 2 mM EDTA, 
10 mM DTT, 0.05% (w/v) Bromophenol blue. 
Stacking gel: 5% (v/v) acrylamide/N,N’-methylene-bis-acrylamide (35.5:1) solution 
(National Diagnostics), 125 mM Tris-HCl, pH 6.8, 9.1% (w/v) SDS, 0.05% (w/v) 
ammonium persulfate (APS, Sigma-Aldrich), 0.005% (v/v) N,N,N’,N’-
tetramethylethylenediamine (TEMED, Serva). 
Resolving gel: 8-15% (v/v) acrylamide/N,N’-methylene-bis-acrylamide (35.5:1) solution, 
325 mM Tris-HCl, 0.1% (w/v) SDS, 0.05% (w/v) APS, 0.005% (v/v) TEMED.  
Running buffer: 25 mM Tris-HCl, 250 mM glycine (Sigma-Aldrich), 0.1% (w/v) SDS, pH 
8.8. 
 
2.7.3. Western blotting 
 
Separated proteins were electrophoretically transferred onto a nitrocellulose membrane 
(Amersham Protran, 0.2 μm NC, GE Healthcare) in transfer buffer under a constant current 
of 80 mA for 10 hours using a tank blotting unit (Hoefer, TE22) [213]. After transfer, 
membrane was rinsed with ddH2O to remove gel debris, and stained with MEM Code 
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(Thermo Scientific) kit to visualize separated proteins. After destaining, membrane was 
rinsed with TBS buffer, and subjected to blocking with blocking buffer for 30 minutes at 
room temperature with moderate shaking, incubated with the primary antibody diluted in 
blocking buffer (diluted according to Table 5) for 3 hours at room temperature, and washed 
3 times with TBS-T for 15 minutes. Next, the membrane was incubated with secondary 
antibodies conjugated with horseradish peroxidase (HRP) or fluorophores diluted in 
blocking buffer according to Table 6 for 1 hour. After subsequent washing (3 times, 15 
minutes), the signal on the membrane was developed with chemiluminescence detection 
system (ECL) on films (Amersham Hyperfilm ECL, GE Healthcare) or detected with 
Odyssey CLx Infrared Imaging System (LI-COR). 
 
Transfer buffer: 25 mM Tris-base, 190 mM glycine, 20% (w/v) methanol.  
TBS: 10 mM Tris-HCl, 150 mM NaCl, pH 7.5. 
TBS-T: TBS, 0.1% Tween-20. 
Blocking buffer: 5% (w/v) skimmed milk (Frema), 0.1% (v/v) Tween-20, TBS. 
Washing buffer: TBS, 0.1% (v/v) Tween-20.  
 
2.7.4. Affinity binding assay with recombinant proteins 
 
Binding assay between myc-tagged N-terminus of Ube3b (IQ-Ube3b) an its putative binding 
substrates was performed with affinity chromatography by Hiroshi Kawabe. Briefly, GST-
fused recombinant pray proteins fragments identified in Yeast Two-Hybrid screenings were 
purified from E. coli BL21-Rosetta strain using pGEX-GST system (GE Healthcare). 40 μg 
of each GST-fused proteins was immobilized on 50 μL of glutathione Sepharose 4B beads 
(GE Healthcare). After subsequent washing with binding buffer (five bed volume), 500 μL 
of the extract of Human Embryonic Kidney 293 (HEK293) cell expressing myc-IQ-Ube3b 
was loaded on the GSH-beads. Next, beads were washed with 750 μL of wash buffer, and 




Binding buffer: 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% (w/v) CHAPS. 
Wash buffer: 50 mM Tris-HCl, pH 7.4, 300 mM NaCl, 1 mM EDTA, 1% (w/v) CHAPS. 
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Elution buffer: 40 mM GSH, 50 mM Tris-HCl, pH 7.4, 300 mM NaCl, 1 mM EDTA, 1% 
(w/v) CHAPS. 
All buffers above were supplemented with 0.2 mM PMSF, 1 μg/mL aprotinin, and 0.5 μg/mL 
leupeptin. 
 
2.7.5. Subcellular fractionation of mouse brains 
 
Subcellular fractionation in sucrose gradients of the brain tissue was performed in 
collaboration with Bekir Altas according to published protocols [214,215] with slight 
modifications. All described procedures were performed at 0-4°C. Immediately after 
decapitation, mouse cortex was isolated in Solution A. Cortices from one mouse were 
homogenized in 3 mL of Solution A supplemented with 0.2 mM PMSF, 1 μg/mL aprotinin, 
and 0.5 μg/mL leupeptin using Teflon-glass homogenizer with 20 strokes at 1200 rpm 
(Potter S, Braun). Homogenate (H) was fractionated by centrifugation at 82 500 g for 2 hours 
in discontinuous sucrose density gradient, comprising of 0.85 M, 1.0 M, 1.2 M sucrose 
solutions. The solution on top of the first interface was collected as supernatant (S), the 
interface between 0.32 and 0.8 M as the P2A fraction (myelin fraction), the one between 0.8 
and 1.0 M as the P2B fraction (ER/Golgi fraction), the one between 1.0 and 1.2 M as the 
P2C fraction (synaptosomes), and the pellet as the P2D (mitochondria-enriched fraction) 
fraction. The P2C fraction was centrifuged at 100 kg for 20 minutes, and the pellet was 
resuspended with the hypo-osmotic buffer (6 mM Tris-HCl, pH 8.0) followed by incubation 
for 45 minutes to disrupt the synaptosomes. The sample was further centrifuged at 32.8 kg 
for 20 minutes to separate the synaptic cytoplasm, and crude synaptic vesicles (SC/CSV) 
fraction in the supernatant from the crude synaptic membrane (CSM) fraction in the pellet. 
The CSM fraction was further resuspended with 6 mM Tris-HCl pH 8.0, 0.32 M sucrose, 
and 0.5% Triton X-100 (Roche), incubated for 15 minutes, and centrifuged at 32.8 kg for 20 
minutes. The pellet contained postsynaptic density fraction (PSD), and the supernatant – 
Triton X-100 extract (TX100-E).  
For the purpose of comparative mass spectrometry, CSM fractions were subjected to 
additional centrifugation in discontinuous sucrose gradient as described above. The interface 
between 1.0 and 1.2 M sucrose solutions was collected as the synaptic plasma membrane 
(SM3) fraction. 
 
Solution A: 0.32 M sucrose (Merck), 1 mM NaHCO3 (Merck). 
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2.7.6. Comparative label free mass spectrometry 
 
Purified brain fractions (P2C fractions for identification of miR-140 targets, and SM3 
fractions for Ube3b substrates) were subjected to free-label mass spectrometry performed 




Protein fractions corresponding to 20 μg protein were processed according to a filter-aided 
sample preparation (FASP) protocol [216] modified as described [217]. Briefly, protein 
samples were lysed and reduced in lysis buffer by shaking for 30 min at 37°C, and 
subsequently loaded on centrifugal filter units (30 kDa MWCO, Millipore). After removal 
of the detergent by washing twice with wash buffer, proteins were alkylated with 50 mM 
iodoacetamide in 8 M urea/0.1 M Tris pH 8.5 (20 min at RT), followed by two washes with 
wash buffer to remove excess reagent. Buffer was exchanged by washing three times with 
50 mM ammonium bicarbonate (ABC) containing 10% acetonitrile. Up to here, all these 
steps were automated on a liquid-handling workstation equipped with a vacuum manifold 
(Freedom EVO 150, Tecan) by using an adaptor device constructed in-house, while the 
following steps were performed by centrifugation to ensure quantitative removal of liquids. 
After three additional washes with 50 mM ABC/10% acetonitrile, proteins were digested 
overnight at 37°C with 500 ng trypsin in 40 μl of the same buffer. Tryptic peptides were 
recovered by centrifugation followed by two additional extraction steps with 40 μl of 50 mM 
ABC and 40 μl of 1 % trifluoroacetic acid (TFA), respectively. Aliquots of the combined 
flow-throughs were spiked with 10 fmol/μl of yeast enolase 1 tryptic digest standard (Waters 
Corporation) for quantification purposes [218] and directly subjected to LC-MS analysis. 
 
Lysis Buffer: 7 M urea (Sigma-Aldrich), 2 M thiourea (Sigma-Aldrich), 10 mM DTT, 2 % 
CHAPS, 0.1 M Tris pH 8.5. 








Nanoscale reversed-phase UPLC separation of tryptic peptides was performed with a 
nanoAcquity UPLC system equipped with a Symmetry C18 5 μm, 180 μm × 20 mm trap 
column, and a HSS T3 C18 1.8 μm, 75 μm × 250 mm analytical column maintained at 45°C 
(Waters Corporation). Injected peptides were trapped for 4 min at a flow rate of 8 μl/min 
0.1% TFA, and then separated over 120 min at a flow rate of 300 nl/min with a gradient 
comprising two linear steps of 3-35% mobile phase B in 105 min and 35-60% mobile phase 
B in 15 min, respectively. Mobile phase A was water containing 0.1% formic acid while 
mobile phase B was acetonitrile containing 0.1% formic acid. Mass spectrometric analysis 
of tryptic peptides was performed using a Synapt G2-S quadrupole time-of-flight mass 
spectrometer equipped with ion mobility option (Waters Corporation). Positive ions in the 
mass range m/z 50 to 2000 were acquired with a typical resolution of at least 20,000 FWHM 
(full width at half maximum), and data were lock mass corrected post-acquisition. Analyses 
were performed in the ion mobility-enhanced data-independent acquisition mode with drift 
time-specific collision energies as described [217,219,220]. 
 
2.7.6.3.Data analysis and protein quantification 
 
Continuum LC-MS data were processed for signal detection, peak picking, and isotope and 
charge state deconvolution using Waters ProteinLynx Global Server version 3.0.2 [221]. For 
protein identification, a custom database was compiled by adding the sequence information 
for yeast enolase 1 and porcine trypsin to the UniProtKB/Swiss-Prot mouse proteome, and 
by appending the reversed sequence of each entry to enable the determination of false 
discovery rate (FDR). Precursor and fragment ion mass tolerances were automatically 
determined by PLGS 3.0.2 and were typically below 5 ppm for precursor ions, and below 
10 ppm (root mean square) for fragment ions. Carbamidomethylation of cysteine was 
specified as fixed, and oxidation of methionine as variable modification. One missed trypsin 
cleavage was allowed. Minimal ion matching requirements were two fragments per peptide, 
five fragments per protein, and one peptide per protein. The FDR for protein identification 
was set to 1% threshold. The freely available software ISOQuant (http://www.isoquant.net) 
was used for post-identification analysis including retention time alignment, exact mass and 
retention time (EMRT), and ion mobility clustering, data normalization, isoform/homology 
filtering, and calculation of absolute in-sample amounts for each detected protein according 
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to the TOP3 quantification approach [217,222]. Based on the peptides identified in the first 
PLGS database search round described above, the stringency for reporting a protein was 
increased further by considering only peptides with a minimum length of six amino acids, 
which were identified with scores above or equal to 5.5 in at least two runs. FDR for both 
peptides, and proteins was set to 1% threshold, and only proteins reported by two and more 




2.8.1. Media and solutions 
 
Papain solution: 20 units of papain (Worthington) were added to 1 mL of 0.2 mg/mL 
cysteine, 1 mM CaCl2, and 0.5 mM EDTA in Dulbecco’s Modified Eagle’s Medium 
(DMEM, Gibco, Life Technologies). The solution was then saturated with carbogen – 95% 
oxygen, and 5 % carbon dioxide – until clear, and filter-sterilized (0.22 μm, Millipore).  
Stop solution: 2.5 mg/mL bovine serum albumin (BSA, Sigma-Aldrich), 2.5 mg/mL 
ovoalbumin (Sigma-Aldrich), 10% (v/v) FBS in DMEM. 
Complete Neurobasal medium: 500 mL Neurobasal A (Gibco, Life Technologies), 50 mL 
FBS (Gibco, Life Technologies), 10 mL B-27 (Gibco, Life Technologies), 5 mL GlutaMAX 
(Gibco, Life Technologies), 5 mL penicillin/streptomycin (Life Technologies, Gibco). 
HEK cell medium: 500 mL DMEM, 50 mL FBS, 5 mL GlutaMAX, 5 mL 
penicillin/streptomycin.  
MEF medium: 500 mL KnockOut-DMEM (Gibco, Life Technologies), 75 mL FBS, 6 mL 
non essential amino acids (Gibco, Life Technologies), 6 mL 200 mM L-glutamine (Gibco, 
Life Technologies), 6 mL β-mercaptoethanol (Sigma-Aldrich), 3 mL 
penicillin/streptomycin, 6 mL G418 (Gibco, Life Technologies).  
ES cell medium: 500 mL KnockOut-DMEM, 95 mL FBS, 6 mL non essential amino acids, 
6 mL 200 mM L-glutamine, 6 mL β-mercaptoethanol, 3 mL penicillin/streptomycin, 6 mL 
G418, 1000 U Leukemia Inhibitory Factor Lif (Chemicon/Millipore). 
Freezing Medium: 30 mL HEK, MEF or ES cell medium, 10 ml FBS, 8 mL dimethyl 
sulfoxide (DMSO, Sigma-Aldrich).  
RIPA buffer: 20 mM Tris-HCl, pH 7.5 (4°C), 150 mM NaCl, 1 mM EDTA, 1% (v/v) NP-
40 (Fluka), 1% (w/v) sodium deoxycholate (Wako Chemicals), PhosphoSTOP (Roche), 10 
mM NaF (Sigma-Aldrich), 0.2 mM PMSF, 1 μg/mL aprotinin, 0.5 μg/mL leupeptin. 
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2.8.2. Murine primary hippocampal neurons 
 
2.8.2.1.Treatment of coverslips for culturing primary neurons 
 
Prior to cell culture, coverslips (Menzel-Gläser) were incubated with 1 M HCl for 16-20 
hours, thoroughly rinsed with dH2O, incubated with 70% ethanol, again washed with dH2O, 
placed in cell culture dishes in sterile conditions (laminar flow hood), and UV-treated for 1 
hour. Further, to provide the primary neurons with an adhesion substrate, the coverslips were 
incubated with poly-L-lysine (Sigma-Aldrich) diluted 1:10 in PBS (Gibco, Life 
Technologies) for 1 hour at 37°C. Next, coverslips were rinsed with PBS three times, and 




Brains of P0 mice were dissected on ice-cold Hank’s Balanced Salt Solution (HBSS) under 
stereomicroscope to collect hippocampi in 1 mL of ice-cold Papain solution. After 1 hour 
incubation at 37°C with gentle shaking, papain solution was carefully replaced by stop 
solution, and the hippocampi were further incubated at 37°C for 15 minutes with moderate 
agitation. Next, the stop solution was discarded, and hippocampi carefully washed twice 
with 900 μL of pre-warmed (37°C) Complete Neurobasal medium. Further, the hippocampi 
were carefully triturated in 200 μL Complete Neurobasal medium 10 times using P200 
pipette tip. The debris were then let sink for 1 minute, and 150 μL the supernatant transferred 
to 900 μL of fresh Complete Neurobasal at 37°C. After second round of trituration, cells 
were counted with Naubauer counting chamber, and neurons were seeded in 24 well-plate 
format. For biochemical experiments, 120 000 cells, and for immunocytochemistry, 40 000 
cells were plated on one coverslip in 1mL of Complete Neurobasal medium. For 
electrophysiological experiments, 4 000 cells were plated onto astrocytic microislands in 6 
well-plate format. The day of neuronal prep was counted at day in vitro 0 (DIV0). Neurons 







2.8.2.3.Calcium phosphate transfection 
 
Primary hippocampal neurons were transfected at DIV1 with calcium phosphate transfection 
method. Prior to transfection, the DNA-calcium precipitates were prepared accordingly to 
published works [223]. For one coverslip of 24 well-plate, 1 μg of plasmid DNA was mixed 
with 3.1 μL of 2 M CaCl2, and sterile H2O was added till 25 μL of total volume. The DNA 
mix was dropwise added to 25 μL of 2XHBS, 1/8 of the solution at a time with gentle 
agitation for 2 seconds after each drop. The solution was then incubated at room temperature 
in darkness for 30 minutes. Complete Neurobasal medium was replaced with the same 
volume of Neurobasal A, filtered, and stored at 37°C. Upon pipetting up, and down for 5 
times, 50 μL of the DNA-calcium solution was applied on each coverslip, and the neurons 
were placed at 37°C in the incubator until precipitates became visible in the light microscope 
(approximately 20 minutes). Coverslips were subsequently washed with HBSS equilibrated 
in 10% carbon dioxide at 37°C until all visible precipitates disappeared. The original 
complete Neurobasal medium was placed back on the neurons, and cells were further 
cultivated at 37°C/5%CO2. 
 
2XHBS: 274 mM NaCl, 10 mM KCl, 1.4 mM Na2HPO4, 15 mM glucose, 42 mM HEPES 
(Sigma-Aldrich, H3375), pH 7.08 adjusted with 10 M NaOH. Buffer was aliquoted, and 
stored at -20°C. 
 
2.8.3. HEK293FT cell line 
 
HEK293FT were used for production of lentivirus, and expression of myc-tagged IQ-Ube3b. 
Unless stated otherwise, HEK293FT cells were maintained in 6 cm Petri dishes (Corning) 
in 10 mL HEK cell medium at 37°C in the presence of 5% carbon dioxide in HERA-cell240 
(Heraeus) incubator. For passaging, semi-confluent cells were washed with PBS, incubated 
with 1 mL of 0.05% trypsin solution (Gibco, Life Technologies) for 1 minute at 37°C, and 
the reaction was stopped by addition of 9 mL of the fresh medium. HEK293FT cells were 








Transfection of HEK293FT was performed at 80-90% confluency using Lipofectamine2000 
(Invitrogen) following manufacturer’s instructions with 1:2 DNA/Lipofectamine2000 ratio 
(μg/μL). 
 
2.8.3.2.Lentivirus production and infection of primary hippocampal cells 
 
Viral particles expressing GFP, and GFP together with iCre were produced by Dr. Hiroshi 
Kawabe. Briefly, HEK293FT cells grown in OPTI-MEM supplemented with 10% FBS on 
15 cm Petri dish, were co-transfected with 40 μg of pFUGW or 40 μg of pFUGWiCre with 
16 μg of packaging plasmid (PACK), and 16 μg of envelope plasmid (ENV). Culture 
medium was exchanged to the HEK cell medium with 2% FBS upplied with 10 mM sodium 
butyrate (Gibco, Life Technologies) 4-6 hours after transfection. Culture medium was 
harvested 48 hours post-transfection, filtered through 45 μm filters (Millipore), and applied 
to AMICON filter system (Millipore) to concentrate viral particles by centrifugation at 3500 
g 
A. The virus stock was further dialyzed against TBS at 4°C for 16-20 hours in a sterilized 
beaker, aliquoted, and flash-frozen in liquid nitrogen. Viruses were stored in -80°C until 
used. Upon thawing the aliquot of the virus stock, appropriate volume of the virus stock was 
added to neuronal medium at DIV1. The virus titer was determined by estimation of GFP 
expression level in neuronal cultures. At appropriate stage of the culture, infected neurons 
were washed with PBS four times, and lysed with RIPA buffer at 4°C. The homogenate was 
centrifuged for 10 minutes at 14 kg in cold bench-top microfuge, and supernatant was used 
in biochemical experiments.  
 
TBS: 20 mM Tris-HCl, pH 8.0 (4 °C), 150 mM NaCl. 
 
2.8.4. Mouse Embryonic Fibroblasts (MEF) 
 
Neomycin-resistant MEFs were purchased from Cell Biolabs (CBA-311) as feeder cells for 
embryonic stem (ES) cell culture. MEFs were maintained in 15 cm Petri dishes coated with 
gelatin (0.1% gelatin in ddH2O, Sigma-Aldrich) at 37°C in 25 mL MEF medium in the 
presence of 5% carbon dioxide in HERA-cell240 (Heraeus) incubator. At confluency, 
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medium was removed, cells were washed with 37°C-warm PBS, and incubated with 10 mL 
MEF medium supplemented with 100 μL of mitomycin C (Sigma-Aldrich) per plate for 2.5 
hours at 37°C. Then, medium was removed, cell washed with PBS, trypsinized for 5 minutes 
with 0.05% trypsin-EDTA solution (Gibco, Life Technologies) at 37°C, resuspended with 
fresh MEF medium, and centrifuged at 1 krpm for 5 minutes at room temperature. 
Inactivated MEF were then resuspended, Freezing medium was added dropwise to the 
suspension, and cells were frozen in Cryo Freezing Container (Nalgene) filled with 
isopropanol at -80°C, and seeded prior to demand. 
 
2.8.5. ES cells 
 
For generation of Ube3b knockout mice, mutant JM8.F6 ES cells were purchased from 
EUCOMM Consortium. The L1L2_gt0 cassette was inserted to the genome at position 
114389925 (UCSC Genome Bioinformatics) of Chromosome 5 upstream of exon 7 of Ube3b 
gene. The cassette was composed of an FRT-flanked lacZ/neomycin sequence followed by 
a 5’ loxP site. An additional loxP site is inserted 3’ downstream of exon 7 at position 
114390710. ES cells were thawn prior to blastocyst injection to minimize the passage 
number. Cells were seeded on a layer of previously prepared and thawn inactivated MEF, 
and maintained in ES cell medium at 37°C in the presence of 5% carbon dioxide in HERA-
cell240 (Heraeus) incubator. Before splitting, cells were supplied with fresh medium for at 
least 3 hours. Passaging was carried out with 0.25% trypsin-EDTA (Gibco, Life 
Technologies), and the reaction was terminated with FBS. Prior to blastocyst injection, 
MEFs were separated from ES cells by plating cell suspension on fresh gelatinized Petri dish 
for 30 minutes at 37°C allowing MEFs to adhere to the bottom of the dish. Transfer of 
injected blastocysts to pseudo-pregnant foster female mice was performed in MPIem Animal 




Cells cultured on coverslips were fixed with cold (4°C) 4% PFA, 4% sucrose (Merck) in PB 
buffer for 20 minutes in room temperature, washed three times with PBS, and incubated with 
blocking buffer for 30 minutes. Next, cells were incubated with primary antibody diluted 
with blocking buffer accordingly to Table 5 for 16-20 hours at 4°C with moderate shaking, 
followed by washing 3 times for 30 minutes with PBS. Further, secondary antibody coupled 
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to appropriate fluorophore diluted in blocking buffer was applied for 2 hours at room 
temperature. After washing 3 times with PBS for 30 minutes, coverslips were briefly rinsed 
with ddH2O, and mounted on Superfrost Plus glass slides (Thermo Scientific) with Immu-
Mount mounting medium (Shandon, Thermo-Scientific). 
 
Blocking buffer: 5% goat serum (Gibco, Life Technologies), 0.3% Triton X-100 (Roche), 






Intracardiac perfusion with 4% PFA in PB buffer was conducted using pump apparatus PA-
SF (IKA Labortechnik) according to the protocols published before [224]. Perfusion was 
performed on animals older than P3. P0 brains were isolated from the skulls, and 
immediately immersed in 4% PFA in PBS for 16-20 hours. Briefly, mice older than P3 were 
deeply anesthetized by intraperitoneal administration of avertin - 99% 2,2,2-tribromoethanol 
(Alta Aesar) dissolved in 2-methylbuthan-2-ol (Sigma) (0.2 mL per mouse of approximately 
20 g). Mouse was then placed in darkness to reach surgical plane of anesthesia, verified by 
toe pinch-response. Lateral incision through abdominal wall was followed by separation of 
the diaphragm from the liver, and diaphragm was further incised together with the rib cage 
until the full exposure of the pleural cavity. Upon fixation of the sternum with hemostat 
above the animal head, sterile 25-gauge winged cannula was introduced to the heart through 
the posterior end of the left ventricle. Cannula was fixed to the heart with a hemostat. A 
small incision with iris scissors was performed in the heart’s right atrium preventing damage 
of the descending aorta to create outlet valve. Initial PBS flush was performed at pump speed 
12 for 1 minute, and paraformaldehyde solution was then delivered at a constant rate (pump 
speed 10) for 2 minutes starting with the observation of the first fixation tremors. The brain 
was further isolated from animal’s skull, and incubated with 4% PFA in PB buffer at 4°C 
for 16-20 hours with moderate agitation. Next, brains were transferred to PBS with 0.01% 







All histological procedures excluding preparation of tissue for in situ hybridization, included 
brain sections prepared on Leica CM3050S cryostat. Prior to cryosectioning, brains were 
incubated for at least 5 hours with 10% sucrose in PBS, followed by incubation with 30% 
sucrose in PBS until the organs reached the bottom of the glass beaker. Next, brains were 
frozen in -38 to -40°C isopentane (Roth). Coronal cryosections of appropriate thickness were 
either collected immediately on Superfrost Plus glass slides or in PBS/0.01% sodium azide 
solution. Sections of 50 μm thickness were collected for spine morphology reconstruction, 
Bielschowsky Silver Impregnation, and immunohistochemistry, and 100 μm-thick sections 
were used for neuronal distribution and polarity classification studies. 
 
 
2.10.3. Bielschowsky Silver Impregnation (BSI) 
 
The staining procedure was performed accordingly to previously published work with slight 
modifications [225]. Brain sections of 50 μm thickness from PFA-perfused mice were 
collected on Superfrost Plus glass slides, and air-dried for at least 4 hours in room 
temperature. Slides were then immersed in pre-warmed (40°C) 10% (w/v) silver nitrate 
(Sigma-Aldrich) solution for 15 minutes until sections turned light brown. Next, slides were 
placed in ddH2O, and washed 3 times. Concentrated ammonium hydroxide was then added 
dropwise to silver nitrate solution until solution turned cloudy. Slides were incubated with 
so prepared ammonium silver solution for 1 hour at 40°C until color development. Slides 
were subsequently placed in developer working solution for 1 minute, and reaction was 
stopped by a quick dip of the slides in 1% ammonium hydroxide. Slides were then washed 
three times with ddH2O, placed in 5% (w/v) sodium thiosulfate (Sigma-Aldrich), washed 
three times with ddH2O, dehydrated, and cleared through 95% ethanol, absolute ethanol 
(Sigma-Aldrich), and xylene (CVH), followed by mounting with Entellan New resinous 
medium (Electron Microscopy Sciences).  
 
Developer stock solution: 20 mL 37-40% formaldehyde (Merck), 0.5 g citric acid, trisodium 
dihydrate (Sigma-Aldrich), concentrated nitric acid (Merck), 100 mL ddH2O. 
Developer working solution: 8 drops of developer stock solution, 8 drops of concentrated 




Brain sections of PFA-perfused mice were washed with PBS three times at room 
temperature, and incubated for 5 minutes with moderate agitation with 1 mg/mL sodium 
borohydride (Sigma-Aldrich) solution in PBS. Subsequently, the sections were thoroughly 
washed with PBS, and incubated with blocking solution for 1 hour at room temperature. 
Further, sections were incubated with the primary antibody, and DAPI diluted in blocking 
buffer accordingly to Table 5 for 16-20 hours at 4°C, washed in PBS three times for 30 
minutes, and incubated with secondary antibody coupled to a fluorophore of choice, 
according to Table 6. Next, sections were incubated with PBS for 30 minutes three times, 
and mounted with cover glass (Menzel-Gläser) and mounting medium (Immu-Mount). 
 
Blocking solution: 5% goat serum, 0.5% (v/v) Triton X-100, PBS. 
 
2.11. In utero electroporation (IUE) 
 
2.11.1. Glass capillary preparation 
 
Micropipettes for IUE were prepared from 1.5 – 1.8 X 100 mm borosilicate glass capillaries 
(Kimble and Chase) using HEKA PIP5 temperature controlled pipette puller. To ensure the 
appropriate tip diameter, the filament was heated to 1000°C, and pulling of glass capillary 
was controlled manually, allowing for slow expansion of heated glass.  
 
2.11.2. Plasmid DNA for IUE 
 
Plasmid DNA was prepared with EndoFree Plasmid Maxi Kit (Qiagen). Prior to IUE, DNA 
was diluted in endotoxin-free TE buffer, and mixed with 0.1% Fast Green FCF (Sigma-
Aldrich). Final concentration of DNA used for transfecting cortical progenitors was 200-500 
ng/μL, and for electroporation of hippocampal progenitors – 1.2 μg/μL. Before injection to 






2.11.3. Mice used for IUE 
 
Table below summarizes the genetic background, and origin of animals used for IUE in this 
study. 
 










































































E14.5 mouse embryos were subjected to IUE according to permit number 33.19-42502-04-
13/1052, and previously published work [72,226]. Pregnant mouse was deeply anesthetized 
with isolfurane (Ecuphar)/oxygen diffusor (Plexx, HNG6), and placed on warm heating pad 
(32°C). Before surgery, the heart rate or the breathing frequency was noted, and the toe 
pinch-reflex enabled to assess the surgical plane. A layer of Vidisic gel (Bausch and Lomb) 
was applied onto each cornea to prevent their damage. To ensure post-operative analgesia, 
3 mg buprenorphine (Temgesic) was administered subcutaneously. Abdominal wall was 
thoroughly washed with 70% ethanol, and 50 mg/mL povidon-iodine (VetSept). Incision of 
about 2 cm in the abdominal cavity was made to expose entire uterus with embryos, which 
were subsequently moistened with warm PBS supplied with penicillin 2000 U/mL, and 2 
mg/mL streptomycin (Gibco). Micropipette with the DNA solution was carefully injected to 
the lateral ventricle of the embryonic brain, and exhausted by expiratory pressure through a 
pneumatic pump (PV820). The forceps-type electrode (CUY650P1, NepaGene) was placed 
around the embryo head accordingly to the targeted brain region [73], and electric current 
was applied with ElectroSquare Porator (ECM830BTX Harvard Apparatus). For 
electroporation of the cortical progenitors, 5 pulses of 34 V were delivered, and for 
transfection of the hippocampal progenitors – 8 pulses, each of 32 V, each pulse of 50 ms 
duration with 950 ms interval. After pulsing, embryo head was thoroughly washed with 
warm PBS with antibiotics. Next, the uterus with embryos was carefully placed back to the 
abdominal cavity, and the body wall was closed with absorbable surgical sutures (Safil, 
Aesculap; 4/0, 28’’; HR17), and the skin with 9 mm Autoclips (Clay Adam). The animals 
were kept on the warm pad until back to consciousness. The mouse was monitored post-
operatively until deceased. 
 
2.11.5. Brain processing after in utero electroporation. 
 
Brains were isolated from skulls of P0 mice, and incubated with 4% PFA in PB buffer at 
4°C for 16-20 hours, washed with PBS, subjected to sucrose gradient (10%-30% w/v sucrose 
in PBS), and sectioned with cryostat (100 μm thickness). For P10 and P21 mice, the 
intracardiac perfusion was performed prior to isolation of the brains. After histological 
processing, brain sections were subjected to immunohistochemistry. 
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Imaging of brain coronal cross sections after in utero electroporation was performed at -1.06 
mm to -2.06 mm from Bregma for P10 brains [227], and at the level of anterior commissure 
for P0 brains.  
 
2.12. Image acquisition, analysis and statistics  
 
2.12.1. Quantitative Western blotting 
 
Quantification of protein levels was performed with ImageStudioLite (Li-Cor) software 
using scans of films after exposure to ECL chemiluminescence or data acquired by Odyssey 
cLX. The bands representing respective proteins were manually outlined, and the signal 
intensity was measured. Signal represents the sum of the individual pixel intensity values 
for a selected shape subtracted by the average intensity value of the pixels in the background, 
and the total number of pixels within the region of interest. Protein level was expressed 
relative to the signal for β-actin detected in respective lane or total protein as measured by 
the integral of MEM Code Staining intensity measured with Tracing tool of ImageJ software 
[228]. For statistical analysis of difference between two groups, t-test was used, and p-value 
of less than 0.05 was considered as significant. 
 
2.12.2. Axon counting assays in vitro 
 
For quantification of number of axons projected by single primary hippocampal neurons, 
number of cells projecting 0, 1 or multiple axons were counted. Axons were defined as 
processes with prominent SMI312 staining, and no MAP2 signals. Cells were imaged, and 
scored by a bling observer. Images of transfected neurons were acquired with AxioImager 
Z.1 (Carl Zeiss), 40X objective and water immersion, and analyzed with AxioVision 
software. Each quantification represents data from at least two different primary cultures. 
For statistical analyses of axon acquisition, χ2 test was employed, and for comparison of 
frequencies in contingency table format, Fisher’s exact test was employed. 
 
2.12.3. Quantification of distribution of cortical neurons and polarity classification 
 
Z-stacks of 100 μm-thick mouse cortices after in utero electroporation were acquired with 
Leica Sp2 confocal microscope with 10X objective (for P0 cortices – zoom 1.5, for P10 
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without any digital zoom). Maximum projections of confocal stacks were divided into 5 bins 
of identical dimensions. Number of transfected neurons in each bin was manually counted 
with Cell Counter plug-in of ImageJ software, and the number of neurons in each bin 
expressed relative to the total number of transfected nerve cells. Based on previously 
published works [229-234], neurons were manually scored based on their morphologies into 
respective classes (Bipolar with two processes emerging from opposite poles of the soma 
parallel to the axis perpendicular to pia or Non-bipolar for P0 cortices, and No Polarity, 
Pyramidal, Multipolar, and Misoriented according to criteria in Table 10 ), and frequencies 
of neurons of each class within a bin were quantified using Cell Counter plug-in of ImageJ 
software. Tracing of representative neurons were performed manually after thresholding of 
binarized images. For statistical analyses, two-way ANOVA with appropriate post-hoc test 
indicated in the figure legend was used. 
 
Table 10. Classification of neuronal polarities after in utero electroporation. 
Polarity class 
Number of apical 
dendrites 
Comment 
No Polarity 0 
No apparent dendrite with prominent apical 
shaft 
Pyramidal 1 
One prominent apical dendrite oriented 
perpendicular to the pial surface 
Multipolar Multiple Multiple prominent dendrites 
Misoriented 1 
Apical dendrite forms an angle larger than 
15° with an axis perpendicular to the pial 
surface 
 
Note: Over the course of this study, we analyzed distribution and morphology of cortical 
pyramidal neurons in wild type mice as well as in several mouse lines at different stages of 
development. It appears that the cortical distribution of layer II/III pyramidal neurons differs 
along anteroposterior and dorsoventral axis of the brain. It is therefore critical that coronal 
brain sections through cortex from the control and experimental group are imaged at 
morphologically equivalent positions for the quantification of neuronal distribution.  
 
2.12.4. Spine morphometrics with STED nanoscopy 
 
Spine morphology was quantified with ImageJ software using images acquired with STED 
microscope in collaboration with Dr. Katrin Willig (MPIem, Göttingen) as described before 
 68 
[235]. Spines were manually counted using Cell Counter plug-in of ImageJ software, and 
classified into morphology classed: stubby, filopodia, thin, mushroom, and bifurcated using 
morphological criteria described before [236]. Spine length was measured as the distance 
from spine emergence on the dendrite until the head tip. The head size was measured as the 
diameter of spine head. For statistical analyses, t-test for comparison of two groups, and one-
way ANOVA with appropriate post-hoc test for analysis of spine classification were 
conducted. 
 
2.12.5. Quantification of axon length and dendritic tree complexity 
 
Axon length was measured using confocal images of neurons acquired by Leica Sp2 with 
20X objective and ImageJ software. Number of primary branches were counted manually 
using Cell Counter plug-in. To measure the complexity of dendritic arbor, images of primary 
hippocampal neurons were acquired with AxioImager Z.1 (Carl Zeiss), using 40X objective 
and water immersion. Next, we applied Sholl analysis with 7.5 μm interval between Sholl 
circles with median span type on tresholded and binarized images using ImageJ. For 
quantification of dendritic tree complexity, we quantified a total number of crossings with 
Sholl circles made by neurites of an individual neuron. For statistical analyzes, t-test was 
used to compare two independent samples, and one way ANOVA with respective post-hoc 
tests for comparison of more than two groups. 
 
2.12.6. Confocal imaging of immunostained brain sections and analysis 
 
For imaging of the overview of Cux1, Sox9, Ctip2, and NeuN immunostaining, Leica Sp2 
confocal microscope with 10X objective was used. Cux1-positive neuronal nuclei 
expressing miR-140-3p-Sponge were manually counted using Cell Counter plug-in in 
ImageJ software. Cortical thickness of Ube3bf/f and Ube3bf/f;Emx1-Cre+/- was measured as 
the distance from the pia to the end of layer VI on coronal cross section. Tresholded binarized 
images after Watershed segmentation algorithm using ImageJ were used for quantification 
of number of neurons. NeuN-positive punctae more than 50 μm2 in size were counted as 
somata. For statistical analysis to compare two groups, t-test was employed.  
To acquire representative images of primary branches of CA1 apical dendrites of neurons 
expressing GFP and myrVenus, and for quantitative imaging of Sox9 signal from Sox9f/f 
neurons expressing GFP, or GFP and iCre, Leica Sp5 microscope with 40X objective with 
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confocal scanning Zoom 2.5 was used. Quantitative imaging was performed using ImageJ 
measure tool on manually selected somata. 
 
2.12.7. Light and epifluorescence microscopy 
 
Apochromatic fluorescence stereomicroscope Leica MZ16F was used to acquire images of 




Electrophysiological characterization of Ube3b knockout in neurons using autaptic culture 
system was performed by Dr. Silvia Ripamonti. Gamma-oscillations from CA3 hippocampal 
neurons were recorded in collaboration with Dr. Silvia Ripamonti and Dr. Matthieu 
Hammer. Both experiments were supervised by Dr. Jeong Seop Rhee (Molecular 
Neurobiology, MPIem).  
 
2.13.1. Autaptic neurons 
 
Briefly, autaptic cultured neurons (9-14DIV) were whole-cell voltage–clamped at −70 mV 
with the amplifier EPSC10 (HEKA) under the control of the Patchmaster 2 program (HEKA) 
[237]. All acquired traces were analyzed using AxoGraph X (AxoGraph 
Scientific). Recordings were performed with a patch-pipette solution and the extracellular 
solution (BASE+Ca2++Mg2+). EPSCs and IPSCs were evoked by depolarizing the cell from 
-70 to 0mV at a frequency of 0.2 Hz. The ready releasable pool (RRP) size was measured 
after 6 s application of 0.5 M hypertonic sucrose solution. The vesicular release probability, 
Pvr, was calculated as a ratio of the charge transferred during an action potential induced-
PSC divided by the charge during sucrose application. Short-term plasticity was measured 
by recording PSC during 10 Hz stimulation. Miniature EPSC (mEPSC) and IPSC (mIPSC) 
were recorded in the presence of 300 nM tetrodotoxin (TTX, Tocris Bioscience). Surface 
expression of glutamate, and GABA receptors was measured by application of 100 μM 
glutamic acid (Sigma) or 3 μM GABA (Sigma), respectively. 
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Patch-pipette solution: (all reagents from Sigma-Aldrich): 138/16.8 mM potassium 
gluconate/Hepes pH 7.4 at 310 mOsm, 10 mM NaCl, 1 mM MgCl2, 0.25 mM EGTA, 4 mM 
ATP-Mg2+, 0.3 mM GTP-Na+. 
BASE+Ca2++Mg2+: 140 mM NaCl, 2.4 mM KCl, 10 mM Hepes, 10 mM glucose, 4 mM 




Gamma oscillations were recorded in Ube3bf/f and Ube3bf/f;Emx1-Cre+/- mice at P15-23. 
Transverse hippocampal sections (300 µm thickness) were prepared from age-matched 
littermates as described previously [238] using a Leica VT1200S vibratome. Brain isolation 
and slice preparation were performed in sucrose-based slicing solution at 4°C in the presence 
of carbogen. After sectioning, slices were placed in a holding chamber containing artificial 
cerebrospinal fluid (ACSF) and let recover for 15 min before recording. Gamma-oscillations 
were recorded in CA3 field of hippocampus, where the peak power of kainate-induced 
gamma-oscillations is the highest [239]. Interface recording chamber (BSCBU Base Unit 
with the BSC-HT Haas Top, Harvard Apparatus) was used during recordings. Slices were 
steadily perfused with ACSF, and 33°C temperature was maintained. Extracellular recording 
electrode filled with ACSF was inserted into CA3 pyramidal cell layer, and extracellular 
field potential were recorded for more than 20 min before the addition of 50 nM or100 nM 
kainate. Baseline (20 min), and oscillatory activity (30 min) were measured using a 700B 
amplifier (Axon Instruments, Molecular Devices), low pass Bessel filtered at 3 KHz, and 
digitized by the Digidata 1440A data acquisition system (Axon Instruments, Molecular 
Devices). All traces were analyzed using Axograph X software (AxoGraph Scientific). 
Power spectra were calculated upon Fourier transforms of 10-min epochs (last 10 min of 
each recording) of recorded field activity. The baseline power spectrum was subtracted from 
the power spectrum obtained during kainate application. The dominant frequency within 25-
45 Hz was used to quantify the peak frequency. The power was calculated as the area under 
the respective peak in the power spectrum. 
 
Sucrose-based slicing solution: 230 mM sucrose, 26 mM NaHCO3, 2 mM KCl, 1 mM 
KH2PO4, 2 mM MgCl2, 10 mM D-glucose, 0.5 mM CaCl2. 
ACSF: 120 mM NaCl, 26 mM NaHCO3, 1 mM KH2PO4, 2 mM KCl, 1 mM MgCl2, 10 mM 
D-glucose, 2 mM CaCl2. 
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2.14. Behavioral testing 
 
Behavioral analysis of Ube3b conditional knockout mice (cKO) was performed by Prof. 
Ekrem Dere and Prof. Hannelore Ehrenreich (Clinical Neuroscience, MPIem, Göttingen).  
 
2.14.1. Animals and housing conditions 
 
For behavioral testing, mice were housed in groups of 5 in standard cages, with food, and 
water available ad libitum. Animals were kept under a 12 h light-dark cycle with lights on 
at 7:00 AM, and an ambient temperature of 20-22°C.  
 
2.14.2. Behavioral phenotyping 
 
All behavioral experiments were performed by a blind observer. Experiments were 
conducted during the light phase of the day (between 8:00 AM and 5:00 PM). Male 
Ube3bf/f;Emx1-Cre+/- mice (N=11), and their control Ube3bf/f littermates (N=8) were tested 
in an extensive behavioral test battery. The behavioral tests were conducted as previously 
described [240-243]. In this study, we only present the results concerning water-maze, 
nesting, social interaction in pairs and sociability, and social memory in the tripartite 
chamber. The age of mice at the beginning of testing was 8 weeks. 
 
2.14.3. Spatial learning, and memory: Morris water-maze 
 
Spatial learning and memory were assessed with the water maze test. A large circular tank 
(1.2 m in diameter and 0.68 m in depth) was filled with opaque water to a depth of 0.6 m. 
An escape platform (10x10 cm) was submerged 1 cm below the surface. The swim trajectory 
of the mouse was recorded by a computer and the video-tracking system VIEWER 2 
(Biobserve). The escape latency, swim speed, and path length were measured for each 
mouse. During the first 2 days, mice were trained to swim towards a visible platform (visible 
platform task), marked with a 15 cm high black flag, and placed randomly in different 
locations across trials (non-spatial training). The extra-maze cues were hidden during these 
trials. After 2 days of visible platform training, hidden platform training (spatial training) 
was performed. For 8 days, mice were trained to find a hidden platform (i.e. the flag was 
removed), located at the center of one of the four quadrants of the pool. The location of the 
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platform was fixed throughout testing. Mice had to navigate using extra-maze cues that were 
placed on the walls of the testing room. Every day, mice performed 4 trials with an inter-
trial interval of 5 min. For each trial, mice were placed into the pool facing the side wall 
randomly, and allowed to swim until they found the platform or for a maximum of 90 s. A 
mouse that failed to find the platform within 90 s was guided to the platform. The animal 
then remained on the platform for 20 s before being removed from the pool. After completion 
of the hidden platform training, a spatial probe trial was conducted. The platform was 
removed from the pool, and mice were allowed to swim freely for 90 s. 
The preference for the former platform zone was expressed as percent of time spent in the 
target zone relative to the total time spend in the pool (90 s). Control and cKO mice were 
also compared regarding the number of entries into the target zone. 
 
2.14.4. Social behavior 
 
2.14.4.1. Nesting  
 
The mice were single-housed for 1 h in the cage with bedding material and nesting towels 
before lights were turned off. After 2 nights of habituation, nesting towels were replaced by 
nestlets (pressed cotton squares ~3 g of weight). Nest building was assessed on the next 
morning. The remainder/leftover of the nesting material was weighted, and the proficiency 
of nest building was rated using a scale that ranged from 1-5 with lower scores indicating 
poor nest building behavior. 
 
2.14.4.2. Social interaction in pairs 
 
Every mouse was first individually habituated to the testing cage (30x30x30 cm) for 10 min 
over 2 consecutive days. Then, 3 pairs of unfamiliar mice of the same genotype were placed 
in the testing cage for 10 min. The duration of closed contact was recorded by a trained 







2.14.4.3. Sociability and social memory (Tripartite chamber)  
 
Social preference and memory was tested in the tripartite chamber. The apparatus consisted 
of a rectangular box that was divided into 3 chambers (40x20x22 cm). The dividers were 
made of transparent Plexiglas and had rectangular entries (35x220mm). The floor of the box 
was covered with bedding, exchanged between trials. The test mouse was introduced into 
the middle chamber, with the entries to the other 2 chambers closed, and allowed to 
acclimatize for 5 min. Next, a small wire cage (140x75x60 mm) containing an unfamiliar 
male C57BL/6N mouse of the same age and the similar weight (stranger 1) was placed in 
one outer chamber. An empty wire cage was positioned in the other outer chamber. The 
location (outer left or right chamber) of stranger 1 was alternated between trials. After 
unblocking the entries to the outer chambers the test mouse was allowed to freely move 
between chambers for 10 min. Time spent in and number of entries into each chamber were 
recorded by a video tracking system (Viewer2, Biobserve). Each mouse received second and 
third trials. The second trial was identical to the first, except for the stranger mouse being 
placed into the other outer chamber to control for possible side bias. On the third trial, the 
test mouse was presented with the familiar stranger 1 and an unfamiliar stranger 2. 
Sociability and social memory indexes were calculated as follows: Sociability index = (time 
investigating stranger)/((time investigating stranger)+(time investigating empty cage))x100; 
Memory index = (time investigating unfamiliar mouse)/(time investigating 
unfamiliar+familiar mouse)x100. 
 
2.15. Statistical analysis 
 







3.1.miR-140, Wwp1 and Wwp2, and Sox9 as regulators of neuronal development 
 
3.1.1. Downregulation of Wwp1 and Wwp2 in primary hippocampal neurons 
leads to axon acquisition defects 
 
Although the roles of Wwp1 and Wwp2 HECT-type ubiquitin ligases have been investigated 
in dividing cells, the function of both ligases in postmitotic neurons remains yet to be 
unveiled. Interestingly, an ortholog of murine Wwp1, C. elegans wwp-1, has been 
functionally correlated to sad-1, an ortholog of mammalian SAD-A and SAD-B kinases, and 
to syd-2, an ortholog of mammalian Liprin-α [244]. Despite a well-described role in 
controlling neurotransmitter release at the presynaptic specializations [245], SAD kinases 
govern proper axon-dendrite polarity acquisition in worm and mouse [233,234,246]. Indeed, 
former work of Mika Suga [199] in the lab proved that Wwp1 and Wwp2 are indispensable 
for acquisition of axons and formation of neuronal polarity. To further corroborate her 
findings and extend our understanding of the molecular context both ligases operate in, we 
transfected primary hippocampal neurons with a plasmid carrying a scramble sh-RNA 
(control) or with two plasmids, each carrying an sh-RNA targeting Wwp1 or Wwp2 to 
downregulate both ligases (Wwp1/2 double knock-down, dKD). All three knock-down 
constructs contained a myristoilated Venus (myr-Venus) expression cassette that allowed 
the visualization of cellular morphology. Relatively low efficiency of the calcium phosphate 
transfection method employed enabled the tracing of neurites projected from a single neuron. 
Nerve cells were fixed seven days after plating (DIV7). Primary hippocampal neurons, at 
this stage of culture, display apparent neuronal polarity with a prominent single axon and 
multiple dendrites. Immunostaining against the marker proteins: neurofilament M, 
recognized by SMI312 antibody, and MAP2 allows the identification of axons and dendrites 
(Fig. 5A, a, and b). We then quantified numbers of neurons projecting zero, one, or multiple 
axons. While 71 % of control neurons projected a single axon, only 46 % of analyzed 
Wwp1/2 dKD neurons did so. Strikingly, 39 % of Wwp1/2 KD neurons specified multiple 
axons, and 14 % showed a lack of SMI312-positive neurites (Fig. 5B), indicating that Wwp1, 
and Wwp2 are necessary for proper axon acquisition in primary hippocampal neurons. To 
ascribe the observed phenotype to the loss of Wwp1 and Wwp2, we biochemically analyzed 
the effect of sh-RNA on the levels of both ligases in neurons. Consequently, Western blotting 
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analysis demonstrated almost complete depletion of Wwp1 (Fig. 5C) and Wwp2 (Fig. 5D) 
from neurons infected with lentiviruses expressing sh-RNAs against Wwp1 or Wwp2 as 
compared to those infected with virus carrying scramble sh-RNA. 
 
 
Figure 5. Simultaneous knock-down of Wwp1 and Wwp2 results in defects in axon 
acquisition in primary cultured neurons. (A) Images of representative primary 
hippocampal neurons transfected with plasmid encoding scramble sh-RNA as a control (a) 
or with two plasmids encoding sh-RNAs to knock-down Wwp1 and Wwp2 (b). Neurons 
were transfected at DIV1 and fixed at DIV7. Arrowheads indicate axons with prominent 
SMI312 and undetectable MAP2 signals. Scale bar, 20 μm. (B) Quantification of the number 
of axons projected from a single neuron. Counted were relative numbers of neurons with 0, 
1, or multiple axons. Control, n = 35 neurons; Wwp1/2 dKD, n = 56 neurons; * p < 0.05, 
Chi-square test. (C, and D) Validation of shRNA expression vectors for Wwp1 (C) and 
Wwp2 (D) by Western blotting. Neurons were infected with lentiviruses expressing non-
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silencing sh-RNA (Control), or sh-RNAs for each E3 ubiquitin ligase (sh-Wwp1 or sh-
Wwp2) at DIV1 and neuronal lysates were harvested at DIV7. 
 
 
3.1.2. Knock-down of Wwp1 and Wwp2 in cortical progenitors leads to striking 
neuronal polarity defects and disrupts distribution of neurons in the cortical 
plate 
 
Shortly after plating, primary neurons form lamellipodia, which extend as short neurites after 
6 – 12 hours. Neuronal polarization takes place around 24 hours post-plating, when one of 
the neurites undergoes rapid outgrowth and acquires axonal fate [47]. This in vitro model of 
neuronal polarization recapitulates major aspects of neuronal polarity acquisition in vivo. 
After cell cycle exit through asymmetric cell division, postmitotic cortical neurons undergo 
transition to multipolar cells, projecting multiple neurites from the soma. One of the neurites 
emerges in radial direction and becomes a leading process. This facilitates radial 
translocation of the neuronal cell body alongside radial glial cell processes, which in turn 
specifies a trailing process located on the opposite pole of the nerve cell. Later on, the leading 
process becomes the main apical dendritic shaft, and the trailing one extends as an axon 
[247,248]. Disturbances of axon specification observed upon Wwp1/2 dKD in primary 
hippocampal neurons are likely to be paralleled by defects in specification of trailing and 
leading processes in newborn neurons, and leads to aberrances of neuronal migration, 
resulting in incorrect positioning of nerve cells throughout the cortical plate. To corroborate 
this hypothesis, and examine the effects of knock-down of Wwp1 and Wwp2 in vivo, we 
electroporated the pool of wild type cortical progenitors at E14.5 in utero with control 
scramble, or Wwp1/2 dKD sh-RNA expression vectors. Brains were sectioned at postnatal 
day 0 (P0), and postnatal day 10 (P10) followed by immunostaining of Venus to visualize 
cellular morphology, and study distribution of neurons throughout the cortex. DAPI staining 
(Fig. 6A, left panels) showed normal cortical layering and morphology, indicating that the 
gross structure of the brain was not affected by the surgery. We acquired Z-stacks of images 
of 100 μm-thick cross sections through a cortex per brain, maximum projected them into one 
image, and divided the cortical plate into five bins of identical dimensions from bin 1 
marking pial surface to bin 5 covering the ventricular zone. Next, we quantified the number 
of Venus-expressing neurons in each bin. The number of neurons counted was then 
expressed relative to total number of electroporated nerve cells. Already at P0, a majority of 
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neurons expressing control, non-silencing sh-RNA completed migration to the upper layers 
of the cortical plate, whereas newborn neurons expressing sh-RNAs for Wwp1 and Wwp2 
(Wwp1/2 dKD) displayed different distribution in the cortical plate (Fig. 6A, right panels). 
While most of control neurons completed migration and settled in cortical bin 2 (control, 
77.1 ± 3.3 %), Wwp1/2 dKD nerve cells displayed rather diffuse distribution in all bins, and 
only 46.1 ± 2.6 % of them were found in bin 2 (Fig. 6B). At this stage of development, 
migrating neurons acquire characteristic bipolar morphology with the leading and the 
trailing processes, each becoming the dendrite and the axon, respectively. Interestingly, 
some delayed neurons expressing sh-RNAs against Wwp1 and Wwp2 projected two leading 
processes or only one extending downwards, towards ventricular zone (Fig. 6C, lower panel, 
cell 2, and 3 from the right). Hence, we then scored control and Wwp1/2 dKD neurons as 
‘Bipolar’ or ‘Non-Bipolar’ based on the number and orientation of their leading and trailing 
processes. The number of cells of a given class was then expressed relative to total neuron 
number within a bin. There was significant decrease in the frequency of bipolar cells upon 
Wwp1/2 dKD as compared to control in lower layers of developing cortical plate (control – 
100 %, Wwp1/2 dKD – 81.7 ± 3.3 % of neurons in bin 4 were bipolar) (Fig. 6D).  
Postmitotic neurons inherit their axon-dendrite polarity from the apical-basal organization 
of the processes of their neuronal progenitors [249-251]. Hence, defects in polarity 
acquisition at early developmental stages (i.e. in P0 cortex) are likely to persist during brain 
development. To validate this hypothesis, we analyzed transfected neurons at P10 as well, 
and concluded that aberrances in polarity formation are striking and paralleled by diffuse 
distribution of neurons throughout the cortical layers (Fig. 7A). We then quantified Venus-
expressing neurons in each bin of cortex in a similar way as for the P0 brains. Majority of 
control neurons localized evenly to bin one and two (cortical layers II/III, bin 1 – 42.6 ± 8 
%, bin 2 – 41.0 ± 3.2 %, bin 3 – 5.6 ± 2.4 %, bin 4 – 0.8 ± 1.0 %, and bin 5 – 10.1 ± 7.1 %), 
which is the destination of pyramidal cortical neurons derived from E14/E15 progenitors 
[252]. Upon Wwp1/2 dKD, neurons distributed rather evenly throughout the cortex (bin 1 – 
22.2 ± 5.3 %, bin 2 – 37.3 ± 4.4 %, bin 3 – 16.9 ± 3.8 %, bin 4 – 5.3 ± 2.1 %, and bin 5 – 
18.2 ± 3.3 %) (Fig. 7B). 
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Figure 6. Knock-down of Wwp1 and Wwp2 follows with aberrant distribution and 
polarity defects in newborn neurons in vivo. (A) Representative images of DAPI signals 
(left panels), and immunostaining with anti-GFP antibody (right panels) in P0 cortices of 
wild type mice. Cortical progenitors were transfected in utero at E14.5 with plasmid 
encoding control non-silencing sh-RNA (upper panel), or cotransfected with two plasmids 
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carrying sh-RNAs to downregulate Wwp1 and Wwp2 (lower panel). Images represent 
maximum projections of Z-stacks through 100 μm thick coronal cryosections, stained with 
DAPI (left), or with anti-GFP antibody (right). Scale bar, 100 μm. (B) Distribution of cortical 
neurons upon double knock-down of Wwp1 and Wwp2 (Wwp1/2 dKD). Images of cortices 
were divided into 5 equal bins, and the relative number of neurons in each bin counted. 
Results are represented as averages ± S.D. Control, n = 2 brains; Wwp1/2 dKD, n = 2 brains; 
***p < 0.001, two-way ANOVA with Bonferroni post-hoc test. (C) Tracings of 
representative neurons in bin 3, and 4 of P0 control, or Wwp1/2 dKD brains. Scale bar, 25 
μm. (D) Quantification of neuronal polarities. Neurons were classified into either bipolar, or 
non-bipolar cells. Results are represented as averages ± S.D. Control, n = 2 brains; Wwp1/2 
dKD, n = 2 brains; ***p < 0.001, two-way ANOVA with Bonferroni post-hoc test.  
 
 
Additionally, whereas axons projected from control pyramidal neurons run along parallel 
trajectories towards the ventricle, Wwp1/2 dKD neurons show loss of such organization of 
fibers, and display extensive branching of neurites (Fig. 7A, enlarged square). Next, we 
examined the morphology of individual neurons in P10 brains. At this stage of development, 
cortical neurons of layer II/III are highly polarized, with the main apical dendrite projecting 
towards the pial surface, and the axon emerging from the opposite pole of the soma [253] 
(Fig. 7C, top panel). Radially arrayed control neurons with such a pyramidal shape 
comprised 99.3 ± 1.3 % of all neurons in bin 1, 93 ± 5.6 % in bin 2, 100.0 % in bin 3, and 4, 
and 46.0 ± 12.5 % in bin 5 (Fig. 7D). Upon Wwp1/2 dKD, we observed a significant decrease 
in the frequency of pyramidal neurons at the expense of cells with no prominent apical 
dendrites or axon (Fig. 7C, bottom panel, cells 1 – 4, and 6 from the left, Fig. 7D). Of note, 
several pyramidal neurons displayed misoriented apical dendrite in relation to the pial 
surface (Fig. 7C, bottom panel, cell 7 from the left). Consequently, Wwp1/2 dKD neurons 
with pyramidal characteristics comprised 89.6 ± 2.9 % of all neurons in bin 1, 66.7 ± 4.6 % 
in bin 2, 74.1 ± 2.9 % in bin 3, 75.3 ± 11.2 % in bin 4, and 24.2 ± 18.5 % in bin 5 (Fig. 7D). 
Interestingly, polarity aberrances were the most prominent in Wwp1/2 dKD neurons found 
in deeper cortical layers, probably due to migration delay, as compared to neurons that 
distributed in layer II/III. Altogether, knock-down of Wwp1, and Wwp2 abrogates axon 
specification in primary hippocampal neurons paralleled by persistent distribution defects 




Figure 7. Knock-down of Wwp1 and Wwp2 leads to persistent distribution aberrances 
and disrupts neuronal polarity in vivo. (A) Representative images of DAPI staining (left 
panels), and GFP immunostaining (right panels) in P10 cortices of wild type mice. Neurons 
were electroporated in utero at E14.5 with a plasmid encoding for myr-Venus and control 
non-silencing sh-RNA (upper panel), or with two plasmids, for expression of myr-Venus 
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and sh-RNAs targeting Wwp1 and Wwp2 (lower panel). Images represent maximum 
projections of stacks through 100 μm thick coronal cryosections, immunostained with an 
antibody against GFP. Scale bar, 100 μm. (B) Distribution of neurons in the cortex upon 
Wwp1/2 dKD in vivo. The number of counted neurons in each bin was expressed as a 
fraction of total number of electroporated nerve cells. Results are represented as averages ± 
S.D. Control, n = 4 brains; Wwp1/2 dKD, n = 3 brains; *** p < 0.001, * p < 0.05, two-way 
ANOVA with Bonferroni post-hoc test. (C) Tracings of representative neurons in bin 3 and 
4 in P10 brains electroporated with control sh-RNA or sh-RNA for KD of Wwp1 and Wwp2. 
Scale bar, 50 μm. (D) Classification of neurons based on polarity upon Wwp1/2 dKD in 
vivo. Neurons were categorized as ‘No Polarity’, (neurons with no prominent dendrite or 
axon), ‘Pyramidal’ (neurons with a single prominent dendritic shaft projecting towards the 
pia), ‘Multipolar’ (neurons with more than one prominent dendrite or more than one axon), 
or ‘Misoriented’ (neurons with misoriented prominent apical dendrite), and the relative 
number of neurons of a given class was expressed as averages ± S.D. Control, n = 4 brains; 
Wwp1/2 dKD, n = 3 brains; *** p < 0.001, ** p < 0.01, * p < 0.05, two-way ANOVA with 
Bonferroni post-hoc test. 
 
 
3.1.3. Genetic deletion of Wwp1 and Wwp2 leads to disturbances in axon 
acquisition in primary hippocampal neurons and disrupts polarity of 
cortical pyramidal neurons in vivo 
 
In order to corroborate if pronounced polarity aberrances in neurons upon Wwp1/2 dKD is 
a specific consequence of the loss of both ligases, we took advantage of Wwp1f/f; Wwp2f/f 
transgenic mice. In this mouse line, critical exons of Wwp1 and Wwp2 genes are flanked by 
loxP sequences. Consistent with deficiencies characterized for Wwp1/2 dKD, 39 % of 
Wwp1f/f; Wwp2f/f primary hippocampal neurons expressing Cre recombinase displayed 
multiple axons versus only 15 % of control Wwp1f/f; Wwp2f/f nerve cells expressing GFP 
endowed with multiple axons (Fig. 8A, and 8B). To support that the axon acquisition 
disturbances are indeed induced by loss of both Wwp ligases from the brain cells, we 
performed biochemical analyses in control Wwp1+/+; Wwp2+/+ and conventional double 
knockout Wwp1-/-; Wwp2-/- mice. For this purpose, we crossed Wwp1f/f; Wwp2f/f with the 
E2A-Cre driver line in which Cre recombinase is expressed ubiquitously, therefore 
generating conventional Wwp1-/-; Wwp2-/-. Western blotting using antibodies against Wwp1 
and Wwp2 (Fig. 8C) confirmed complete depletion of both ligases from Wwp1-/-; Wwp2-/- 




Figure 8. Disturbances in axon acquisition upon double knockout of Wwp1 and Wwp2 
in primary hippocampal neurons. (A) Images of representative primary hippocampal 
neurons prepared from Wwp1f/f; Wwp2f/f mice. Neurons were transfected with an expression 
plasmid encoding EGFP as a control (a), or Cre recombinase to knockout Wwp1 and Wwp2 
(b), fixed at DIV7, and immunostained for axonal and dendritic marker proteins. 
Arrowheads indicate axons. Scale bar, 20 μm. (B) Quantification of the number of axons 
projected from a single neuron. Control, Wwp1f/f; Wwp2f/f + EGFP, n = 21; double Wwp1 
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and Wwp2 knockout, Wwp1f/f; Wwp2f/f + EGFPiCre, n = 41 neurons; * p < 0.05, Chi-square 
test. (C) Validation of the loss of Wwp1 and Wwp2 by Western Blotting in cortical lysates 
prepared from Wwp1+/+; Wwp2+/+, and Wwp1-/-; Wwp2-/- P7 mice.  
 
 
Knock-down of Wwp ligases in cortical neurons leads to severe morphological defects in 
vivo. Hence, we next studied the impact of genetic depletion of Wwp1 and Wwp2 in neuronal 
progenitors by transfecting plasmids encoding GFP (control), or GFP and Cre recombinase 
(Wwp1/2 dKO) by in utero electroporation in Wwp1f/f; Wwp2f/f mice (Fig. 9A). The Wwp1/2 
dKO neurons exhibited slight accumulation of cells in deeper cortical layers (bins 3 and 4, 
Fig. 9B). The impact of Wwp1 and Wwp2 loss on neuronal morphology in deeper cortical 
layers was marked, and neurons with defective polarity resembled the ones described for 
WWP1/2 dKD neurons (Fig. 7C, lower panel, cells 1 – 4, and 6 from the left). Whereas 91.7 
± 11.8 % of control, GFP expressing neurons in bin 3, and 100 % in bin 4 presented a single 
apical dendrite, 30.2 ± 22.5 % of Wwp1/2 dKO neurons in bin 3 and 34.3 ± 8.1 % in bin 4 
were categorized as pyramidal (Fig. 9D). Some neurons devoid of Wwp1 and Wwp2 
manifested multiple dendritic shafts emerging from the soma (Fig. 9C, lower panel, cells 1 
– 5, and cell 7 from the left, and Fig. 9D). Taken together, both knock-down of Wwp1 and 
Wwp2, and genetic depletion of Wwp1 and Wwp2 from neurons results in striking 
disturbances in specification of axon-dendrite polarity, and possibly leads to disruption of 
neuronal migration. In conclusion, both ligases are indispensable for acquiring proper 




Figure 9. Knockout of Wwp1 and Wwp2 follows with severe neuronal polarity defects 
in vivo. (A) Representative images of DAPI (left panels), and GFP fluorescence signals 
(right panels) in P10 cortices of Wwp1f/f; Wwp2f/f mice. Neurons were electroporated in utero 
at E14.5 with plasmids encoding myr-Venus and GFP (upper panel), or myr-Venus, GFP, 
and Cre recombinase (iCre) (lower panel) to induce double knockout of Wwp1 and Wwp2 
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(Wwp1/2 dKO). Scale bar, 100 μm. (B) Quantification of neuronal distribution upon Wwp1/2 
dKO in vivo. Results are represented as averages ± S.D. Control, Wwp1f/f; Wwp2f/f + EGFP, 
n = 2 brains; Wwp1/2 dKO, Wwp1f/f; Wwp2f/f + EGFPiCre, n = 2 brains; two-way ANOVA 
with Bonferroni post-hoc test. (C) Tracings of representative control and Wwp1/2 dKO 
neurons in bin 3 and 4 of P10 brains. Scale bar, 50 μm. (D) Classification of neuronal 
polarities upon Wwp1/2 dKO. Results are represented as averages ± S.D. Control, Wwp1f/f; 
Wwp2f/f + EGFP, n = 2 brains; Wwp1/2 dKO, Wwp1f/f; Wwp2f/f + EGFPiCre, n = 2 brains; 
** p < 0.01, * p < 0.05, two-way ANOVA with Bonferroni post-hoc test. 
 
3.1.4. miR-140 is expressed in nerve cells 
 
Interestingly, Wwp2 gene harbors a locus of miR-140, and concomitant expression of 
truncated splicing isoform of Wwp2 and its intron-retained miR-140 has been reported in 
non-neuronal tissue [172]. microRNAs (miRNAs) comprise an evolutionarily conserved 
molecular mechanism to post-transcriptionally control gene expression [144,254,255]. 
Intronic miRNAs have been functionally linked with their host genes [183]. It has been 
proposed that upon concomitant transcription of host gene and its intragenic miRNAs, both 
genes are involved in one molecular pathway either supporting one another [256] or 
functioning as mutual antagonists [257]. Indeed, Wwp2 and miR-140 are both expressed in 
dividing and differentiating cells, such as chondrocytes [172], or stem cells [258], where 
they play crucial roles regulating their targets post-translationally and post-transcriptionally. 
To unravel if both Wwp2 and miR-140 undergo coordinated expression to regulate polarity 
formation in postmitotic neurons, we sought miR-140 in the central nervous system. We 
performed in situ hybridization on developing and adult brain sections with antisense probe 
directed against intronic Wwp2 sequence spanning miR-140 stem-loop, pri-miR-140 (Fig. 
10A, top scheme). We detected strong hybridization signals in the ventricular zone of the 
developing cortical plate, ganglionic eminences (Fig. 10A), and throughout entire adult brain 
(Fig. 10B). However, rather than transcription of miR-140 precursor locus, it is the 
processing and maturation of pri-miR-140, that leads to generation of effector miRNA 
duplex [259,260]. We employed qRT-PCR using specific primers (Fig. 10C) to detect both 
mature miR-140 strands (-5p and -3p) in developing and adult mouse cortex (Fig. 10D). 
Interestingly, miR-140-3p displayed a distinct expression profile with early embryonic 
induction and rather stable postnatal level. In contrast, miR-140-5p was expressed at 
constant levels through the development and did not present such dynamic changes of 
expression. This indicates that miR-140-3p may serve as the guide miR-140 strand to silence 
mRNAs of genes critical during neuronal development at embryonic to perinatal stages.  
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Figure 10. miR-140 is expressed in murine central nervous system. (A and B) Results of 
in situ hybridization of the antisense probe for intronic Wwp2 spanning miR-140 locus 
(upper scheme) on sagittal sections of E16 (A), and P20 (B) wild type mouse brain. Images 
in the top right inserts represent signals from the control sense probe; (A) cortical plate (cp), 
ganglionic eminence (ge); (B) cortex (cx), hippocampus (hip), cerebellum (ce), brain stem 
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(st), thalamus (th), striatum (str), and olfactory bulb (ob). (C) Validation of qRT-PCR primer 
specificity for miR-140-5p, and -3p. cDNA samples were prepared from total RNA extracted 
from cerebral cortices of miR-140+/+, miR-140+/-, and miR-140-/- mice at P21. The level of 
each miR-140 strand was expressed relative to component of spliceosome, U6 snRNA - 
RNU6B. (D) Developmental profile of miR-140 expression in developing mouse cortex. 
Total RNA was isolated from cortices of mice of depicted age. The level of each miR strand 
was expressed relative to RNU6B, and to the miR level at E13. Results are represented as 
averages ± S.E.M, n = 2 independent experiments. (E) In situ hybridization with locked-
nucleic acid probes (upper scheme) for mature miR-140-3p (top panel), dendritic miR-134 
(middle panel), and scramble control (bottom panel) in DIV7 primary hippocampal neurons. 
Scale bar, 10 μm. 
 
 
To validate if developing neurons express miR-140-3p, and to study its cellular localization, 
we performed further in situ hybridization with locked nucleic acid probes on DIV7 primary 
mouse hippocampal neurons in collaboration with Dr. Tamara Rabe and Prof. Ahmed 
Mansouri (MPIbpc, Göttingen). Scramble probe was used as a negative control, and as a 
positive reporter, we used brain-enriched miR-134 [261]. As was the case for miR-134, at 
this developmental stage miR-140-3p did enrich neither in dendritic nor in axonal 
compartments, and localized at somatic endosomes (Fig. 10E). Taken together, miR-140 as 
well as Wwp2 is expressed in developing and adult murine neurons, implicating that miR-
140 may function in postmitotic neurons. 
 
3.1.5. Loss of miR-140 phenocopies the knockout of Wwp1 and Wwp2 in regard to 
axon-dendrite specification in neurons and leads to aberrant distribution of 
developing nerve cells 
 
In order to test the hypothesis that miR-140 exerts synergistic or antagonistic effects on the 
role of its host Wwp2, we analyzed miR-140 KO (miR-140-/-) mice in terms of axon 
acquisition. Surprisingly, primary hippocampal neurons prepared from miR-140 KO animals 
display strong defects in axon specification (Fig. 11A, a, and b) with 45 % of miR-140 KO 
neurons projecting multiple axons (Fig. 11B). Exogenous delivery of miR-140 to miR-140 
KO neurons by transfecting a plasmid encoding for the precursor of the duplex (pre-miR-
140), reversed the aberrant axon acquisition phenotype (12 % miR-140 KO neurons 




Figure 11. Loss of miR-140 in neurons phenocopies loss of Wwp1 and Wwp2 regarding 
axon acquisition in primary hippocampal neurons. (A) Images of representative primary 
hippocampal neurons prepared from miR-140+/+ (a, and c) or miR-140-/- (b, and d) mice. 
Neurons were transfected with expression plasmid encoding EGFP, and scramble miR (a, 
and b), or EGFP, and miR-140 (c, and d), and fixed at DIV7. Arrowheads point to SMI312-
positive axons. Scale bar, 20 μm. (B) Quantification of number of axons specified by 
individual neurons. miR-140+/+, n = 41 neurons; miR-140-/-, n = 49 neurons; miR-140+/+ + 
miR-140, n = 35 neurons; miR-140-/- + miR-140, n = 41 neurons; *** p < 0.001 by Chi-




Next, we studied morphology and cortical distribution of P0 miR-140 KO neurons after in 
utero electroporation of plasmids encoding for GFP and Venus at E14.5 (Fig. 12A). The 
miR-140 KO neurons display altered distribution throughout cortical plate delay as 
compared to control nerve cells, suggesting a defect in neuronal migration. Majority of 
control neurons, 57.0 ± 10.1%, completed migration towards the pial surface, whereas only 
20.0 ± 7.0 % of the miR-140 KO neurons was found in bin 1. Additionally, significantly 
more of miR-140 KO neurons were located to bin 2 (54.3 ± 14.4 %) as compared to 31.9 ± 
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12.1 % of control nerve cells (Fig. 12B). Moreover, miR-140 KO cells displayed strong 
defects in terms of morphology. Significantly more miR-140 KO neurons found in the deeper 
layers of cortical plate possessed multiple neurites directed towards the pia (Fig. 12C, lower 
panel, cells 1, and 2 from the left), or failed to specify a prominent neurite (Fig. 12C, lower 
panel, cell 3, and 9 from the left) as compared to the wild type cells. Consequently, majority 
of the control cells in the deeper layers of developing cortical plate presented bipolar 
morphology (95.8 ± 7.2 % in bin 4, and 83.3 ± 23.6 % in bin 5), whereas only a small fraction 
of miR-140 KO neurons were classified as bipolar (39.5 ± 21.2 % in bin 4, and 29.7 ± 14.9 
% in bin 5) (Fig. 12D). Altogether, similarly to Wwp ubiquitin ligases, miR-140 governs 
axon-dendrite specification in primary hippocampal neurons, and is indispensable for proper 




Figure 12. Knockout of miR-140 leads to abnormal neuronal distribution and disturbs 
polarity acquisition in newly born neurons in vivo. (A) Representative images of DAPI 
stain (left panels), and GFP/Venus fluorescence (right panels) in P0 cortices of miR-140+/+ 
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(wild type, WT), or miR-140-/- (knockout, KO) mice. Neurons were transfected in utero at 
E14.5 with plasmids encoding myr-Venus and GFP. Scale bar, 100 μm. (B) Distribution of 
neurons in the cortical plate upon miR-140 KO. Bars represent averages of relative number 
of neurons ± S.D. miR-140+/+, n = 3; miR-140-/-, n = 4 of analyzed brains; *** p < 0.001, * 
p < 0.05, two-way ANOVA with Bonferroni post-hoc test. (C) Tracings of representative 
neurons in bin 3 and 4 in miR-140+/+, and miR-140-/- brains at P0. Scale bar, 25 μm. (D). 
Classification of neuronal morphologies upon miR-140 KO. Bars represent averages of 
relative number of neurons ± S.D. miR-140+/+, n = 3 brains; miR-140-/-, n = 4 brains; *** p 
< 0.001, two-way ANOVA with Bonferroni post-hoc test.  
 
 
3.1.6. miR-140-3p, but not miR-140-5p is the mediator of axon specification in 
primary hippocampal neurons 
 
It has been reported, that in chondrocytes, miR-140-5p functions as the guide strand and 
regulates gene expression. In each miRNA, the strand with lower stability of base pairing 
from the second to fourth nucleotide is preferentially incorporated into miRNA-induced 
silencing complex to exert its gene silencing functions, whereas the remaining strand, the 
passenger strand, is degraded, or less biologically active [162,262,263]. RNA modifications, 
RNA-binding proteins, alternative Drosha processing mechanisms, or other molecular 
contexts can lead to an exchange of the guide strand of a given microRNA duplex in so-
called ‘arm switching’ [200,264-266]. During cortical development, it is the expression of 
miR-140-3p strand that is induced early (Fig. 10D). In order to verify which strand of miR-
140 duplex is necessary for proper axon acquisition in neurons, together with Fritz Benseler 
(AGCT Lab, MPIem, Göttingen), we designed sponge constructs to downregulate individual 
miR-140 strands in neurons. RNA-sponge technology relies on complementary binding of 
targeted miRNA to its tandemly repeated binding sites. Upon delivery of the sponge-
expressing plasmid to the neuron, targeted miRNA molecules are sequestered, and lead to 
de-inhibition of transcription of its target mRNAs. The specificity of sponge constructs 
towards each miR-140 strand was confirmed using PITA algorithm, allowing for 





Figure 13. Knock-down of miR-140-3p, but not of miR-140-5p, leads to formation of 
multiple axons in primary hippocampal neurons. (A) Images of primary hippocampal 
neurons prepared from wild type mice. Nerve cells were transfected with control sponge (a), 
or miR-140-5p sponge (b), and with control sponge (c), or miR-140-3p sponge (d), and fixed 
at DIV7. All plasmids contained a Venus expression cassette that enabled tracing of 
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individual neurites. Scale bar, 20 μm. (B) Quantification of the number of axons projected 
by sponge-transfected single neurons. Control, n = 30 neurons; miR-140-5p-Sponge, n = 19 
neurons; control, n = 20 neurons; miR-140-3p-Sponge, n = 25 neurons; *** p < 0.001 by 
Chi-square test, and *** p < 0.01, Fisher’s exact test between neurons expressing control 
sponge (c), and neurons expressing miR-140-3p sponge (d). (C) Representative images of 
neurons expressing control (a), and miR-140-3p sponge (b) at DIV7.  
 
 
While KD of miR-140-5p by expressing miR-140-5p-Sponge in wild type primary 
hippocampal cells did not induce any morphological and polarity defects (Fig. 13A, a, and 
b; B, a, and b), cells transfected with plasmid encoding miR-140-3p-Sponge exhibited a 
remarkable increase in neurons projecting multiple axons (Fig. 13A, c, and d; Fig. 13B; 7 % 
of control cells, 68 % miR-140-3p-Sponge expressing neurons). Those apparent axon 
acquisition aberrances were paralleled by numerous peculiar filopodia-like protrusions 
identified on some neurons expressing miR-140-3p-Sponge (Fig. 13C). Those findings 
demonstrate that -3p strand of miR-140 duplex is essential for normal axon specification 
operating in primary hippocampal neurons. 
 
3.1.7. Knock-down of miR-140-3p in cortical progenitors leads to persistent 
polarity aberrances and migration disturbances 
 
In order to study if aberrant axon acquisition in primary neurons upon acute knock-down of 
miR-140-3p is paralleled by morphological alterations of developing cortical neurons, we 
introduced plasmids encoding miR-140-3p-Sponge to cortical progenitors by in utero 
electroporation at E14, and sectioned mouse brains at P0 and P10 (Fig. 14A, and 15A). At 
P0, five days after transfection of the miR-140-3p knock-down construct to neurons, we 
observed no differences in neuronal distribution in cortical plate (Fig. 14B). Nonetheless, 
we distinguished remarkable aberrances in morphology of newborn neurons transfected with 
miR-140-3p-Sponge construct (Fig. 14C, lower panel, cells 1 – 3 from the right with 
multipolar morphology; cells 4 and 5 from the right with misoriented leading processes). 
Notably, some of those neurons resembled abnormal newborn Wwp1/2 dKD nerve cells 
(compare Fig. 14C and Fig. 6C). Indeed, significantly less of miR-140-3p-Sponge 
expressing neurons retained bipolar morphology as compared to control Sponge expressing 
cells (Fig. 14D; miR-140-3p-Sponge, 80.4 ± 8.6 % bipolar neurons in bin 4, and 75.7 ± 17.1 
% in bin 5 of -3p-Sponge expressing neurons; control Sponge, 95.2 ± 5.5 % in bin 4, and 
92.7 ± 7.3 % in bin 5). 
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In later stages of the development, at P10, miR-140-3p KD neurons consistently manifested 
morphological defects paralleled by strong aberrances in distribution of nerve cells in the 
cortex (Fig. 15A). Fig. 15B illustrates that significantly more of miR-140-3p-Sponge 
transfected neurons distributed in bin 1 (miR-140-3p-Sponge, 28.2 ± 9.2 %; control Sponge, 
19.9 ± 5.3 % of transfected neurons), and in bin 3 (miR-140-3p-Sponge, 10.3 ± 4.7 %; 
control Sponge, 1.4 ± 1.1 %) at the expense of nerve cells in bin 2 (miR-140-3p-Sponge, 
58.2 ± 7.3 %; control Sponge, 78.7 ± 4.6 %). Morphological analysis of individual neurons 
revealed pronounced defects in polarity, mostly manifested by acquisition of multiple apical 
dendrites, or misorientation of the dendritic axis (Fig. 15C, lower panel, multiple apical 
dendrites: cell 1, 6 – 9, 13; misoriented dendritic axis towards the pia: cell 2, 3, 10, 14 from 
the left). Majority control neurons in bin 3 was pyramidal (66.7 ± 55.7 %), whereas only 18 
± 15.3 % miR-140-3p-Sponge transfected neurons in bin 3 displayed normal pyramidal 
morphology (Fig. 15D). 
Taken together, depletion of miR-140-3p from cortical nerve cells leads to pronounced 





Figure 14. Knock-down of miR-140-3p in newborn neurons leads to polarity formation 
defects in vivo. (A) Representative images of DAPI staining (left panels), and Venus 
fluorescence (right panels) in P0 cortices of wild type mice. Neurons were electroporated in 
utero at E14.5 with plasmids encoding Venus, and control sponge (upper panel) or Venus, 
and miR-140-3p sponge (lower panel). Scale bar, 100 μm. (B) Neuronal distribution upon 
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miR-140-3p KD. Results are represented as averages ± S.D. Control, n = 7 brains; miR-140-
3p-Sponge, n = 7 brains; two-way ANOVA with Bonferroni post-hoc test. (C) Tracings of 
representative control, and miR-140-3p KD neurons in bin 3, and 4 of P0 brains. Scale bar, 
25 μm. (D) Classification of neuronal morphologies. Results are represented as averages ± 
S.D. Control, n = 7 brains; miR-140-3p-Sponge, n = 7 brains; * p < 0.05, ** p < 0.01 two-
way ANOVA with Bonferroni post-hoc test.  
 
 
3.1.8. Altered distribution of neurons upon miR-140 depletion is not caused by 
aberrances in neurogenesis 
 
As the neurogenesis proceeds, progenitors in the ventricular and subventricular zone give 
birth to neocortical neurons of different cortical layers in a precisely controlled temporal 
fashion from E11.5 to E17.5 in mice [268]. Postmitotic neurons distribute in each layer of 
the developing neocortex depending on their identity specified at birth. Cut-like homeobox 
1 (Cux1) is induced in immature neurons of layer II/III/IV and its expression prevails upon 
completion of cortical lamination [29]. Mutations in homeobox genes controlling laminar 
organization of the cortex lead to expansion or shrinkage of different cortical different layers 
due to aberrant identity specification of neurons. 
Loss of polarity formation in neurons either driven by dKD of Wwp ligases or by miR-140-
3p is always paralleled by altered positioning of neurons in the cortex (Fig. 16A). In order 
to corroborate, that observed altered distribution of neurons is not due to alterations of 
neuronal identity, we immunostained neurons transfected miR-140-3p-Sponge constructs in 
vivo at E14.5 for Cux1 (Fig. 16B). As illustrated in Fig. 16C, 88.0 ± 2.2 % of miR-140-3p-
Sponge expressing neurons in bins 3 and 4 were positive for Cux1. On the whole, we 
concluded that aberrant distribution of miR-140-3p KD neurons is not caused by 
misregulation of neuronal identity, but is rather due to morphological defects in neurons that 




Figure 15. Knock-down of miR-140-3p leads to migratory defects and persistent 
polarity disruption in cortical neurons in vivo. (A) Representative images of DAPI 
staining (left panels), and Venus fluorescence (right panels) in P10 cortices of wild type 
mice. Neuronal progenitors of the cortex were electroporated in utero at E14.5 with plasmids 
encoding Venus and control sponge (upper panel), or Venus and miR-140-3p sponge (lower 
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panel). Scale bar, 100 μm. (B) Neuronal distribution upon miR-140-3p KD in vivo. Results 
are represented as averages ± S.D. Control, n = 5 brains; miR-140-3p-Sponge, n = 8 brains; 
*** p < 0.001, * p < 0.05, two-way ANOVA with Bonferroni post-hoc test. (C) Tracings of 
representative control and miR-140-3p KD neurons in bins 3 and 4 in P10 brains. Scale bar, 
50 μm. (D) Neuronal polarity classification upon miR-140-3p KD. Results are represented 
as averages ± S.D. Control, n = 5; miR-140-3p-Sponge, n = 8; *** p < 0.001, two-way 
ANOVA with Bonferroni post-hoc test. 
 
 
Figure 16. Cortical neurons expressing miR-140-3p display aberrant polarity and 
express markers of upper cortical layer identity. (A) Example images of Venus 
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fluorescence in neurons transfected with control (left panel), or miR-140-3p sponge (right 
panel). Scale bar, 100 μm. (B) Cux1 immunostaining of neurons transfected with miR-140-
3p sponge. (C) Quantification of relative number of Venus-positive, miR-140-3p sponge 
transfected and Cux1-positive, or negative neurons in bin 3 and 4. Results are represented 




3.1.9. Overexpression of miR-140 in primary hippocampal neurons abrogates 
axon formation 
 
In order to study if overexpression of miR-140 exerts opposite effects on axon formation as 
compared to miR-140 KO or miR-140-3p KD, we designed and cloned a plasmid expressing 
tandem repeat of pri-miR-140 (Fig. 17A). Almost half (47 %) of primary hippocampal 
neurons overexpressing pri-miR-140 (miR-140 OE) failed to project SMI312-positive, and 
MAP2-negative axons, while 80 % of neurons expressing control plasmid were endowed 
with a single axon (Fig. 17B). This indicates miR-140-mediated gene expression regulation 
of axon specification is dose-dependent, namely its depletion leads to formation of multiple 




Figure 17. Overexpression of miR-140 abolishes axon formation in primary 
hippocampal neurons. (A) Nerve cells were transfected with expression plasmid encoding 
EGFP as a control (a) or EGFP, and a tandemly repeated precursor sequence of miR-140 
(miR-140 OE) (b), and fixed at DIV7. Scale bar, 20 μm. (B) Quantification of polarities in 
miR-140 overexpressing neurons. Control, n = 13; miR-140 OE, n = 17 neurons; * p < 0.05 
by Chi-square test, and * p < 0.05, Fisher’s exact test between wild type neurons expressing 





3.1.10. Detrimental effects of miR-140 and Wwp1/Wwp2 loss in neurons do not seem 
to depend on reciprocal miR-host gene interaction 
 
Genetic depletion of miR-140 requires excision of part of Wwp2 intronic DNA [201]. This 
in turn may lead to aberrant pre-mRNA splicing of Wwp2 transcript followed by frame shift 
or destabilization of pre-mRNA. Additionally, transcription of Wwp1 and Wwp2 might be 
compromised by the loss of miR-140, which has been reported to target mRNAs of several 
transcription factors, like FoxP2, Klf9, and Sox2 [269-271]. Described neuronal effects of 
miR-140 loss may therefore be attributable to the downregulation of Wwp1 and Wwp2. In 
order to study if miR-140 depletion from the genome results in changes of Wwp1 and Wwp2 
levels, we performed Western blotting in miR-140+/+ and miR-140-/- mouse brains using 
antibodies specific for both Wwp1 and Wwp2 ligases (Fig. 18A). No changes of Wwp 
ligases levels were detected in brains devoid of miR-140 (Fig. 18B, and 18C). 
Alternatively, Cre-mediated critical excision of critical exon in Wwp2 may prompt 
degradation of its altered mRNA and result in loss or downregulation of miR-140. To 
corroborate this hypothesis, we performed qRT-PCR to detect both miR-140 strands using 
P0 brains of Wwp2+/+ and Wwp2-/- mice. Similarly, we observed no alterations in miR-140 
levels in Wwp2-/- animals (Fig. 18D, and Fig. 18E). 
Altogether, it seems that miR-140- and Wwp-mediated regulation of neuronal development 





Figure 18. Reciprocal regulation of miR-140 and Wwp ligases. (A) Quantitative Western 
blotting of the levels of Wwp1 and Wwp2 in cortices of miR-140+/+ (WT) and miR-140-/- 
(KO) P0 mice. (B, and C) Wwp1 and Wwp2 protein levels were normalized to β-actin, and 
expressed relative to the level of each ligase in miR-140+/+ cortex. Results are represented as 
averages ± S.D. Control, miR-140+/+, n = 4; miR-140-/-, n = 3; unpaired t-test. (D, and E) 
qRT-PCR for of -3p (D), and -5p (E) miR-140 strands in P0 cortices of Wwp2+/+, and Wwp2-
/- mice. Wwp2+/+, n = 3; Wwp2-/-, n = 2; unpaired t-test.  
 
 
3.1.11. Proteomic screens for putative miR-140 targets involved in regulation of 
neuronal polarity acquisition 
 
microRNA exerts several effects on its target mRNA it associates with. Most commonly 
known effects include recruitment of decapping enzymes, endo- and exonucleases that affect 
mRNA stability, inhibition of translation initiation or repression of translation elongation 
[272]. Consequently, knockout of a given microRNA results in slight up-regulation of 
protein expression of its targets [273]. To identify downstream molecular components of 
miR-140-mediated regulation of axon formation and neuronal morphology and distribution, 
we applied a mass spectrometric approach using synaptosomal fractions from miR-140+/+ 
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and miR-140-/- mouse cortices (Fig. 19A). Homogenized mouse cortex were subjected to 
centrifugation in a sucrose gradient. Synaptosome fractions (P2C) collected from the 
interphase between 1.0 M and 1.2 M sucrose from 5 cortices of miR-140+/+ and 5 of the miR-
140-/- mice were subjected to label-free comparative mass spectrometry (with Olaf Jahn, 
MPIem, Göttingen). Next, we validated the purification procedure by Western blotting in 
protein fractions obtained along the procedure. PSD-95, a marker of postsynaptic density 
(PSD), was consequently enriched in P2C, which was paralleled by persistent level of 
cytoplasmic Rab-GDI (Fig. 19B). Based on the number and amount of each unique peptide 
detected by mass spectrometry, we computed p-values of detection with Bonferroni post-
hoc test. Putative miR-140 target mRNAs were chosen based on fold increase in miR-140 
KO synaptosomes (log2 ratio WT/KO), p-value, and Bonferroni post-hoc test (Fig. 19C). To 
exclude indirect effects of miR-140 depletion, we focused on mRNAs with putative miR-
140-3p binding sites in 3’ untranslated regions (3’UTRs). PITA algorithm, allowing for 
calculation of Gibbs free energy changes upon microRNA-mRNA binding, revealed 
candidate miR-140-3p binding sites in 3’UTRs of Nefm and Fyn mRNAs (asterisks, Fig. 
19D). We detected one sequence in Nefm, and five in Fyn 3’UTRs putatively bound by miR-
140-3p. We then validated the results of proteomics results by Western blotting in 
synaptosomal fractions of miR-140+/+ (WT) and miR-140-/- (KO) mouse brains, using 
antibodies against neurofilament M (NFM, encoded by Nefm gene) and Fyn kinase (encoded 
by Fyn gene) (Fig. 19E). Quantification of relative levels of NFM and Fyn revealed a trend 
towards a slight up-regulation of both proteins in synaptosomal fraction of miR-140 KO 




Figure 19. Identification of miR-140 downstream targets. (A) A schematic of 
synaptosome purification from miR-140+/+ and miR-140-/- mouse brains. (B) Validation of 
synaptosomal preparation by Western blotting. (C) List of selected putative miR-140 targets 
identified by quantitative proteomics. Asterisks depict proteins possessing putative miR-
140-3p binding sites along their 3’ UTR according to PITA free Gibbs energy calculation 
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algorithm. (D) Schematic of mRNAs of Nefm and Fyn with putative miR-140 binding sites 
in their 3’UTR (@). Scale bar, 300 base pairs. (E) Validation of the proteomics experiment 
by Western blotting with antibodies against NFM (upper panel), and Fyn (lower panel) in 
synaptosomal fractions from miR-140+/+ and miR-140-/- cortices. (F) Quantification of 
Western blotting experiment in (E). The level of NFM, and Fyn was normalized to protein 
loading and expressed relative to the level in miR-140+/+. Results are represented as averages 
± S.D. miR-140+/+, n = 5; miR-140-/-, n = 5, unpaired t-test. 
 
 
3.1.12. Sox9 is expressed in postmitotic neurons of the murine central nervous 
system 
 
We revealed that Wwp ligases alongside miR-140 are indispensable for proper neuronal 
distribution in the cortex and control neuronal polarity acquisition in primary hippocampal 
nerve cells and cortical neurons in vivo. Concomitant expression patterns of Wwp2 and miR-
140 have been reported in non-neuronal tissue by several independent groups [172,258,274]. 
Interestingly, both genes seem to be the major targets of Sox9 transcription factor in cartilage 
[258]. Sox9 has been previously reported as a regulator of differentiation expressed in radial 
glial cells, chondroprogenitor cells, and cardiac mesenchymal cells, where it plays a crucial 
roles in gliogenesis [275], chondrocyte differentiation [276], and endothelial-mesenchymal 
transition [277]. Interestingly, developmental profiling of Sox9, Wwp1, and Wwp2 mRNAs 
isolated from developing and adult murine cortex reveals expression of Sox9 in adult murine 
brain and striking resemblance of Sox9 and Wwp2 expression patterns (Fig. 20A). Moreover, 
the Sox9 protein level mirrors the amount of Wwp2 in cortical homogenates prepared from 
mice at different developmental stages (Fig. 20B), while the level of Wwp1 seem to be 
inversely correlated to Sox9 and Wwp2. This indicates that Sox9 may also serve as the major 
transcriptional regulator of Wwp2 in the brain, and may regulate Wwp2/miR-140 duo in 
neurons. Next, we sought the Sox9 expression in postmitotic nerve cells. We stained the 
coronal sections of P0 mouse cortex with antibodies against Sox9 and neuronal identity 
marker Ctip2 (COUP-TF interacting protein 2) [278]. Intriguingly, we observed extensive 
Sox9 immunostaining signals in hippocampal and cortical neuronal nuclei positive for Ctip2. 
To then further corroborate the specificity of Sox9 labeling, we immunolabeled P10 brain 
sections of Sox9f/f mice after in utero electroporation at E14.5 with plasmid encoding GFP 
(control) or two plasmids, each for GFP and Cre recombinase (Sox9 KO) with Sox9 antibody 
used previously (Fig. 20 C), and NeuN to distinguish neuronal nuclei (Fig. 20D). Sox9 
labeling signal was pronounced in control neurons, but unambiguously absent in Sox9 KO 
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nerve cells. Immunolabeling intensity was further measured on manually selected somata 
with ImageJ software to elucidate almost complete loss of staining in Sox9 KO neurons 
(Sox9f/f+GFP 1 ± 0.21; Sox9f/f + GFP + iCre 0.05 ± 0.21) (Fig. 20E). Taken together, Sox9 
is expressed in postmitotic neurons of the cortex, and its expression pattern strongly 
resembles the one of Wwp2.  
 
3.1.13. Sox9 regulates axon specification in postmitotic primary hippocampal 
neurons 
 
To corroborate if Sox9 acts along with Wwp2 and miR-140 in the regulation of axon 
acquisition, we performed Sox9 KD and overexpression study in primary hippocampal 
neurons (Fig. 21A) by transfecting sh-RNA expression vectors encoding Venus, or co-
transfecting EGFP and Sox9 expression vectors to wild type neurons. Sox9 KD resulted in 
the emergence of neurons projecting multiple axons (Fig. 21A, a, and b). While only about 
10 % of control neurons projected multiple axons, 38 % of nerve cells transfected with Sox9 
KD plasmid displayed more than a single axon (Fig. 21B a, and b). Conversely, 
overexpression of Sox9 in nerve cells, like overexpression of miR-140, leads to loss of axon 
specification (Fig. 21A, c, and d). Moreover, 88 % of neurons presented a single axon whilst 
23 % of Sox9 overexpressing neurons failed to specify an axon, characterized by pronounced 
SMI312 signals and absent MAP2 labeling (Fig. 21B c, and d). Given that primary neurons 
were prepared form P0 hippocampi, when the neurogenesis of glutamatergic neurons had 
been completed [279,280], we concluded that Sox9 plays an important role in axon 




Figure 20. Sox9 expression in postmitotic neurons of the murine central nervous 
system. (A) Developmental expression profiling of Wwp1, Wwp2, and Sox9 mRNAs by 
qRT-PCR in murine cortices of different developmental stages. Results are represented as 
averages ± SEM. Transcript level of each gene was normalized to housekeeping Gapdh, and 
Oaz1 at each developmental time point. (B) Western blotting in cortical lysates of mice of 
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depicted age using antibodies against Wwp1 (upper panel), Wwp2 (second from top), Sox9 
(second from bottom), and β-actin (bottom panel). (C) Immunostaining in coronal sections 
of P0 wild type mouse brain using DAPI (leftmost panels), and antibodies against Sox9 
(second panel from the left), and neuronal marker Ctip2 (third panels from the left), CA1, 
hippocampal subfield CA1; cx, cortex. Scale bar, 100 μm. Arrowheads on the bottom panels 
point to Sox9-, and Cux1- positive neuronal nuclei in the CA1 field of mouse hippocampus. 
(D) Expression of Sox9 in postmitotic neurons. Sox9f/f neurons were electroporated in utero 
with GFP (control, top panel), and GFP and Cre recombinase expressing plasmids (Sox9 
knockout, KO, bottom panel) at E14.5. Brains at P10 were immunostained against Sox9, and 
NeuN. Note the prominent signal of Sox9 staining in the nuclei of control cells (arrowheads, 
top panel), and loss thereof in Cre-expressing, Sox9 KO neurons (bottom panel). Asterisk on 
the bottom panel indicates Sox9-positive nucleus of a neuron not transfected with Cre 
plasmid. (E) Quantification of immunostaining signal intensity in neurons expressing GFP 
or GFP and Cre recombinase. Results are represented as averages ± S.D. Control, Sox9f/f + 
GFP, n = 6 neurons; KO, Sox9f/f + GFP + iCre, n = 5 neurons. Note the almost complete loss 
of Sox9 staining in Sox9 KO neurons. Sox9f/f mouse brains, after in utero electroporation, 
were provided by Dr. Mikio Hoshino (National Institute of Neuroscience, Japan). *** p < 
0.001, unapired t-test. 
 
 
Figure 21. Sox9 regulates axon acquisition in primary hippocampal neurons. (A) 
Representative images of wild type primary hippocampal neurons. Nerve cells were 
transfected at DIV1 with plasmid encoding non-silencing sh-RNA (a; control), or sh-RNA 
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to downregulate Sox9 (b; Sox9 KD), or EGFP (c; control), or co-transfected with EGFP, and 
expression vector for Sox9 (d; Sox9 OE), fixed at DIV7 and immunostained for SMI312 and 
MAP2. Scale bar, 20 μm. (B) Quantification of number of axons projected by a single 
neuron. Control (a), n = 30 neurons; Sox9 KD (b), n = 32 neurons; control (c), n = 17; Sox9 
OE (d), n = 31 neurons; **** p < 0.0001 by Chi-square test, and * p < 0.05, Fisher’s exact 
test between wild type neurons expressing control sh-RNA (a), and Sox9 KD neurons (b); * 
p < 0.05, Fisher’s exact test between control neurons (c), and Sox9 OE neurons (d). 
 
 
3.1.14. Sox9 emerges as a potent regulator of neuronal distribution an a regulator 
of cortical neuron polarity formation 
 
To study if loss of Sox9 poses detrimental effects on postmitotic neurons, we studied 
distribution, and morphology of cortical neurons after in utero electroporation. We 
transfected the pool of cortical progenitors at E14.5 with a plasmid encoding for non-
silencing sh-RNA (control), or sh-RNA against Sox9 (Sox9 KD) (Fig. 22A). Quantitative 
analysis of neuronal distribution revealed statistically significant differences in the number 
of cells located in bin 1. While most of control neurons (72.7 ± 4.8 %) distributed in bin 1, 
only 47.8 ± 5.1 % of Sox9 KD neurons were counted there. Moreover, in deep cortical layers, 
we observed hardly any control cells (bin 3, 0.4 ± 0.6 %; bin 4, 0.2 ± 0.4 %; bin 5, 2.0 ± 2.2 
%), whereas increased fraction of Sox9 KD neurons were found in bin 3 (6.9 ± 2.3 %), bin 
4 (3.9 ± 2.7 %), and bin 5 (12.3 ± 11 %) (Fig. 22B). Due to mere control cells in deep cortical 
layers (bin 3 to bin 5), for morphological studies we split the analyzed cortices in three 
instead of five bins. Although we detected no statistically significant differences, we 
observed a clear trend towards an increase in Sox9 KD neurons with multiple apical 




Figure 22. Acute KD of Sox9 alters distribution of cortical neurons in vivo. (A) 
Representative images of DAPI staining (left panels), and anti-GFP immunolabeling (right 
panels) in P10 cortices of wild type mice. Cortical progenitors were electroporated in utero 
at E14.5 with plasmids encoding Venus, and control non-silencing RNA (upper panel) or 
Venus, and sh-RNA to downregulate Sox9 (Sox9 KD, lower panel). Scale bar, 100 μm. (B) 
 111 
Neuronal distribution upon Sox9 KD in vivo. Results are represented as averages ± S.D. 
Control, n = 5 brains; Sox9 KD, n = 4 brains; *** p < 0.001, two-way ANOVA with 
Bonferroni post-hoc test. (C) Tracings of representative control, and Sox9 KD neurons in 
bin 3 of P10 brains. Scale bar, 50 μm. (D) Morphological classification of neurons upon 
Sox9 KD. Results are represented as averages ± S.D. Control, n = 5 brains; Sox9 KD, n = 4 
brains; two-way ANOVA with Bonferroni post-hoc test. 
 
 
Next, we analyzed brains of Sox9f/f animals, where Sox9 was depleted from a fraction of 
cortical progenitors by in utero electroporation with the Cre expression plasmid. Observed 
neuronal distribution alterations and morphological deficits upon Sox9 knockout (Sox9 KO) 
from neurons were far more pronounced than those upon Sox9 KD (Fig. 23A). Like in the 
case of the Sox9 KD experiment, majority of control (Sox9f/f + GFP) pyramidal neurons 
reached bin 1 (77.2 ± 13.7 %). Additionally, we found only four control neurons among all 
cortical cross sections analyzed from five P10 brains within bins 3 and 4, and all of them 
displayed polarized morphology, typical for pyramidal neurons (Fig. 23 C, upper panel; Fig. 
23D). On the other hand, only 27.8 ± 7.4 % of Sox9 KO reached bin 1, while majority of 
Sox9 KO nerve cells aberrantly located in bin 2 (65.5 ± 9.9 %), and 5.5 ± 3.6 % of Sox9 KO 
neurons were found in bin 3. Additionally, only a minor fraction of Sox9 KO neurons in bin 
3 presented normal pyramidal morphology (6.3 ± 7.4 %). Nerve cells devoid of Sox9 in bin 
3 did not present a prominent apical dendrite (17.9 ± 22.5 %), while 50.8 ± 3.4 % projected 
more than one prominent dendrite (Fig. 23C, lower panel, cell 2, 3, 6, 8 from the left), and 
25.0 ± 16.7 % showed a misoriented prominent dendrite, sometimes running parallel to the 
pial surface or aberrantly projecting towards the corpus callosum (Fig. 23C, lower panel, 
cell 1, 4, 5, 7 from the left; Fig. 23D). Marked, almost complete loss of pyramidal cell 
characteristics in Sox9 KO neurons of bin 3 and 4 makes this genetic manipulation causative 
of the most pronounced polarity defects we have encountered during this study. Altogether, 
these data prove that Sox9 has an important role in shaping neuronal polarity, and regulating 
migration of developing cortical neurons of layer II/III. Moreover, Sox9, together with Wwp 





Figure 23. Loss of Sox9 results in severe migratory aberrances and strong polarity 
defects in cortical neurons in vivo. (A) Representative images of DAPI staining (left 
panels), and GFP/Venus fluorescence (right panels) in P10 cortices of Sox9f/f mice. Neurons 
were electroporated in utero at E14.5 with plasmids encoding myr-Venus and GFP as a 
control (upper panel), or myr-Venus, GFP, and Cre recombinase to induce Sox9 knockout 
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(Sox9 KO, lower panel). Scale bar, 100 μm. (B) Quantification of neuronal distribution upon 
Sox9 KO in vivo. Results are represented as averages ± S.D. Sox9f/f + GFP, n = 5; Sox9f/f + 
GFP + iCre, n = 4 brains; *** p < 0.001, two-way ANOVA with Bonferroni post-hoc test. 
(C) Tracings of representative control, and Sox9 KO neurons in bin 3 and 4 of P10 brains. 
Scale bar, 50 μm. (D) Classification of neuronal polarities upon Sox9 KO. Results are 
represented as averages ± S.D. Sox9f/f + GFP, n = 5; Sox9f/f + GFP + iCre, n = 4 brains. 
Sox9f/f mouse brains after in utero electroporation were provided by Dr. Mikio Hoshino 
(National Institute of Neuroscience, Japan); *** p < 0.001, ** p < 0.01, * p < 0.05, two-way 
ANOVA with Bonferroni post-hoc test. 
 
 
3.2.HECT ligases of Nedd4 family in mature neurons 
 
3.2.1. Wwp ligases control development of dendritic spines 
 
Notably, Wwp1 and Wwp2 are expressed in the cerebral cortex of mature mice, and protein 
expression of Wwp1 is developmentally up-regulated (Fig. 20B). Such an expression profile 
is a characteristic feature of proteins involved in synapse formation and function [281]. 
Although Wwp2 protein expression decays as the cortical development proceeds, its levels 
are stable in the mature brain (compare levels of Wwp2 between P21 and P56, Fig. 20B). 
This indicates that Wwp1 and Wwp2 may play an important role in synaptogenesis, and 
regulate synaptic transmission in mature neurons. Supportive of this hypothesis are the 
results of genetic screens in C. elegans demonstrating that mutations in wwp-1 (an ortholog 
of murine Wwp1) disrupted the distribution of a synaptic marker protein [282]. These 
observations illustrate that wwp-1 may be implicated in worm synaptogenesis. 
To verify if Wwp ligases play roles in synapse formation, we established and analyzed a 
neuron specific, NEX1-Cre driven conditional double knockout of Wwp1, and Wwp2 
(Wwp1f/f; Wwp2f/f; NEX1-Cre+/-; Wwp1/2 dcKO) [202]. We transfected pools of 
hippocampal and cortical progenitors in control (Wwp1f/f; Wwp2f/f) and Wwp1/2 dcKO mice 
in utero at E14.5 with plasmids encoding for GFP and myr-Venus to visualize cellular 
morphology of the neurons. Brains were fixed at P21, sectioned, and immunostained against 
GFP and Venus. Using STED microscopy, together with Dr. Katrin Willig (MPIem, 
Göttingen) we imaged dendritic spines on primary branches of apical dendrites of cortical 
and hippocampal pyramidal neurons (Fig. 24A). Using maximum projections of Z-stacks 
acquired through 15 μm section thickness, we performed basic morphometrics on dendritic 
spines in control and Wwp1/2 dcKO neurons.  
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Strikingly, loss of Wwp ligases lead to a significant increase in density of dendritic spines as 
compared to control neurons in the cortex (Fig. 24B, and 24D; control 1.42 ± 0.29 spines/μm; 
Wwp1/2 dcKO, 1.81 ± 0.38 spines/μm), and a non-significant increase in hippocampal 
pyramidal neurons (Fig. 24C, and 24 H; control, 1.33 ± 0.33 spines/μm; Wwp1/2 dcKO, 1.59 
± 0.21 spines/μm). Measurements of spine morphology revealed a statistically significant 
decrease in the length of filopodia upon Wwp1/2 dcKO in hippocampal neurons (control, 
1.07 ± 0.22 μm; Wwp1/2 dcKO, 0.79 ± 0.17 μm) (Fig. 24I), and a specific increase in the 
diameter of mushroom spine head in cortical Wwp1/2 dcKO neurons (control, 0.65 ± 0.05 
μm; Wwp1/2 dcKO, 0.73 ± 0.07 μm) (Fig. 24F). We observed no significant differences in 
morphological classification of spines in the Wwp1/2 dcKO animals (Fig. 24G, and Fig. 
24K).  
Taken together, depletion of Wwp1 and Wwp2 from cortical and hippocampal progenitors 
alters spine morphology and results in an increase of spine density in cortical nerve cells. As 
such, Wwp ligases control various aspects of neuronal development, polarity specification, 




Figure 24. Spine morphometrics in neuron-specific Wwp1 and Wwp2 double knockout 
mouse. (A) Tracing of pyramidal cortical neuron of layer II/III expressing GFP and myr-
Venus. Square in dashed line depicts imaged dendritic compartment of the neuron analyzed. 
(B, C) Maximum projections of anti-GFP immunostaining from dendrites of cortical (B) and 
hippocampal (C) neurons of control (left panel), and Wwp1 and Wwp2 conditional double 
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knockout mice (Wwp1/2 dcKO, right panel) acquired with STED microscope. (D to K) 
Results of morphometrics of spines in cortical (D to G), and hippocampal neurons (H to K). 
(D, and H) Quantification of spine densities in cortical (D), and hippocampal neurons (H) of 
control and Wwp1/2 dcKO mice. (E, and I) Averages of spine lengths in cortical (E), and 
hippocampal neurons (I) of control and Wwp1/2 dcKO mice. (F, and J) Averages of spine 
head diameter in control and Wwp1/2 dcKO neurons of the cortex (F), and hippocampus (J). 
(G, and K) Spine classification into morphological groups in cortical (G), and hippocampal 
neurons (K) of control, and Wwp1/2 dcKO mice. Bars on all graphs represent averages ± 
S.D. Cortex: control, Wwp1f/f; Wwp2f/f, n = 2 animals, n = 9 cells, n = 186 spines; Wwp1/2 
cKO, Wwp1f/f; Wwp2f/f; NEX1-Cre+/-, n = 2 animals, n = 8 cells, n = 218 spines; 
hippocampus: control, Wwp1f/f; Wwp2f/f, n = 2 animals, n = 9 cells, n = 152 spines; Wwp1/2 
cKO, Wwp1f/f; Wwp2f/f; NEX1-Cre+/-, n = 1 animal, n = 7 cells, n = 167 spines. * p < 0.05, 
*** p < 0.001, unpaired t-test. 
 
 
3.2.2. Nedd4-2 regulates spine size and leads to emergence of bifurcated spines 
 
Nedd4-2 shares similar domain architecture as Wwp1 and Wwp2, and its role in synaptic 
transmission has been well described before [129]. Our in situ hybridization experiments 
demonstrate relative abundance of Nedd4-2 mRNA in central murine nervous system (Fig. 
25A) and its relative enrichment in the hippocampus (Fig. 25A, enlarged square). In order 
to study involvement of Nedd4-2 in spinogenesis and its possible control over dendritic spine 
morphology, we performed in utero transfection of hippocampal progenitors at E14.5 in 
control (Nedd4-2f/f) and neuron-specific Nedd4-2 conditional knockout animals (Nedd4-2f/f; 
NEX1-Cre+/-, Nedd4-2 cKO) with GFP- and myr-Venus plasmids. We studied the number 
and morphology of dendritic spines on primary branches of apical dendrites upon Nedd4-2 
deletion from hippocampal CA1 pyramidal neurons using STED microscopy (Fig. 25B). 
Although, dendritic spine density was not affected by Nedd4-2 loss (Fig. 25C), the 
morphometric analysis of individual spines in Nedd4-2 cKO neurons revealed striking 
defects. We observed a statistically significant increase in the length of filopodia (control, 
0.88 ± 0.24 μm; Nedd4-2 cKO, 1.26 ± 0.28 μm), thin (control, 0.92 ± 0.19 μm; Nedd4-2 
cKO, 1.19 ± 0.24 μm), and mushroom spines (control, 0.80 ± 0.16 μm; Nedd4-2 cKO, 1.00 
± 0.26 μm) (Fig. 25D), and in the thin spine head size (control 0.35 ± 0.07 μm; Nedd4-2 
cKO, 0.43 ± 0.09 μm) (Fig. 25E). Additionally, loss of Nedd4-2 leads to a statistically 
significant decrease in the frequency of mushroom spines (control 0.20 ± 0.06; Nedd4-2 
cKO 0.11 ± 0.06) at the expense of an increased prevalence of the bifurcated type (control 
0.03 ± 0.03; Nedd4-2 cKO 0.07 ± 0.04) (Fig. 25F). Altogether, loss of Nedd4-2 in neurons 
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leads to severe alterations in spine morphology, which places Nedd4-2 among potent 
regulators of dendritic spine development. 
 
 
Figure 25. Spine morphometrics in neuron-specific Nedd4-2 conditional knockout 
mouse. (A) In situ hybridization with probes for Nedd4-2 mRNA on sagittal sections of P20 
wild type murine brain. Control reaction with sense probe on the bottom left image. Black 
signals represent strong hybridization. Brain stem (st), cerebellum (ce), cortex (cx), thalamus 
(th), striatum (str), olfactory bulb (ob), Cornu Ammonis area 1 CA1, dentate gyrus DG 
Nedd4-2 mRNA is enriched in CA1 and dentate gyrus (DG) of hippocampus (enlarged 
square). (B) Representative maximum projections of STED images of anti-GFP 
immunolabeling from dendrites of control (Nedd4-2f/f, left panel) and neuron-specific 
Nedd4-2 knockout (Nedd4-2f/f; NEX1-Cre+/-, right panel) CA1 neurons. (C) Quantification 
of spine densities on Nedd4-2f/f and Nedd4-2f/f; NEX1-Cre+/- dendrites. (D) Averages of spine 
lengths in Nedd4-2f/f and Nedd4-2f/f; NEX1-Cre+/- hippocampal neurons. Note consistent 
increase in spine lengths upon Nedd4-2 deletion (see also B). * p < 0.05, *** p < 0.001, 
unpaired t-test. (E) Average head diameters in Nedd4-2f/f and Nedd4-2f/f; NEX1-Cre+/- 
neurons. Note the thicker heads of thin spines upon Nedd4-2 deletion. * p < 0.05, unpaired 
t-test. (F) Spine classification reveals significant loss of mushroom spines, and gain of 
bifurcated type in neurons devoid of Nedd4-2. Two way ANOVA with Bonferroni multiple 
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comparisons test; * p < 0.05. Bars on all graphs represent averages ± S.D. Control, Nedd4-
2f/f, n = 2 animals, n = 11 cells, n = 288 spines; Nedd4-2
f/f; NEX1-Cre+/-, Nedd4-2 cKO, n = 
2 animals, n = 12 cells, n = 315 spines.  
 
 
3.3.HECT type ubiquitin ligase Ube3b is essential for normal neuronal 
development and function 
 
3.3.1. Loss of Ube3b in mice recapitulates human Kaufman oculocerebrofacial 
syndrome 
 
Phylogenic tree of HECT-type ubiquitin ligases distinguishes 28 HECT ligases in humans. 
Over the course of this study, we elucidated that three murine homologs – Wwp1, Wwp2, 
and Nedd4-2 – regulate dendritic spine number and morphology, implicating their pivotal 
role in shaping synaptic transmission [92]. To date, four genes encoding human HECT 
ligases – UBE3A, UBE3B, NEDD4-2, and HUWE1 – have been reported as causative for 
human disorders [111,131,136,283,284]. Among those, UBE3B caught our attention. The 
research groups of Prof. Guntram Borck and Prof. Giuseppe Zampino identified truncating 
mutations in UBE3B in patients suffering from Kaufman oculocerebrofacial syndrome 
(KOS) [136,138] (Fig. 26A), an autosomal recessive disorder characterized by facial 
dysmorphisms, developmental delay, and severe mental retardation with absent speech (Fig. 
26A, a, b, c). Some of the neurological aspects of the disease encompass hypoplasia of the 
corpus callosum, microcephaly (Fig. 26B), and Chiari malformation (Fig. 26C). Cerebellar 
tonsils are displaced towards the foramen magnum, obtruding the outflow of cerebrospinal 
fluid, often leading to hydrocephalus in Chiari Type I malformation [285]. UBE3B encodes 
for ubiquitin ligase E3B. Importantly, truncated UBE3B in KOS patients is devoid of the C-
terminal catalytic HECT domain, implicating the loss of enzymatic ubiquitin ligase activity 
in disease pathology. Although numbers of human mutations in UBE3B have been reported 
in KOS patients [137], no molecular characterization of Ube3b exists to date. 
In order to study the role of murine Ube3b (an ortholog of human UBE3B) in the brain, we 
employed Cre-loxP technology to knockout Ube3b in mice (Fig. 26D). Embryonic stem (ES) 
cell clones with exon 7 of Ube3b flanked by two loxP sites and the lacZ/neomycin cassette 
flanked by two FRT sites (Fig. 26D, depicted as ‘Recombined’) were purchased from the 
EUCOMM Consortium. ES cells were expanded and injected to blastocysts of pseudo-
pregnant mice. Chimeric mice with germline transmitted mutant Ube3b allele were then 
 119 
crossed with FLP deleter mice (B6;SJLTg(ACTFLPe), 9205Dym/J, Jackson Laboratory) to remove 
lacZ/neo selection cassette from the mutant Ube3b allele (Fig. 26D, depicted as ‘Floxed’). 
Then, we crossed mice with floxed Ube3b alleles with Cre-driver lines to delete Ube3b 
conventionally and conditionally. 
Gene targeting was validated by PCR, Southern, and Western blotting (Fig. 26E to 26G, and 
Fig. 26J). We performed long range PCR using a primer pair specific to lacZ/neo cassette 
and to the sequence of Ube3b outside of the short arm of the plasmid used for homologous 
recombination and detected a specific band for the recombined allele in the DNA of 
heterozygote ES cells (Fig. 26E). Further, we performed multiplex PCR (Fig. 26F) using 
three primers: a pair recognizing the DNA sequence of wild type Ube3b up-, and 
downstream of integrated 3’ loxP site, and one complementary to loxP. The reaction using 
mutant DNA yielded two bands, proving correct insertion of 3’loxP sites. Moreover, 
Southern blotting using a probe outside of the short arm of the targeting vector distinguished 
correct recombination of the mutant DNA into Ube3b locus (Fig. 26G).  
In order to conventionally delete Ube3b, we crossed Ube3bf/f mice with E2A-Cre driver 
mice. Conventional Ube3b knockout animals (Ube3b-/-) presented striking resemblance to 
KOS patients (Fig. 26H). Animals were smaller, severely malnutritioned (probably due to 
micrognathia or frail teeth), and displayed prominent snout malformations including orbital 
arch (sometimes preventing the animals from opening the eye), and pronounced kyphosis. 
Ube3b-/- mice also presented with a shuffling gait when moving. Examination of Ube3b-/- 
brains revealed microcephaly, corroborating the condition present in KOS patients. Finally, 
to confirm depletion of Ube3b in Ube3b-/- mice, in collaboration with Synaptic Systems 
(Göttingen) we developed an antibody against HECT domain of Ube3b. Western blotting 
using brain homogenates from P7 animals showed complete loss of Ube3b in the brains of 
Ube3b-/- mice (Fig. 26J). Interestingly, heterozygous animals (middle lane, Fig. 26J) 




Figure 26. Ube3b knockout in mice recapitulates human Kaufman Oculocerebrofacial 
Sydrome (KOS). (A) Mutations of Ube3b in KOS patients and facial dysmorphisms in 
KOS. (Top panel) Gene structure of Ube3b. Rectangles, and horizontal lines represent exons 
and introns. Black, blue, and orange filled rectangles correspond to exons encoding 
untranslated regions, the IQ motif and the HECT domain, respectively. On top and bottom 
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of the scheme, the truncating mutations in patients with KOS are listed. (Bottom panels, a to 
c) Three individuals with KOS. (B) Cranial MRI scan of a control (left panel) and a KOS-
diagnosed individual in photo a in (A) (right panel). (C) Schemes of control brain (left panel) 
and Chiari Type 1 malformation, present on MRI scan of the KOS individual (right panel). 
(D) Gene targeting strategy of murine Ube3b. The domain structure of Ube3b, wild type and 
targeted Ube3b alleles are depicted. Exons, loxP sites, FLP-recombinase target sites (FRT) 
are symbolized as black rectangles, red triangles, and green rectangles, respectively. Exon 7 
of Ube3b is flanked by two loxP sites. lacZ/neomycin cassette serves as a selection marker. 
Mutant mice with the recombined allele were crossed with FLP deleter animals to remove 
the selection cassette, and further crossed to Cre-driver lines, leading to removal of exon 7 
conditionally or conventionally. (E, F, G) Validation of Ube3b gene targeting. +/+ wild type, 
rec/+ indicates heterozygous recombined mutant. (E) The result of long range PCR using 
primers depicted as blue arrows in D. Band of the predicted size was observed only using 
genomic DNA purified from rec/+ mutant as a template. (F) The result of multiplex PCR 
using primers depicted as pink arrows in D. PCR using genomic DNA from targeted ES cells 
yields two bands (left lane), and PCR using wild type ES cells genomic DNA as a template 
results in one band. (G) Southern blotting analysis of genomic DNA purified from targeted 
ES cells. Genomic DNA isolated from control and ES cells carrying ‘Recombined’ allele of 
Ube3b was digested with SapI enzyme. The band at 8.0 kb represents the wild type allele, 
and the band at 6.6 kb represents the mutant allele. (H) Gross morphology of Ube3b+/+ (left) 
and Ube3b-/- (right) mice at 20 days post birth. (I) Brains of Ube3b+/+ (left) and Ube3b-/- 
(right) mice isolated 20 days after birth. (J) Results of Western blotting using P7 brain lysates 
from Ube3b+/+ (left), Ube3b+/- (middle), and Ube3b-/- (right) animals with an antibody raised 
against HECT domain of Ube3b. MEM Code staining (lower panel) displays comparable 
amounts of total protein in all lanes after SDS-PAGE, and electrotransfer onto the 
nitrocellulose membrane. (A) and (B) adapted from [136,138], and published under Creative 




3.3.2. Ube3b is expressed in developing and adult murine central nervous system 
and is enriched at PSDs 
 
As a basic characterization of Ube3b, we studied the expression of this ligase in murine brain 
(Fig. 27). We designed a DIG-probe recognizing mRNA sequence spanning the middle 
region and a portion of HECT domain of Ube3b (top scheme, Fig. 27A), and performed in 
situ hybridization using sagittal brain sections from a mouse embryo (top panel, Fig. 27A) 
and an adult (bottom panel, Fig. 27A). Notably, we detected strong hybridization signal in 
the ventricular zone of the developing cortex and ganglionic eminences. Consistently in the 
adult brain, Ube3b transcript was abundant and expressed throughout entire central nervous 
system, with strong hybridization signals from the cerebral cortex and hippocampus, 
indicative of a putative role of Ube3b in learning, memory, and higher cognitive functions, 
(Fig. 27A). Next, we performed developmental expression profiling of Ube3b by Western 
 122 
blotting using cortical lysates from mice at prenatal to postnatal stages (Fig. 27B). 
Interestingly, Ube3b was expressed at constant levels throughout embryonic development 
and its expression increased 6-fold from P0 to P21 to reach a plateau phase (Fig. 27C). We 
next analyzed the distribution of Ube3b in different regions of P56 mouse brain. The level 
of Ube3b was higher in the cerebral cortex, olfactory bulb, and hippocampus as compared 
to other regions of the central nervous system (i.e. cerebellum, midbrain, striatum, pons, 
thalamus, and medulla) (Fig. 27D).  
In the next experiment, we examined subcellular localization of Ube3b in brain cells. For 
this purpose, we purified subcellular fractions from 6 – 7 weeks old animals (Fig. 27E, also 
Fig. 19A). Strikingly, Ube3b was predominantly found in the PSD fraction (Fig. 27F; 
compare the top panel for PSD-95 with the bottom panel for Ube3b), indicating that this 
ligase associates with postsynaptic specialization in neurons.  
Taken together, Ube3b is expressed in developing, and mature cortical pallium where it 




Figure 27. Ube3b is expressed in developing and mature murine central nervous 
system. (A) In situ hybridization on sagittal sections of E16 (upper panel) and P20 (lower 
panel) of mouse brains with antisense probe for mRNA encoding HECT domain of Ube3b 
(top scheme) and sense control probe (right top panels). Note the enrichment of Ube3b 
mRNA in developing cortex (cortical plate, cp), and ganglionic eminence (ge), and overall 
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abundance in the adult central nervous system (cerebellum, ce; brain stem, st; hippocampus, 
hip; cortex, cx; thalamus, th; striatum, str; olfactory bulb ob). (B) Developmental expression 
profile of Ube3b. Cortical homogenates at different developmental stages (indicated on top 
panel) were used for Western blotting with antibodies against Ube3b (top panel), and β-actin 
(bottom panel, loading control). (C) Quantification of Ube3b levels in mouse cortex during 
brain development. Ube3b level was normalized to β-actin and expressed relative to the 
ligase level in E13 embryonic cortex. Each point represents mean Ube3b level from three 
cortices ± S.E.M. (D) Western blotting using homogenates of different adult mouse brain 
regions with antibodies against Ube3b (top panel), and β-actin (bottom panel, loading 
control). (E) Scheme of brain fractionation in sucrose gradient after synaptosomes 
purification (see also Fig. 19A). After osmotic shock, synaptosomal fraction were further 
centrifuged to separate synaptic cytoplasm (SC) / crude synaptic vesicles (CSV) from crude 
synaptic membrane (CSM). CSM is treated with TritonX-100-containing buffer to separate 
the detergent insoluble postsynaptic density (PSD) from TritonX-100-extractable fraction 
(TX100-E). (F) Results of Western blotting using subcellular fractions (compare also Fig. 




3.3.3. Ube3b knockout abrogates neurite branching in primary hippocampal 
neurons 
 
Impaired dendritogenesis has been long known as a major aspect of a plethora of intellectual 
disability syndromes [286-289]. In order to study the impact of Ube3b loss on dendrite 
development, we analyzed the morphology of primary hippocampal neurons prepared from 
Ube3bf/f mice expressing GFP (control), or GFP and Cre recombinase (Ube3b KO). Already 
at DIV4, Ube3b KO neurons display pronounced deficits in neurite branching (Fig. 28A). 
Next, we infected Ube3bf/f primary hippocampal neurons with lentiviruses expressing GFP, 
or Cre recombinase and concluded that at DIV5, Ube3bf/f neurons expressing Cre 
recombinase are almost completely devoid of Ube3b. Then, we measured the length of 
axons, identified as the longest neurite projected by a single neuron. Notably, Ube3b KO 
neurons projected significantly less primary branches at DIV4 as compared to control (Fig. 
28C; control, 4.06 ± 2.03 primary branches; Ube3b KO, 2.71 ± 1.88 primary branches). At 
a later stage of neuronal development, DIV7 (Fig. 28D), we quantified the complexity of 
neurites by Sholl analysis (Fig. 28E, and 28F). For this purpose, concentric circles at 7.5 μm 
intervals were drawn on the binarized image of the GFP signal from an individual neuron 
and numbers of neurites crossing each circle were counted [290]. Ube3b KO neurons display 
less complex neurite branching as compared to control nerve cells (Fig. 28E), with fewer 
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overall numbers of crossings (control, 61.7 ± 20.7 crossings; Ube3b KO, 93.1 ± 31.4 
crossings) (Fig. 28F).  
To study if impaired dendritogenesis is a specific consequence of Ube3b enzymatic activity 
loss, we transfected Ube3bf/f primary hippocampal neurons with plasmids encoding GFP 
alone (control), or GFP and Cre (Ube3b KO) together with either myc-tagged wild type 
Ube3b (Fig. 28I, and 28J), or with the catalytically inactive point mutant of Ube3b (Ube3b 
C/S) (Fig. 28G, and 28H). Experiments described in Figs. 28G to 28L were performed as a 
single set of experiments with the ones in Figs. 28D to 28F. Upon expression of Ube3b C/S 
mutant in the Ube3b KO neurons, the complexity of neurites was similar to the one of Ube3b 
KO neurons expressing only GFP (compare Fig. 28D, right panel, and 28G). On the contrary, 
expression of wild type Ube3b in Ube3b KO neurons restores neurite branching (compare 
Fig. 28D, left panel, and Fig. 28I). The impact of re-expression of wild type Ube3b in Ube3b 
KO neurons on the neurite branching was significantly stronger than that of expression of 
Ube3b C/S (Figs. 28 K, and 28L; the sum of total crossings of neurites, Ube3b KO+Ube3b, 
81.1 ± 24.1; Ube3b KO+Ube3b C/S, 57.6 ± 20.4). Interestingly, the expression of wild type 
Ube3b in the control neurons had almost no effect on neurite arborizations (compare Fig. 
28I, and 28J). Possibly, endogenous Ube3b expression level required for proper dendritic 
branching is saturated.  
Expression of Ube3b C/S in control neurons resulted in statistically significant decrease in 
the sum of crossing neurites as compared to control neurons expressing GFP (Figs. 28F, and 
28L; control neurons+Ube3b C/S, 61.8 ± 21.6; control neurons+GFP, 93.1 ± 31.4; also 
compare Fig. 28D, and Fig. 28H). We conclude that this indicates dominant-negative effects 
of Ube3b C/S overexpression, as experiments in Figs. 28D to 28F were performed 
simultaneously with those presented on Figs. 28G to 28L. Additionally, overexpression of 
Ube3b C/S has almost no effect in the Ube3b KO background (Figs. 28K, and 28L, also 




Figure 28. Ube3b loss in neurons leads to dramatic impairment of neurite branching. 
(A) Images of primary hippocampal neurons at day 4 in vitro (DIV4) prepared from Ube3bf/f 
mice and transfected with calcium phosphate method either with plasmid encoding GFP 
(control, CTR), or plasmid co-expressing GFP and Cre recombinase to induce Ube3b 
knockout (KO). (B) Western blotting against Ube3b in neuronal lysates. Primary 
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hippocampal neurons from Ube3bf/f mice were infected at DIV1 with lentiviruses expressing 
GFP (CTR), or Cre recombinase (KO), and harvested at DIV5. (C) Mean numbers of primary 
axonal branches, counted in DIV4 control and KO neurons. The longest neurite projected by 
an individual neuron was measured as an axon. CTR, n = 36; KO, n = 24; * p = 0.012, 
unpaired t-test. (D) Images of control (CTR) and KO primary hippocampal neurons 
expressing GFP at DIV7. (E) Sholl analyses of control and KO neurons. Each point 
represents mean number of crossing neurites with concentric circles emerging from the soma 
± S.E.M. CTR, n = 47; KO, n = 42 neurons. (F) Average sum of total crossings with Sholl 
circles from a single neuron. CTR, n = 47; KO, n = 42 neurons; *** p < 0.001, unpaired t-
test. (G) Example images of GFP fluorescence (left panel) and myc immunostaining (right 
panel) from KO neuron transfected with plasmids encoding for GFP and myc-tagged 
catalytically inactive mutant of Ube3b (myc-Ube3b C/S). (H) Example images of a CTR 
neuron expressing GFP (left panel) and myc-Ube3b C/S (right panel). (I) GFP fluorescence 
(left) and myc-staining (right panels) from KO neuron expressing myc-tagged wild type 
Ube3b (myc-Ube3b). (J) A control neuron expressing GFP (left panel) and myc-Ube3b. (K) 
Sholl analyses of neurite branching in CTR and KO neurons expressing myc-Ube3b, or myc-
Ube3b C/S. (L) Mean sum of crossing neurites with Sholl circles made by single neurons. 
KO+myc-Ube3b C/S, n = 15; KO+myc-Ube3b, n = 23; CTR+myc-Ube3b C/S, n = 24; 
CTR+myc-Ube3b, n = 34 neurons. One-way ANOVA of the interaction between the 
genotype and myc-Ube3b variants, *** p = 0.0007. Tukey’s multiple comparisons between 
KO+myc-Ube3b and KO+myc-Ube3b C/S, * p < 0.05; between CTR+myc-Ube3b and 
CTR+myc-Ube3b C/S, ** p < 0.01; between CTR+myc-Ube3b and KO+myc-Ube3b C/S, 
** p < 0.01. Bar graphs represent averages ± S.D. Scale bar, 20 μm. 
 
 
3.3.4. Pathogenic point mutations in UBE3B abrogate neurite branching 
 
During the course of this study, our collaborating group of Guntram Borck, identified 
additional two point substitution mutations in HECT domain, Arg997Pro (R997P) and 
Gly779Arg (G779R) present in patients with KOS [137]. Those patients display intellectual 
disabilities with absent speech, and patients bearing G779R are diagnosed with seizures. 
Additionally, KOS patients display a number of non-neuronal symptoms (e.g. 
hypocholesterolemia or elevated thyroid-stimulating hormone, TSH in serum [136]. Our 
Ube3b-/- mice showed a general developmental delay, resembling KOS patients. In order to 
circumvent secondary effects caused by non-neuronal developmental defects, to study the 
role of Ube3b in the brain, we generated neuron- and glia-specific conditional Ube3b KO 
(Ube3bf/f; Emx1-Cre+/-, Ube3b cKO) mouse line (Fig. 29A). In Emx1-Cre+/- driver line, Cre 
is expressed in Emx1-positive cell lineage, which gives rise to glutamatergic neurons and 
glia of the forebrain [203,291]. Next, we confirmed almost complete loss of Ube3b from the 
cortex of Ube3b cKO mice by Western blotting (Fig. 29B). Residual Ube3b expression 
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comes likely from non-Emx1 expressing cells, i.e. GABAergic inhibitory neurons. 
Additionally, this indicates that Ube3b is expressed in the neurons and glia of the forebrain. 
In the next set of experiments, we studied the consequences of G779R and R997P mutations 
for the role of Ube3b in neurite branching. We prepared primary hippocampal neurons from 
mice and expressed GFP as a control (Fig. 29C), or co-expressed GFP and HA-tagged wild 
type human UBE3B (HA-hUBE3B; Fig. 29D), GFP and HA-tagged G779R mutant (HA-
hUBE3B G779R; Fig. 29E), or GFP and HA-tagged R997P mutant of hUBE3B (HA-
hUBE3B R997P; Fig. 29F) by calcium phosphate transfection. All UBE3B plasmids were 
generated and provided by Rüstem Yilmaz and Guntram Borck (University of Ulm). 
Neurons were fixed and immunolabeled with anti-HA at DIV7. Overexpression of human 
UBE3B in Ube3b cKO neurons results in an increase of neurite branching as compared to 
GFP expressing Ube3b cKO neurons (Figs. 29C, 29D, 29G, 29H). This indicates conserved 
role of Ube3b in neuronal development. Strikingly, expression of both point mutants of 
UBE3B fails to rescue defective neurite branching phenotype (compare Figs. 29C with 29E, 
and 29F). Sholl analyses and comparison of mean sums of crossing neurites showed 
significant differences between Ube3b cKO neurons expressing HA-hUBE3B, and HA-
hUBE3B G779R, and between Ube3b cKO neurons expressing HA-hUBE3B, and HA-
hUBE3B R997P (Figs. 29G, and 29H; Ube3b cKO, 24.3 ± 10.5 crossings; Ube3b 
cKO+hUBE3B, 35.5 ± 15.9 crossings; Ube3b cKO+hUBE3B G779R, 22.8 ± 9.3 crossings; 
Ube3b cKO+hUBE3B R997P 24.1 ± 8.6 crossings). Of these mutants, HA-hUBE3B R997P 
displayed a peculiar perinuclear localization, while N-terminally tagged HA-hUBE3B was 
abundantly expressed in neurons at DIV7 (Fig. 29F, and Fig. 29C), In conclusion, G779 and 
R997 of UBE3B mutated in patients with KOS are essential for its function in neurite 





Figure 29. Pathogenic point mutations in UBE3B identified in KOS patients abrogate 
neurite branching. (A) Reporter β-galactosidase stainings of knock-in Emx1-Cre+/- mice. 
In this mouse line, lacZ reporter and Cre gene is inserted directly into exon 1 of the Emx1 
gene. Histochemical staining of the reporter to track brain regions subjected to Cre-mediated 
recombination in E12.5 embryo (A’), the coronal brain section (A’’), and the entire brain of 
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an adult mouse (A’’’). (B) Validation of Ube3b loss in the conditional, Emx1-Cre+/- driven 
Ube3b knockout (Ube3b cKO) cortex. Western blotting using cortical lysates of adult 
control (Ube3bf/f, left lane) and Ube3b cKO (Ube3bf/f; Emx1-Cre+/-, right lane) mice with 
the antibody against Ube3b. (C to F) Primary hippocampal neurons from Ube3bf/f; Emx1-
Cre+/- (Ube3b cKO) mice transfected with plasmids encoding GFP and variants of HA-
tagged human UBE3B. Neurons were fixed at DIV7. Representative images of GFP (left 
panels) and HA staining (right panels) in Ube3b cKO neuron expressing GFP alone (C), 
GFP with HA-tagged wild type human UBE3B (HA-hUBE3B) (D), GFP with HA-tagged 
human UBE3B G779R point mutant (HA-hUBE3B G779R) (E), GFP with HA-tagged 
human UBE3B R997P point mutant (HA-hUBE3B R997P) (F). Scale bar, 20 μm. (G) Sholl 
analyses of Ube3b cKO neurons expressing indicated proteins. Each point represents mean 
number of crossing neurites with concentric circles emerging from the soma ± S.E.M. (F) 
Averaged sum of total crossings with Sholl circles until 50 μm from the center of the soma. 
Ube3b cKO+GFP, n = 33; Ube3b cKO+GFP+HA-hUBE3B, n = 15; Ube3b cKO+GFP+HA-
hUBE3B G779R, n = 31; Ube3b cKO+GFP+HA-hUBE3B R997P, n = 24. One-way 
ANOVA of the interaction between the genotype and HA-hUbe3b variants, ** p = 0.002. 
Tukey’s multiple comparisons between Ube3b cKO+GFP and Ube3b cKO+GFP+HA-
hUBE3B, ** p < 0.01; between Ube3b cKO+GFP+HA-hUBE3B and Ube3b 
cKO+GFP+HA-hUBE3B G779R, ** p < 0.01, and between Ube3b cKO+GFP+HA-
hUBE3B and Ube3b cKO+GFP+HA-hUBE3B R997P, ** p < 0.01. Bar graphs represent 
averages ± S.D. 
(A) After [291]. Adapted in line with Open Access Publishing convention. 
 
 
3.3.5. Neuron and glia specific Ube3b knockout mice display reduction of cortical 
thickness 
 
Next, we examined the gross morphology of the brain in Ube3b cKO mice. Brains from 9 
weeks old Ube3b cKO (Ube3bf/f; Emx1-Cre+/-) male mice reveal a non-significant tendency 
towards a reduction in cortical thickness as compared to control (Ube3bf/f) mice (control, 
1.00 ± 0.16; Ube3b cKO, 0.85 ± 0.12; p = 0.051; Fig. 30A, and 30B), while numbers of 
cortical neurons in the coronal cross sections show no difference between control and Ube3b 
cKO (control, 1.00 ± 0.22; Ube3b cKO, 0.99 ± 0.19; Fig 30C). Consistently, there was a 
slight trend towards an increased density of neurons in the Ube3b cKO brains as compared 
to control (control, 1.00 ± 0.34; Ube3b cKO, 1.14 ± 0.25; Fig. 30D), indicating that reduced 
neurite arborization upon Ube3b loss might be the primary cause of reduction of cortical 
thickness in Ube3b cKO mice. Bielschowsky silver impregnation revealed no apparent 
differences in defects of myelinated axonal tracts in Ube3b cKO brains. Nonetheless, we 
noticed prominent ventricular dilatation upon Ube3b cKO (Fig. 30E), corroborating the 
condition described for KOS patients.  
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Hydrocephalus has been described as a cause of reactive-astrogliosis, accumulation of 
macrophages in the brain and neuronal death by several independent research groups [292-
294]. In order to exclude the possibility that neuronal loss is the cause of thinner cortex in 
Ube3b cKO, we examined control and Ube3b cKO brains for astrogliosis by 
immunostaining of coronal brain sections for astrocytic marker, glial fibrillary acidic protein 
(GFAP). As shown in Fig. 30F, we found no obvious difference in staining intensity between 
control and Ube3b cKO.  
Next, we assessed inflammatory response as a readout of ongoing apoptosis or degeneration 
in control and Ube3b cKO brains. We immunostained coronal sections of control and Ube3b 
cKO brains with antibodies for markers for activated microglia (Ionized calcium-binding 
adapter molecule 1, Iba1, Fig. 30G) or macrophages (Lysosomal-associated membrane 
protein 2, Lamp-2, also known as Mac3, Fig. 30H), and detected no obvious differences in 
staining intensities.  
Altogether, conditional deletion of Ube3b from neurons and glia leads to a tendency towards 




Figure 30. Morphological defects in brain-specific Ube3b conditional knockout mice. 
(A) Reduced cortex thickness in Ube3bf/f; Emx1-Cre+/- mice. Representative images of 
immunostaining with antibodies for neuronal nuclear marker, NeuN. Coronal sections 
through somatosensory cortex of Ube3bf/f (left panel) and Ube3bf/f; Emx1-Cre+/- mouse 
(right panel) were immunolabeled. Scale bar, 100 μm. (B) Mean cortical thickness from pial 
surface to the bottom edge of cortical layer VI in Ube3bf/f and Ube3bf/f; Emx1-Cre+/- mice. 
Values are expressed relative to thickness of control cortex. (C) Averaged numbers of 
neurons in Ube3bf/f and Ube3bf/f; Emx1-Cre+/- cortices. The number of NeuN-positive nuclei 
in a cortical region of 560 μm width was counted, and expressed relative to the value in 
Ube3bf/f cortex. (D) Averaged neuronal densities in Ube3bf/f and Ube3bf/f; Emx1-Cre+/-
cortices quantified as a number of NeuN-positive nuclei over the cortex area and expressed 
relative to Ube3bf/f. Bar diagrams in B, C, and D represent average ± S.D. (E) Bielschowsky 
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silver impregnation (BSI), and immunostainings using antibodies against GFAP (F), Iba1 
(G), and MAC3 (H) on coronal brain sections of Ube3bf/f, and Ube3bf/f; Emx1-Cre+/- mice. 




3.3.6. Increased spine density and longer spines with enlarged heads upon Ube3b 
deletion in hippocampal neurons 
 
One of the common features characterized for intellectual disability syndromes, such as 
Angelman syndrome, Rett syndrome, Down’s syndrome, X-linked intellectual disability is 
altered spine number and/or spine morphology [286,295-297]. Therefore, we studied the 
features of dendritic spines in CA1 hippocampal neurons in control and Ube3b cKO mice. 
We transfected hippocampal progenitors in utero at E14.5 with GFP and myr-Venus 
encoding plasmids to visualize dendritic spines. Brains were fixed at P21, when 
synaptogenesis in mouse brain has been accomplished and dendritic branches stabilized [46]. 
Upon imaging of GFP and myr-Venus signals from primary branches of apical dendrites 
projected by CA1 neurons with confocal microscopy, we noted a dramatic increase in spine 
density in Ube3b cKO neurons as compared to control (Fig. 31A). Moreover, spine 
morphology seemed markedly altered, hinting at longer spines with wider heads. In order to 
perform spine morphometrics with super-resolution microscopy, together with Dr. Katrin 
Willig (MPIem, Göttingen), we employed STED microscopy (Fig. 31B). As illustrated on 
Figs. 31D, and 31E, we observed a marked statistically significant increase in spine density 
in Ube3b cKO neurons as compared to control (control, 1.45 ± 0.32; Ube3b cKO, 1.82 ± 
0.31 spines/μm dendrite) (Fig. 31D). In addition, spine heads of thin spines were larger in 
Ube3b cKO neurons (head diameter; control, 0.36 ± 0.08 μm; Ube3b cKO, 0.44 ± 0.05 μm). 
We observed a slight trend towards increased mushroom spine head diameter upon Ube3b 
cKO, however, not statistically significant. To verify, if observed alterations in dendritic 
spine number and morphology were mediated by Ube3b in cell-autonomous manner, we in 
utero electroporated E14.5 hippocampal progenitors of Ube3bf/f mice with plasmids 
encoding GFP and myr-Venus (control), or GFP, myr-Venus, and Cre recombinase (Ube3b 
KO) and analyzed dendritic spines in P21 CA1 pyramidal neurons (Fig. 31C). Expression of 
Cre was verified by immunostaining with anti-Cre antibody (data not shown). Cre 
expressing neurons displayed similar, even more pronounced changes in terms of spine 
number and morphology as compared to nerve cells with Ube3b deleted by Emx1-Cre 
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expression (compare Fig. 31D, and Fig. 31F, also Fig. 31B, and Fig. 31C, right panels). Cre-
mediated deletion of Ube3b led to an increase in spine density (control, 1.51 ± 0.09; Ube3b 
KO, 2.20 ± 0.30 spines/μm dendrite) (Fig. 31F). Moreover, statistically significant increase 
in diameters of heads in Ube3b KO was congruent with observed alterations in Ube3b cKO 
neurons and affected both classes of head-endowed spines: thin, (control, 0.38 ± 0.06 μm; 
Ube3b KO, 0.48 ± 0.06 μm) and mushroom type (control, 0.64 ± 0.13 μm; Ube3b KO, 0.78 
± 0.11 μm) (Fig. 31G). Further, we observed a statistically significant increase in the length 
of spines upon Cre-mediated Ube3b loss in each morphological class: stubby (control, 0.43 
± 0.05 μm; Ube3b KO, 0.50 ± 0.06 μm), filopodia (control, 0.92 ± 0.28 μm; Ube3b KO, 1.15 
± 0.20 μm), thin (control 0.95 ± 0.18 μm; Ube3b KO, 0.11 ± 0.13 μm), and mushroom 
(control 0.82 ± 0.23 μm; Ube3b KO, 1.09 ± 0.19 μm) (Fig. 31H). No differences concerning 
the frequency of spine types between control and Ube3b KO neurons were observed (Fig. 
31I). Altogether, Ube3b emerges as a pivotal ubiquitin ligase controlling spine number and 




Figure 31. Ube3b deletion in neurons induces morphological aberrances in dendritic 
spines. (A) Representative images of anti-GFP immunostaining signal from primary apical 
branches of CA1 pyramidal neurons in Ube3bf/f (control, left panel) and Ube3bf/f; Emx1-
Cre+/- (Ube3b cKO, right panel) mice. Hippocampal progenitors were in utero electroporated 
at E14.5 with plasmids encoding for GFP and myr-Venus and brains were fixed, sectioned, 
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and stained at P21. (B) Maximum intensity projections of STED images of anti-GFP 
immunostaining signal from dendrites of CA1 pyramidal neurons of control (left panel) and 
Ube3b cKO (right panel) mice. (C) Maximum intensity projections of STED images of anti-
GFP immunostaining signal from dendrites of Ube3bf/f hippocampal neurons transfected in 
utero at E14.5 with plasmids encoding GFP and myr-Venus (control, left panel) or GFP, 
myr-Venus, and Cre recombinase (Ube3b KO, right panel). (D) Quantification of spine 
densities. Counted were number of spines per μm dendrite in control and Ube3b cKO CA1 
hippocampal neurons (compare also with B). * p = 0.012, unpaired t-test. (E) Averaged head 
diameters of thin, and mushroom spines in control and Ube3b cKO CA1 hippocampal 
neurons. * p = 0.024, unpaired t-test. (F) Averaged spine densities in GFP (control), or GFP 
and Cre (Ube3b KO) expressing Ube3bf/f hippocampal neurons. *** p < 0.001, unpaired t-
test. (G) Averaged head diameters of thin and mushroom spines in control and Ube3b KO 
neurons. *** p < 0.001, unpaired t-test. (H) Averaged spine length, measured from the 
emergence of spine on the dendrite until the head tip. *** p < 0.001, unpaired t-test. (I) 
Dendritic spines in control and Ube3b KO neurons were classified into morphological 
groups. The graph represents the frequencies of spines of each class. Two-way ANOVA 
with Sidak’s multiple comparisons revealed no significant interaction between the genotype 
and classes of spines. Data on all bar graphs are represented as averages ± S.D. Control, 
Ube3bf/f, n = 1 animal, n = 10 cells, n = 205 spines; Ube3b cKO, Ube3bf/f; Emx1-Cre+/-, n = 
2 animals, n = 11 cells, n = 286 spines. Control, Ube3bf/f+GFP, n = 6 animals, n = 21 cells, 
n = 457 spines; Ube3b KO, Ube3bf/f+GFP+iCre, n = 7 animals, n = 19 cells, n = 649 spines. 
 
 
3.3.7. Increased synaptic transmission in Ube3b KO neurons 
 
Morphological aberrances involving branching deficiencies and spine morphology 
alterations upon Ube3b deletion from neurons prompted us to study the effects of Ube3b 
loss on synaptic transmission. Together with Dr. Silvia Ripamonti and Dr. Jeong Seop Rhee, 
we analyzed glutamatergic autaptic hippocampal neurons from Ube3bf/f (control) and 
Ube3bf/f; Emx1-Cre+/- mice (Ube3b cKO) with electrophysiological methods [298]. 
We first recorded evoked excitatory postsynaptic currents (EPSCs) by depolarizing the cell 
from -70 to 0 mV at a frequency of 0.2 Hz (Fig. 32A). We observed a slight tendency of an 
increase in mean amplitude for Ube3b cKO neurons as compared to control (p = 0.176). 
Additionally, we detected no differences in capacitance, reflecting no differences in soma 
sizes between control and Ube3b cKO neurons (Fig. 32J). Next, we analyzed the basic 
parameters of presynaptic release in control and Ube3b cKO neurons, such as readily 
releasable pool (RRP) size, vesicular probability of release (Pvr), and short-term plasticity 
(STP). The size of RRP, measured as the charge transferred during application of hypertonic 
sucrose solution (Figs. 32B, and Fig. 32D), and Pvr measured as integral of response 
transferred during an action potential evoked EPSC divided by the charge transferred during 
sucrose application (Fig. 32E) were not affected upon Ube3b cKO in nerve cells. During the 
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application of stimuli at 10 Hz, the EPSC amplitudes recorded from control and Ube3b cKO 
neurons declined equally, indicating that STP is not altered upon deletion of Ube3b (Fig. 
32F). These findings indicate that presynaptic release in nerve cells is not affected by the 
loss of Ube3b. 
Increased spine densities in mature neurons observed upon Ube3b loss (Fig. 31) can lead to 
an increase in the number of synapses formed by mutant nerve cell. We then analyzed 
miniature EPSCs reflecting spontaneous, action potential-independent release of 
neurotransmitter at the synapse (Fig. 32G). While the amplitudes of mEPSCs were not 
altered (Fig. 32H), the frequency of mEPSCs was dramatically increased (Fig. 32I) in Ube3b 
cKO neurons compared to control nerve cells (control, 5.33 ± 0.82 Hz; Ube3b cKO, 9.45 ± 
1.39 Hz). These findings illustrate that upon Ube3b loss, the number of functional synapses 
is increased, while the number of functional receptors on a single dendritic spine is unaltered 
in Ube3b cKO neurons. 
In order to examine the number of postsynaptic receptors expressed on the cell surface, we 
recorded postsynaptic currents induced by exogenous application of 100 μM glutamate (Fig. 
32K) or 3 μM γ-aminobutyric acid (GABA) (Fig. 32L) in control and mutant neurons. While 
we detected no differences in the response to exogenous GABA application (Fig. 32O), there 
was a trend towards an increase in current amplitude following exogenous glutamate 
application in Ube3b cKO neurons (control, 1.02 ± 0.10 nA; Ube3b cKO, 1.31 ± 0.12 nA; p 
= 0.063; Fig. 32N). In order to further examine glutamatergic transmission in Ube3b cKO 
neurons, we analyzed the abundance of AMPA- and NMDA-glutamate receptors by 
measuring the ratio between the currents passing through both receptor types. Interestingly, 
we observed increased NMDA/AMPA ratio for Ube3b cKO neurons as compared to control 
(control, 0.18 ± 0.02; Ube3b cKO, 0.29 ± 0.04; p = 0.013; Fig. 32P), indicating alterations 




Figure 32. Altered synaptic transmission in Ube3b knockout neurons. (A) Sample traces 
of evoked excitatory postsynaptic currents (EPSCs) from Ube3bf/f (control) and Ube3bf/f; 
Emx1-Cre+/- (Ube3b cKO) autaptic neurons. (B) Sample traces of postsynaptic currents 
following hypertonic sucrose application in control and Ube3b cKO neurons. (C) Averaged 
amplitudes of evoked EPSCs from control and Ube3b cKO neurons (control, n = 69; Ube3b 
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cKO, n = 63 neurons; p = 0.18; unpaired t-test). (D) Mean sizes of readily releasable vesicle 
pool in control and Ube3b cKO neurons (control, n = 53; Ube3b cKO, n = 55 neurons). (E) 
Average release probability in control and Ube3b cKO neurons (control, n = 53; Ube3b cKO, 
n = 55 neurons). (F) Plots of normalized peak amplitude (± S.E.M) versus number of stimuli 
at 10 Hz frequency in control and Ube3b cKO autaptic nerve cells (control, n = 52; Ube3b 
cKO n = 41). (G) Sample traces of miniature EPSCs in control and Ube3b cKO neurons 
recorded in the presence of 300 nM tetrodotoxin (TTX). (H) Averaged amplitudes of 
miniature EPSCs (mEPSCs) in control and Ube3b cKO neurons (control, n = 37; Ube3b 
cKO, n = 38 neurons). (I) Averaged frequencies of mEPSCs in control and Ube3b cKO 
neurons. Note almost double increase of the EPSC frequency in Ube3b cKO neurons 
(control, n = 37; Ube3b cKO, n = 38; * p = 0.014; unpaired t-test). (J) Averaged capacitances 
of control and Ube3b cKO (control, n = 69; Ube3b cKO, n = 63 neurons; p = 0.08, unpaired 
t-test). (K) Sample traces of postsynaptic currents induced by 100 μM exogenous glutamate 
application in control and Ube3b cKO neurons. (L) Example traces of currents upon 
application of 3 μM GABA in control and Ube3b cKO neurons (M) Sample traces of 
postsynaptic currents upon activation of both - NMDARs and AMPARs by Mg2+-free 
extracellular solution, 1.8 mM CaCl2, and 10 μM glycine in control and Ube3b cKO neurons. 
(N) Averaged glutamate induced responses in control and Ube3b cKO neurons (control, n = 
58; Ube3b cKO, n = 59; p = 0.06, unpaired t-test). (O) Averaged GABA-induced responses 
in control and Ube3b cKO neurons (control, n = 31; Ube3b cKO, n = 15). (P) Averaged 
ratios between current amplitudes through NMDARs and AMPARs in control and Ube3b 
cKO neurons (control, n = 22; Ube3b cKO, n = 16; * p = 0.013, unpaired t-test). Results are 
represented as average ± S.E.M.  
 
 
3.3.8. Imbalance of excitatory/inhibitory transmission in the hippocampus of 
Ube3b cKO mice 
 
Our findings indicate that Ube3b loss results in increased synaptic strength paralleled by 
altered spine morphology and increased spine density on glutamatergic hippocampal 
neurons. This in turn may lead to altered properties of hippocampal circuitry in Ube3bf/f; 
Emx1-Cre+/- (Ube3b cKO) animals, affecting the ability of neurons to synchronize and 
oscillate. In order to validate this hypothesis, with Dr. Silvia Ripamonti and Dr. Matthieu 
Hammer, we recorded γ-oscillatory activity from P14-P24 in brain slices in CA3 field of 
hippocampus at the frequency of 25 – 45 Hz upon kainate application. Strikingly, inducing 
γ-oscillations by application of 100 nM kainate resulted in epileptiform activity in 
approximately 90 % of slices prepared from Ube3b cKO mice (Fig. 33C). Application of 50 
nM kainate resulted in decreased number of slices with epileptic seizure-like activity,and 
enabled to record the γ-oscillations (Figs. 33 A, and 33B). While no changes in the frequency 
of γ-oscillations were detected between Ube3bf/f control and Ube3b cKO animals (Fig. 33D), 
we observed a trend towards an increase in average power of γ-oscillations in Ube3b cKO 
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as compared to control mice (Fig. 33E). These data indicate that hippocampal circuitry in 
Ube3b cKO exhibits higher sensitivity to kainate resulting in epileptiform activity. 
 
 
Figure 33. Gamma-oscillations in Ube3b cKO mice. (A, and B) Representative traces of 
recordings of gamma oscillations before application of kainate (A), and during slice 
treatment with 50 nM kainate (B) in Ube3bf/f (top traces, A, and B; control) and Ube3bf/f; 
Emx1-Cre+/- (bottom traces, A, and B; Ube3b cKO). (C) Quantification of the number of 
brain slices in control and Ube3b cKO mice with epileptiform activity upon 50, or 100 nM 
kainate treatment. (D) Quantification of frequency of γ-oscillations in control and Ube3b 
cKO mice following 50 nM kainate treatment. (E) Quantification of power of γ-oscillations 
in control and Ube3b cKO mice during 50 nM kainate application. All bars represent average 










3.3.9. Severe loss of spatial memory and disturbances in social interaction in 
Ube3b cKO mice 
 
The disruption of spatial learning in Ube3b cKO mice indicates defects in synaptic 
transmission in hippocampal CA1 region [299]. To analyze the behavioral changes upon 
neuronal loss of Ube3b, we collaborated with Prof. Ekrem Dere and Prof. Hannelore 
Ehrenreich (MPIem, Göttingen), who performed a battery of behavioral examinations of 
Ube3bf/f (control) and Ube3bf/f; Emx1-Cre+/- (Ube3b cKO) mice. In this thesis, we are 
presenting the data on spatial memory and social interactions in control and Ube3b cKO 
mice.  
First, we performed visible platform test assessing motivation to escape from swimming in 
the pool as well as the ability to swim and navigate to a visible platform within the pool. The 
latency to escape onto the visible platform (p < 0.001 for control and Ube3b cKO, Fig. 34A) 
and the distance swum until the visible platform was reached (p < 0.001 for control and 
Ube3b cKO, Fig. 34B) was significantly lower on the second as compared to the first day of 
visible platform training in both control and Ube3b cKO, indicating intact procedural 
learning. The swim speed of control mice was significantly higher on the second as 
compared to the first day of testing (p = 0.001, Fig. 34C). No such effect was observed in 
the Ube3b cKO mice (p = 0.124), indicating that they were equally motivated to escape from 
the pool on both days of testing. No significant differences were observed for escape 
latencies, path lengths, or swim speeds between the two groups. These results depict that 
Ube3b cKO are sufficiently motivated to escape from the pool, have intact swimming 
abilities, and can use visual information to navigate to a certain position in space. 
Further, we investigated spatial learning measured during the eight days of hidden platform 
acquisition, where the mice navigated to a platform submerged underneath the water. The 
latency to locate the hidden platform as well as the distance swum until the mice arrived 
onto the platform significantly decreased during subsequent days of hidden platform training 
(main effect of training day, latency: p < 0.001; path length: p < 0.001, Fig. 34D, and 31E). 
No such effect of training day was observed for the swim speed (p = 0.739; Fig. 34F). 
Compared to the control mice, Ube3b cKO animals displayed significantly impaired spatial 
learning. During the eight days of hidden platform training, Ube3b cKO mice presented 
significantly increased escape latencies (main effect of genotype: p = 0.006) and swum 
significantly longer distance in the pool (p < 0.001) before finding the hidden platform as 
compared to the control. The spatial learning deficits upon Ube3b cKO were not due to 
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changes in swimming ability or swim speed (p = 0.397, Fig. 34F). Given that no significant 
differences between control and Ube3b cKO mice were observed in the visible platform test 
as described above, the spatial learning deficit is not a consequence of secondary changes in 
the motivation to escape, motor deficits or aberrances of sensory-motor integration. 
Therefore, Ube3b depletion from glutamatergic neurons of the forebrain and glia leads to 
severe hippocampus-dependent spatial learning deficit. 
A day after the hidden platform training, we tested spatial memory in control and Ube3b 
cKO animals with the platform removed from the water-maze. As compared to control, 
Ube3b cKO mice spent less time searching for the platform in the area with previously 
located platform (p = 0.128, Fig. 34G) and made significantly fewer visits to the former 
platform quadrant (p = 0.020; Fig. 34H). These results illustrate that Ube3b cKO mice were 
unable to associate the spatial position of the platform with salient extra-maze cues. 
As part of a social behavior-testing paradigm, we then investigated nesting behavior in 
control and Ube3b cKO mice. There were no significant differences between both groups 
neither in terms of the quality of the nest built overnight (p = 0.966; Fig. 34I), nor in the 
amount of material used (p = 0.868; Fig. 34J) to construct the nest. In summary, Ube3b cKO 
seem not to affect nesting behavior in mice. 
Next, we analyzed social interactions, where a pair of unfamiliar mice of the same genotype 
is placed into a familiar environment to measure the propensity to engage in social 
interactions. Ube3b cKO mice during the first five minutes of the test spent significantly 
more time on social interactions (p = 0.016; Fig. 34K) as compared to the wild type mice. 
This difference was no longer evident during the last five minutes of the test (p = 0.330; Fig. 
34L), when the animals were already familiar with each other. These results hint that Ube3b 
cKO in mice leads to an increase in social interactions or sociability. 
We then tested for sociability and social memory of control and Ube3b cKO in the tripartite 
chamber. No significant differences between control and Ube3b cKO mice was observed 
during the sociability test, where the animals had to discriminate between a chamber with 
unfamiliar mouse and a chamber with empty cage (Fig. 34M). Interestingly, while control 
mice showed a significant preference for the chamber with unfamiliar mouse over the empty 
chamber (p = 0.017), no such inclination was detected in the Ube3b cKO mice (p = 0.865). 
Moreover, during the social memory test on the third trial the Ube3b cKO performed much 
better than the control animals and spent significantly more time in the compartment with 
unfamiliar mouse as compared to the chamber where the familiar mouse was presented (p = 
0.0004; Fig. 34N). Further, Ube3b cKO mice spent significantly more time in the 
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compartment where the unfamiliar mouse was located as compared to control (p = 0.003). 
No such difference was observed for the time spent in the chamber where the familiar mouse 
was located (p = 0.615). These findings indicate dissociation between spatial and social 
memory performance in Ube3b cKO animals. Our results pinpoint that the neural substrates 
of spatial and social memory are distinct and can be affected independently from each other. 
In conclusion, the Ube3b cKO mice exhibit complex behavioral phenotype with both gain 
and loss of function, including a facilitated processing of intensive, high-arousal sensory 
stimuli, behavioral switch towards self-directed actions (both data not shown), impaired 




Figure 34. Behavioral testing of Ube3b cKO mice. (A) Quantification of escape latencies 
in control, Ube3bf/f and cKO, Ube3bf/f; Emx1-Cre+/- mice. Circles represent average ± S.E.M 
escape latency (s) to the visible platform on indicated days. (B) Quantification of distances 
until the visible platform was reached on indicated days. Circles represent mean ± S.E.M 
distance swum (cm) (C). Averages of swim speed. Circles represent mean ± S.E.M swim 
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speed (cm/s) on indicated days. (D) Plot of escape latencies during eight days of Morris 
Water Maze testing. Circles represent mean ± S.E.M escape latency (s) to the hidden 
platform on indicated days. ** p = 0.006, Repeated Measures ANOVA. (E) Plot of average 
distance swum until the hidden platform was reached on indicated days. Circles represent 
mean ±S.E.M. *** p < 0.001, Repeated Measures ANOVA. (F) Plot of average swim speed 
on indicated days. Circles represent mean ±S.E.M. (G) Average time of control and Ube3b 
cKO mice in target zone. Bars represent mean ± S.E.M % time spent in the former platform 
quadrant. Red line indicates performance at chance likelihood. (H) Averages of number of 
visits a mouse made to former platform quadrant. Bars represent mean ± S.E.M number 
swims into the target zone. Unpaired t-test; * p = 0.02. (I) Averages of nesting score in 
control and Ube3b cKO animals. Bars represent mean ± S.E.M. (J) Quantification of the 
average material used for building a nest. Bars represent mean ± S.E.M unused nesting 
material. (K) Social interaction in pairs test. Bars represent mean ± S.E.M contact time 
between two unfamiliar mice of the same genotype during the first five minutes of the test. 
* p = 0.016, unpaired t-test. (L) Bars represent mean ± S.E.M contact time during the last 
five minutes of the test. (M) Sociability and social memory of control and Ube3b cKO mice 
was tested in the tripartite chamber. Bars represent mean ± S.E.M time spent in the 
unfamiliar mouse and empty compartments. * p = 0.017, paired t-test. (N) Bars represent 
mean ± S.E.M time spent in the compartments containing an unfamiliar and familiar mouse. 
** p = 0.003, unpaired t-test. All described test were conducted with males; control, n = 8; 
Ube3b cKO, n = 11. 
 
 
3.3.10. Proteomic screens reveal putative Ube3b substrates 
 
In the final set of experiments, we studied molecular pathways involving Ube3b that underlie 
neuronal development. To identify Ube3b substrates relevant for neurite and spine 
development, we performed screening using yeast two-hybrid method using N-terminal 
sequence of Ube3b as a bait and mouse embryo and rat brain cDNA libraries (Fig. 35A). We 
identified eight proteins as potential binding partners of Ube3b (Fig. 35A). In order to 
validate the binding between the bait and prey proteins, HEK cells were transfected with a 
plasmid encoding for myc-tagged Ube3b. The protein extract was loaded to glutathione 
beads coupled with GST-fused prey proteins identified in the screen. Western blotting with 
an anti myc-tag antibody demonstrated that Ube3b specifically binds to GST-fused Tacc1, 
Paip1, Cep120, Celf2, and Ap2b1 but not to negative control, GST (Fig. 35B). 
As an alternative approach to identify the substrates of Ube3b, we performed comparative 
proteomics. The C-terminal structure of the HECT domain specifies the type of 
polyubiquitin chain conjugated with the substrate protein [300]. Ube3c, whose C-terminus 
shares high homology to the one of Ube3b, mainly endows the target proteins with Lys48-
linked polyubiquitin chains [301]. This indicates that Ube3b conjugates Lys48-linked 
polyubiquitin chains to its substrates, mediating their proteasomal degradation. Given that 
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Ube3b is highly enriched at the postsynaptic density fraction (Fig. 27F), we hypothesized 
local Ube3b-mediated ubiquitylation and accumulate of Ube3b substrates at the postsynapse 
in the Ube3bf/f; Emx1-Cre+/- mouse. Based on this hypothesis, to identify Ube3b substrates, 
we purified synaptic plasma membrane fractions (SM3) from Ube3bf/f (control) and 
Ube3bf/f; Emx1-Cre+/- (Ube3b cKO) mice and subjected them for comparative mass 
spectrometry (performed by Olaf Jahn, MPIem, Göttingen). 
First, we validated the purification of SM3 fractions by Western blotting with antibodies 
against PSD-95, and RabGDI (Fig. 35C), and confirmed depletion of Ube3b in SM3 
fractions purified from Ube3b cKO mice (Samples M4 to M6 in Fig. 35D). Based on the 
number and mass spectrum of unique peptides recognized by the spectrometer, we obtained 
a list of synaptic of proteins up-regulated in SM3 fractions from Ube3b cKO as compared 
to the ones prepared from control mice (Fig. 35E). We then validated the results by Western 
blotting with the antibody against the top hit protein, protein phosphatase 3, catalytic subunit, 
gamma isoform, Ppp3cc (Fig. 35 F). The level of Ppp3cc is significantly increased in Ube3b 
cKO samples as compared to control samples (control, 1 ± 0.47; Ube3b cKO, 3.68 ± 0.90; 




Figure 35. Proteomic screens for Ube3b substrates. (A) The scheme of yeast two hybrid 
screening for Ube3b binding proteins using N-terminus of Ube3b containing IQ motif as bait 
(left scheme). The list of putative Ube3b interacting proteins is displayed on the right 
scheme. (B) Validation of Ube3b binding proteins is displayed on the right scheme. The 
binding of myc-Ube3b with indicated proteins was confirmed by Western blotting using 
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anti-myc antibody. (C) Western blotting validation of subcellular fractionation of Ube3bf/f, 
control (Mouse 1 – 3) and Ube3bf/f; Emx1-Cre+/-, Ube3b cKO (Mouse 4 - 6) brains using 
antibodies against PSD-95, and RabGDI. Homogenate (H), supernatant (S), synaptosomes 
(P2C), synaptic cytoplasm, crude synaptic vesicles (SC/CSV), crude synaptic membrane 
(CSM), synaptic membrane fraction (SM3). (D) Validation of Ube3b loss in SM3 samples 
purified from Ube3b cKO (compare also C) by Western blotting. (E) List of proteins up-
regulated in the SM3 fraction from Ube3bf/f; Emx1-Cre+/- by proteomic screening. (F) 
Validation of comparative proteomics (compare also D, and E) by Western blotting using 
SM3 fractions of control and Ube3b cKO brains with antibodies against the top hit, Ppp3cc 
(top panel). MEM code staining of nitrocellulose membrane used for Western blotting 
(bottom panel). (G) Quantification of Ppp3cc levels in control and Ube3b cKO SM3 
fractions. Protein level was normalized to MEM Code staining intensity, and expressed 
relative to Ppp3cc level in the control. Data are represented as averages ± S.D. Control, n = 





4.1.Wwp ubiquitin ligases, miR-140, and Sox9 regulate neuronal polarity 
acquisition 
 
4.1.1. Wwp1 and Wwp2 are indispensable for axon specification in primary 
hippocampal neurons  
 
Wwp1 and Wwp2 ligases have been extensively studied in dividing cells, however their role 
in postmitotic neurons remain uncharted. During this study, we corroborated essential roles 
of Wwp1 and Wwp2 in axon acquisition of hippocampal neurons in vitro, polarity formation 
of cortical nerve cells, and their distribution throughout cortical plate in vivo.  
An increase in the fraction of neurons projecting multiple axons upon Wwp1/2 dKD and 
upon Wwp1/2 dKO (Fig. 5 and Fig. 8) indicates indispensable roles of Wwp1 and Wwp2 in 
axon specification. To date, little examples of gene KO resulting in gain-of-function in axon 
specification have been reported. Loss of tuberous sclerosis 1 (Tsc1), or KD of tuberous 
sclerosis 2 (Tsc2) induces formation of ectopic axons in primary hippocampal neurons, 
resembling the phenotypic change in Wwp1/2 dKO and Wwp1/2 dKD neurons [302].  
Tsc1 and Tsc2 control axon formation by negatively regulating mammalian target of 
rapamycin complex 1 (mTORC1) pathway. Interestingly, KD of phosphatase and tensin 
homolog (Pten), alternative regulator of mTOR pathway, results in a gain-of-function 
phenotype in axon formation. Pten acts upstream of glycogen synthase kinase 3β (GSK3β), 
whose siRNA-mediated KD also leads to multiple axons [303].  
Our data show that Wwp1 and Wwp2 regulate a molecular pathway essential for the 
regulation of axon formation in hippocampal neurons.  
 
4.1.2. Wwp1 and Wwp2 are essential for acquisition of neuronal polarity 
formation in vivo  
 
Defectful axon formation upon Wwp1/2 dKD and Wwp1/2 dKO in vitro might reflect 
aberrant apico-basal polarity acquisition in progenitor cells, or defectful multipolar-bipolar 
transition essential for initiation of radial migration (Fig. 6 and 7) [304,305]. We cannot 
exclude the possibility that Wwp1/2 dKD might induce changes of neuronal progenitor 
identity and thereby destines neurons to deeper cortical layers formed earlier in neurogenesis 
 150 
[306]. Nonetheless, observed concomitant loss of bipolar morphology in newly born neurons 
upon Wwp1/2 dKD in vivo implies defects in specification of leading and trailing processes, 
both of which are critical for establishment of axon/dendrite polarity [232,307]. 
Given that we do not observe clustering of non-polarized neurons at the ventricular zone, 
observed for mutations leading to loss of axons, Wwp1/2 dKD in neurons seem to disrupt 
the maintenance and not the initiation of radial migration. LKB1 KO abrogates axon 
formation in neurons and KD of LKB1 results in an ultimate arrest of neuronal migration 
[230,234,308]. Deletion of transforming growth factor receptor β type II, (TgfrβII) in 
neocortical neurons abrogates axon formation and results in accumulation of nerve cells at 
the ventricular zone [232]. Presumptively, loss of axon upon LKB1 KO, or TgfrβII KO 
mirrors defective specification of leading and trailing processes and hamper attachment of a 
neuron to RGC processes, resulting in the delay of migration [309].  
 
4.1.3. Nedd4 ligases orchestrate neuronal development 
 
Interestingly, Nedd4 family of ubiquitin ligases display very similar domain architecture 
with C2-, WW-, and HECT-domains. WW-domains of all members of Nedd4 family 
recognize similar amino acid motives in substrates and bind proline rich stretches in proteins 
[310,311]. Intriguingly, deficiencies of each Nedd4 ubiquitin ligase ensue with different 
consequences for neuronal morphology. Ubiquitin ligase Nedd4-1 is a positive regulator of 
neurite branching, and is dispensable for axon specification [97,98]. KD of Smurf1 abrogates 
axon formation in Par6- and RhoA-dependent mechanisms [96]. Here, we report that loss of 
Wwp1 and Wwp2 in neurons leads to specification of multiple axons. Diverse role of Nedd4 
family of E3 ligases implicate that despite highly homologous amino acid sequences, Nedd4 
ligases ubiquitylate discreet sets of substrates and mediate different cellular signaling 
pathways controlling different aspects of neuronal development. 
 
4.1.4. miR-140 acts synergistically to Wwp1 and Wwp2 ligases in regard to axon 
acquisition 
 
We demonstrate that miR-140 is indispensable for uncompromised neuronal development. 
Genetic deletion of miR-140 leads to induction of ectopic axons in primary hippocampal 
neurons. Exogenous delivery of miR-140 to miR-140-/- neurons restores specification of 
single axons (Fig. 11), indicative of cell-autonomous mode of miR-140 action in neurons. 
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Conversely, expression of tandemly repeated pri-miR-140 in wild type neurons leads to loss 
of axon specification (Fig. 17). Overexpression of a given miRNA might cause RISC 
saturation and induce phenotypic artifacts attributable to loss of other miRNAs associated 
with RISC [273,312]. However, miR-140 overexpression leads to the opposite phenotypic 
change as miR-140 KO. Therefore, it is likely that miR-140 suppresses axon formation. 
Intriguingly, aberrances of axon specification in vitro, defectful morphology of neurons in 
vivo, and disruption of cortical distribution is similar for Wwp1/2 dKD, Wwp1/2 dKO, miR-
140 KO, and miR-140-3p KD (Compare Figs. 5, 6, 8, 11, 12, and 16). These observations 
imply that miR-140 acts synergistically to its host gene Wwp2 and homologous Wwp1 in 
regulation of neuronal polarity formation. In the future, it would be interesting to study the 
combined effects of miR-140 and Wwp1/2 loss on neuronal morphology by knocking down 
miR-140 in Wwp1/2 dKO, or knocking down Wwp1/2 in miR-140 KO. 
MiR-Base (GRCm38) as of June 2014 reports that 1915 mature murine miRNAs have been 
annotated. Some of them have been reported as critical regulators of neuronal development 
and function, e.g. miR-9 [313], miR-124 [314], miR-132 [315], or miR-137 [316]. However, 
none of annotated miRNAs has been reported indispensable for polarity formation before, 
placing miR-140 among the regulators of axon specification in neurons. 
Interestingly, genetic deletion of Dicer in neurons leads to disruption of neuronal migration 
in vivo, paralleled with loss of bipolar morphology of migrating neurons. Loss of Dicer 
results in pleiotropic neuronal phenotype due to the loss of miRNA processing. Interestingly, 
expression of mature miR-124 in Dicer KO neurons restores their bipolar morphology [176]. 
Similarly, genetic deletion of miR-140 disrupts polarity of newly born neurons and affects 
distribution of cortical nerve cells (Fig. 12). Thus, miR-140 and miR-124 are both involved 
in regulating polarity formation in nerve cells.  
 
4.1.5. miR-140-3p acts as a biologically active guide strand to regulate neuronal 
polarity 
 
It has been reported, that miR-140 is highly expressed in cartilage during zebrafish 
ontogenesis [317]. The role of miR-140 has been well characterized in chondrocytes, where 
miR-140-5p represents more biologically active, guide strand of miR-140 duplex 
[201,318,319]. Intriguingly, systematic analysis of miRNA expression in neurons using 
miRNA-tagging and affinity purification method revealed that miR-140-3p strand is 
expressed in nerve cells, and by far outnumbers miR-140-5p [200]. 
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Here, we show that it is the miR-140-3p that is up-regulated in the brain during 
embryogenesis, and reaches high levels at perinatal stages, when neurons establish axon-
dendrite polarity (Fig. 10D). Moreover, we demonstrate that sponge-mediated 
downregulation of miR-140-3p leads to ectopic formation of multiple axons in neurons, and 
that miR-140-5p is dispensable for axon specification (Fig.13).  
In situ hybridization using locked nuclei acid experiments illustrate that miR-140-3p is 
expressed in primary hippocampal neurons, where it enriches in somatic endosome-like 
structures (Fig. 10E). This finding is in line with somatic localization of miRNA-loaded 
RISC, and its association with multivesicular bodies, critical for miRNA-mediated gene 
regulation [320,321]. This indicates that miR-140-3p regulates axon acquisition through 
global repression of target genes rather than through local suppression of mRNA translation 
[322]. 
Our observations suggest that RISC loading complex specifies a guide strand of miR-140 in 
tissue-specific manner; miR-140-5p in chondrocytes, and miR-140-3p in neurons. Tissue-
specific strand selection of miR-140 broadens its regulatory capacity of transcriptome in the 
entire organism, as each strand targets different pools of mRNAs [200]. 
Upon RNA sponge-mediated miR-140-3p KD, primary hippocampal neurons, apart from 
profound defects in axon specification, display high density of conspicuous membrane 
protrusions, morphologically resembling filopodia (Fig. 13C). Given that filopodia 
formation relies on precise regulation of actin cytoskeleton [323], and that destabilization of 
actin filaments is sufficient to induce multiple axons [57], it is likely, that miR-140 is a 
potential regulator of actin stability in neurons. 
Alteration of neuronal distribution within the cortical plate upon miR-140-3p KD in P10 
brains (Fig. 15) might be attributable to miR-140-mediated regulation of homeobox genes 
controlling laminar organization of the cortex. We demonstrate that vast majority of miR-
140-3p KD neurons abnormally located in deeper cortical layers expressed the marker of 
layer II/III/IV neurons, Cux1 [29] (Fig. 16). Electroporated cortical progenitors at E14.5-
E15.5 give rise to layer II/III neurons, thus implicating that miR-140 does not affect 
expression of homeobox genes. It is therefore likely, that aberrant distribution of miR-140-





4.1.6. Neuronal polarity formation is not controlled by reciprocal regulation of 
miR-140 and Wwp1/2 
 
In this study, we illustrate that miR-140 acts synergistically with Wwp1 and Wwp2 in 
neuronal development. To verify if miR-140 and Wwp ligases constitute a reciprocal 
regulatory loop, such as for miR-26b and its host c-terminal domain small phosphatase 1, 
ctdsp2 gene [257], we sought levels of Wwp1 and Wwp2 upon miR-140 KO, and for levels 
of miR-140 upon Wwp2 KO (Fig. 18). We report that neither loss of host gene Wwp2 causes 
changes of miR-140 levels, nor deletion of miR-140 affects Wwp1 and Wwp2 protein 
expression levels in mouse brain. These data excludes reciprocal interaction between miR-
140 and Wwp ligases, and implies that those molecules operate in the cell in an independent, 
yet intertwined manner in regulating neuronal polarity acquisition. 
 
4.1.7. miR-140 regulates mRNAs of proteins involved in polarity acquisition in 
neurons 
 
To extend our understanding of molecular context of miR-140-mediated regulation of 
neuronal development, we sought miR-140 target mRNAs in mouse cortex. By quantitative 
mass spectrometry, we identify NFM, and Fyn as potential miR-140 targets, involved in 
polarity formation in developing neurons (Fig.19). 
Western blotting validation of quantitative mass spectrometric screening revealed a not 
statistically significant increase in expression levels of Fyn and NFM in miR-140-/- 
synaptosomes, as compared to miR-140+/+ samples (Fig. 19E and 19F). Fyn is essential for 
transduction of semaphorin 3A signals to developing neurons, and thereby for proper 
orientation of apical dendrites in developing cortex [231,307]. NFM is a critical regulator 
for neuronal morphology by modulating cytoskeleton stability [324]. Moreover, NFM seems 
to regulate radial growth of the axon [325]. To verify, if Fyn, or NFM is indeed involved in 
miR-140-mediated control of neuronal polarity acquisition, the morphological consequences 
of overexpression of both proteins need to be assessed in primary hippocampal neurons as 
well as in cortical nerve cells. 
Mass spectrometry has been previously successfully applied to identify miRNA targets 
[326,327]. Spectrometric analyses of changes in proteome induced by transfection of HeLa 
cells with miR-155 reveal that roughly 70% of putative target genes were down-regulated 
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by approximately 30% [328]. This implies that in general, miRNA-mediated gene regulation 
mostly relies on fine-tuning gene expression.  
A single miRNA molecule is predicted to target from 200 to 300 different mRNAs. 
Conserved miRNA-binding sites are present in 60% of human protein-coding genes [146]. 
It has been proposed, that the phenotype observed upon deletion of a certain miRNA 
molecule is the additive effect of up-regulation of its several mRNA targets, as is the case 
for miR-128, or miR-137. CamKII-Cre-driven miR-128-2 cKO leads to early onset 
hyperactivity, and strong tonic-clonic seizures in mice resulting in death. Interestingly, miR-
128 deletion leads to up-regulation of ERK2 signaling pathway, however ERK2 kinase is 
not a direct miR-128 target. Over-activation of ERK2 signaling cascade is due to up-
regulation of direct miR-128 targets. Indeed, pharmacological inhibition of ERK2 in miR-
128-2 cKO improves defectful motor performance in mice [329]. 
Single nucleotide polymorphisms in miR-137 gene have been described in schizophrenic 
patients and have been reported to elevate miR-137 levels. Interestingly, miR-137 controls 
the expression of genes that encode proteins of crucial importance for the presynaptic vesicle 
release in neurons, such as complexin 1 (Cplx1), N-ethylmaleimide sensitive fusion protein 
(NSF), synapsin III (Syn3), and synaptotagmin 1 (Syt1). Interestingly, viral overexpression 
of miR-137 in the murine dentate gyrus disrupts vesicle pool at the presynaptic terminals of 
mossy fibers. Exogenous delivery of miR-137 sponge to neurons induced from fibroblasts 
of schizophrenic patients restored levels of Cplx1, NSF, and Syt1 and improved vesicle 
trafficking at the presynapse. Additionally, overexpression of only one of identified miR-
137 targets, Syt1, was able to restore the deficiencies observed upon miR-137 
overexpression in neurons only partially [316].  
Both reports corroborate, that phenotypic changes observed upon miRNA deletion, or 
overexpression should be considered as the broad effects, that miRNA exert on the entire 
transcriptome, rather than attributing them to miRNA-mediated translation inhibition of a 
single mRNA.  
 
4.1.8. Sox9 regulates axon specification, polarity formation, and cortical 
distribution of postmitotic neurons 
 
Expression of Sox9 has been previously reported in dividing cells [172,258,274]. In the 
developing brain, Sox9 mRNA and protein are developmentally downregulated with the 
highest expression level during neurogenesis (E13) (Fig. 20A, and 20B). Intriguingly, 
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postmitotic hippocampal and cortical neurons of layer II/III displayed nuclear Sox9 
expression, indicative of Sox9 roles in neurons (Fig. 20C, and 20D). Wwp2 expression 
resembles the one of Sox9, both at the levels of mRNA, and protein. This implies, that Sox9 
presumptively operates as a major transcriptional regulator of Wwp2 in developing cortex. 
Wwp1 protein expression is inversely correlated to the one of Sox9, indicative of other 
means of transcriptional control of Wwp1 gene. Wwp1 and Wwp2 mRNA levels peak 
perinatally. Additionally, cortical level of miR-140-3p also increases at birth (Fig. 10D). 
This suggest that at P0, developmental stage when axons, and dendrites are specified in the 
mouse cortex, Sox9 is the main regulator of both Wwp1, Wwp2, and precursor miR-140 
expression (Fig. 20A and 20B).  
We also observe that the mRNA and protein expression profiles of Wwp1 are uncorrelated 
over the course of cortical development. Expression of Wwp1 mRNA is induced during 
neurogenesis, peaks at P0 and decays until P21 as shown by qRT-PCR using primers 
complementary to the middle part of Wwp1 mRNA (NM_177327.3) (Fig. 20A). On the 
other hand, Western blotting for Wwp1 using an antibody raised against C-terminal HECT 
domain showed that Wwp1 protein is developmentally up-regulated, and increases 
constantly until birth, where it reaches the plateau phase (Fig. 20B). It is possible, that Wwp1 
mRNA detected in our qRT-PCR is not an isoform that encodes for Wwp1 protein detected 
in our Western blotting experiments. Alternatively, Wwp1 mRNA undergoes complex 
posttranscriptional regulation and drives the expression of Wwp1 protein independently of 
its mRNA levels [330]. 
We demonstrate that KD of Sox9 in postmitotic hippocampal neurons induces formation of 
multiple axons and that overexpression of Sox9 abrogates axon formation. Genetic deletion 
of Sox9 leads to early embryonic lethality with profound defects of neural crest [276,331]. 
For this reason, to verify involvement of Sox9 in the regulation of neuronal polarity in vivo, 
we took advantage of sh-RNA mediated KD and Cre-induced deletion of Sox9 using in utero 
electroporation in Sox9f/f mice (Fig. 20D, 22 and 23). Both KD and KO of Sox9 in cortical 
progenitors led to significant alteration of neuronal distribution within cortical plate. 
Moreover, Cre-driven deletion of Sox9 in single neurons induced abnormal neuronal polarity 
in vivo. These data indicate that Sox9 operates in postmitotic neurons, where it is essential 




4.1.9. Sox9/Wwp1/2/miR-140-3p axis is critical for regulation of neuronal 
development 
 
In this study, we decipher regulatory mechanisms of neuronal polarity acquisition. We 
demonstrate that miR-140 is indispensable for neuronal development, and acts 
synergistically to Wwp1 and Wwp2 ligases to suppress axon acquisition. Moreover, we 
unveil that Sox9 is critical for the development of the nerve cell. Although more 
experimental evidence is necessary to verify if miR-140 and Wwp1/2 act within one cellular 
pathway, and if Sox9 acts as a master regulator of miR-140 and Wwp1/2 expression in 
neurons, we conclude here that Sox9, miR-140, and Wwp1/2 represent intertwined 
molecular quartet orchestrating neuronal polarity formation.  
 
4.2.HECT-type ubiquitin ligases and dendritic spines 
 
4.2.1. Wwp1 and Wwp2 ubiquitin ligases are potential negative regulators of 
synaptogenesis in cortical and hippocampal neurons 
 
Expression patterns of Wwp ligases, especially of Wwp1, suggest their critical role in mature 
neurons of the murine nervous system. We report that neuron-specific KO of Wwp1 and 
Wwp2 leads to increased spine density in cortical neurons, enlarged spine heads of 
mushroom spines, and reduced length of filopodia in CA1 pyramidal nerve cells (Fig. 24).  
Increased density of dendritic spines implicates that Wwp1 and Wwp2 negatively regulate 
synapse number, either inhibiting synaptogenesis, or augmenting synapse elimination. 
Synapse number in murine brain reaches maximum at P21. As animals progress in 
adolescence (after P21), synapses formed during postnatal synaptogenesis stabilize, and due 
to synapse elimination, synaptic contacts undergo refinement [46,332,333]. Given that we 
quantified spine densities in brains of P21 mice, it is likely that Wwp1 and Wwp2 inhibit 
synaptogenesis. 
According to Fiala and co-workers, changes of spine head size, or spine length affect 
electrophysiological properties of postsynaptic neurons [334]. Spines with enlarged heads 
represent more stable synaptic contacts, and harbor more glutamate receptors resulting in 
increased local conductivity [335,336]. Additionally, reduction in the length of filopodia 
suggests reduced motility of immature spines in Wwp1 and Wwp2 dcKO neurons [337]. For 
this reason, Wwp1 and Wwp2 might suppress synaptogenesis by reducing motility of 
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developing spines [334]. Electrophysiological measurements of amplitudes of evoked 
EPSCs and the frequency of mEPSCs would help to understand the functional consequences 
of morphological alterations of dendritic spines in Wwp1 and Wwp2 dcKO neurons.  
 
4.2.2. Nedd4-2 regulates dendritic spine morphology 
 
Previous reports demonstrating Nedd4-2-dependent ubiquitylation of sodium channels, and 
membrane transporters imply that Nedd4-2 regulates neuronal physiology. Moreover, 
Nedd4-2 gene comprises a potential candidate susceptibility gene for epileptic 
photosensitivity in patients with idiopathic generalized epilepsy [283]. Here, we demonstrate 
that Nedd4-2 deletion from neurons leads to morphological changes in spine shape, i.e. 
longer spines, enlarged heads of thin spines, and reduced density of mushroom-type spines 
at the expense of bifurcated-type spines (Fig.25). 
Spine head size determines the area of postsynaptic density and defines the vesicle pool of 
its presynaptic bouton [338], suggesting augmented synaptic transmission mediated by the 
synapse it specifies. However, longer spines, observed in Nedd4-2 cKO may affect calcium 
distribution within the spine, and thereby reduce activation of the postsynaptic terminals 
[339]. Excitatory postsynaptic potential amplitudes are inversely correlated with spine 
lengths [340].  
Spine head bifurcation has been observed after tetanic stimulation of neuronal afferents to 
induce LTP. Activity-dependent segmentation of postsynaptic density apposed to a single 
presynaptic terminal has been proposed to facilitate synaptic potentiation [341,342]. 
Moreover, longer spines have small, or negligible contribution to action potentials. 
However, upon high-frequency stimulation are able to undergo plastic morphological 
changes and functional plasticity [340]. Presumptively, two phenotypes observed for Nedd4-
2 cKO, longer spines and bifurcated spine heads, might affect induction, and/or maintenance 
of LTP. Electrophysiological characterization of Nedd4-2 cKO neurons using protocols to 
induce LTP is essential to understand the physiological consequence of morphological 
alterations.  
HECT-type ligases of Nedd4 family, Wwp1, Wwp2 and Nedd4-2 share similar domain 
organization (Fig. 3C). Highly homologous WW-domains recognize proline stretches in 
substrate proteins, which suggests functional redundancy of Nedd4 ligases in terms of 
substrate ubiquitylation [343]. However, our data indicate that Wwp1, Wwp2, and Nedd4-2 
 158 
ligases are involved in the regulation of independent cellular pathways controlling dendritic 
spine morphology. 
 
4.3.Ube3b, Kaufman oculocerebrofacial syndrome, and the molecular pathologies 
in intellectual disability 
 
4.3.1. Neuron-specific loss of Ube3b in mice recapitulates neurological defects of 
Kaufman oculocerebrofacial syndrome 
 
Over the course of this study, we characterized Ube3b in the developing and mature brain. 
Recent reports demonstrate that missense, and point mutations in UBE3B, gene encoding for 
ubiquitin ligase E3B lead to Kaufman oculocerebrofacial syndrome (KOS) in humans 
[136,137]. KOS is a developmental disorder with growth arrest, severe intellectual disability, 
and characteristic facial dysmorphisms. In order to reveal the roles of Ube3b, we generated 
conventional, and neuron- and glia-specific conditional Ube3b KO mice. Conventional KO 
of Ube3b gene in the mouse recapitulates major aspects of human KOS (Fig. 26). Therefore, 
our Ube3b KO mouse line can serve as a model of the human KOS. 
 
4.3.2. Ube3b associates with postsynapses 
 
Ube3b mRNA was highly expressed in the developing cortical plate and ganglionic 
eminence at E16, indicating critical roles of Ube3b in neuronal development. In the adult 
brain, Ube3b mRNA was abundantly expressed throughout the cerebral cortex, hippocampus 
and brain stem (Fig. 27A). This mRNA expression pattern resembles mRNA distribution of 
UBE3A, MeCP2, or PQBP-1, genes mutated in patients with mental retardation, and 
therefore essential for uncompromised development and neuronal function [344-346]. 
Expression profile of Ube3b protein over the course of cortical development (Fig. 27B and 
27C) resembles the ones of synaptic proteins, such as PSD-95, SAP102, or neuroligin-1 
[281,347]. In line with this observation, we report massive enrichment of Ube3b in 
postsynaptic density fraction (PSD). This enrichment was even more pronounced than that 
of PSD-95 [348,349] (Fig. 27F). Our data indicates that Ube3b has essential roles at the 
postsynapses, and emerges as a key regulatory molecule involved in the pathology of 
intellectual disability syndrome. 
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4.3.3. Ube3b is a positive regulator of neurite branching 
 
We demonstrate that deletion of Ube3b results in deficient neurite development, which may 
underlie the development of intellectual disability in patients with KOS. Ube3b is essential 
for proper neurite branching, and regulates it a cell-autonomous manner (Fig. 28). Moreover, 
expression of pathogenic point mutants of UBE3B (i.e. G779R and R997P) in Ube3b cKO 
neurons failed to restore proper neurite branching (Fig. 29). Both mutations have been 
reported in homozygous configuration in KOS patients suffering from severe developmental 
delay, and absent speech. Intriguingly, both mutations localize to the HECT domain of 
UBE3B, implicating detrimental effects on its catalytic function.  
Remarkably, we noted that HA-hUBE3B R997P displayed a perinuclear localization in 
nerve cells at DIV7, while wild type HA-hUBE3B and HA-hUBE3B G779R distributed 
uniformly in the neuron (compare Figs. 29D and 29F). We conclude, that arginine residue 
at position 997 is essential for proper localization of hUBE3B in neurons. 
 
4.3.4. Loss of Ube3b deficiency leads to increase in spine density, enlarged spine 
heads and longer spines in hippocampal neurons 
 
We demonstrate that genetic deletion of Ube3b leads to aberrances in spine density and 
alterations of spine morphology (Fig. 31). CA1 pyramidal neurons of Emx1-Cre-driven 
Ube3b cKO mice display significant increase in spine density paralleled by significant 
enlargement of heads of thin spines (Fig. 31A, 31B, 31D and 31 E). Deletion of Ube3b from 
individual CA1 pyramidal neurons recapitulates Ube3b cKO phenotype with a dramatic 
increase in spine density, enlarged spine heads, and longer spines (Fig. 31 C, 31F-31H). 
Given low transfection efficiency by in utero electroporation, these data suggest a cell-
autonomous function of Ube3b in the regulation of spine number and morphology. 
Our morphometrics of dendritic spines were performed with STED nanoscopy. Given that 
resolution of STED is 30 - 60 nm [350] as compared to approximately 200 nm of a confocal 
microscope [351], STED is more suitable for spine morphometrics and enables detection of 






4.3.5. Neuronal morphology and intellectual disability  
 
4.3.5.1.Defective neurite branching in intellectual disability syndromes 
 
Pathophysiology of intellectual disability is not entirely understood, however mutations in 
genes resulting in cognitive defects provide a possibility to reveal its cellular and molecular 
fundaments.  
Interestingly, disturbances of neuronal morphology concerning dendritic and axonal 
branching have been previously reported for numerous genes involved in the pathologies of 
intellectual disability syndromes. Pyramidal neurons of Angelman syndrome mouse model 
display morphological deficiencies concerning apical dendrite outgrowth, and exhibit 
undeveloped, stunted dendrites [120]. Mutations in polyglutamine-binding protein 1 gene, 
PQBP-1, described in approximately ten cases of familial X-linked mental retardation 
diseases, abrogate dendritic branching of mouse cortical neurons [289,353,354]. Reduced 
complexity of dendritic arbor was reported in mouse models of Rett syndrome, deleterious 
for methyl-CpG-binding protein 2, MeCP2 [355,356]. 
Moreover, morphological deficiencies in neurons are also common cellular pathology in 
autism spectrum disorders. Post mortem studies in patients with Rett syndrome, a rare form 
of autism characterized by developmental delay and intellectual disability, reveal reduced 
dendritic branching of hippocampal neurons [357].  
Proper neurite branching is essential for synaptic integration [358]. The geometry of 
dendritic tree affects firing patterns of action potentials [359], and the dendritic arbor defines 
neuronal contribution to network activity and synaptic inputs [360,361]. Therefore, deficient 
neurite arborization in neurons deleterious for Ube3b may contribute to cognitive incapacity 
of KOS patients.  
 
4.3.5.2.Dendritic spine abnormalities and mouse models of intellectual disability 
syndromes 
 
In mental retardation, structural changes in neuronal morphology, i.e. dendritic tree 
arborization and alteration of spine density are causative of altered number of synaptic 
connections, or inappropriate connectivity [362]. Geert Ramakers proposed so called 
‘network hypothesis’ which states that aberrant development and plasticity of synaptic 
circuits constitutes the primary cause of mental retardation [363,364]. Importantly, synaptic 
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activity is linked to dynamic changes of spine shape, size, and numbers. The plasticity of 
spine numbers and their morphology is strongly associated with learning [335,337,365-368]. 
For this reason, morphological changes of dendritic spines in Ube3b-deficient neurons might 
lead to disrupted synaptic activity and altered network connectivity, or function. 
Mouse models of disorders characterized by intellectual disability present spine 
abnormalities, which are linked to disturbances of neuronal network connectivity [334,362]. 
Genetic model of Down syndrome, mice with segmental trisomy 16 (Ts65Dn mice) [369], 
mimic the imbalance of gene dosage on human chromosome 21q21-22.3. Ts65Dn mice 
exhibit decreased spine numbers and enlarged spine heads on the basal dendrites of CA1 
neurons and layer II/III pyramidal neurons, as reported by several independent research 
groups [370,371]. Decreased spine density in CA1 neurons and motor cortex was also noted 
for mouse models of Rett syndrome. Mice with mutations in MeCP2 gene exhibit lower 
spine density, decreased spine heads size, and increased neck lengths [355,372] paralleled 
by altered dendritic spine distribution [373].  
Fragile X syndrome is the most commonly inherited form of mental retardation [374]. On 
the contrary to both Down and Rett syndrome mouse models, KO of Fragile X mental 
retardation 1 gene, FMR1 in mice results in increased number of spines in layer V pyramidal 
neurons and hippocampus [375,376].  
Those observations indicate that cellular pathologies in intellectual disability syndromes 
differ one from another, however all seem to converge on alteration of the structure, or 
number of dendritic spine. Ube3b deficiency in neurons results in increase in spine number, 
rather than in impairment of spine maturation. Association of Ube3b with postsynaptic sites 
implies local regulation of actin cytoskeleton at the synaptic boutons by the ligase. Altered 
morphology of spines of each type (enlarged heads and longer spine necks, Fig. 31E, 31G 
and 31H) advocates Ube3b-mediated changes of plasticity at the level of single spines, rather 
than a global switch in maturation of synaptic contacts.  
 
4.3.6. Deletion od Ube3b leads to increased synaptic transmission and alters 
NMDAR to AMPAR ratio 
 
In line with increased spine numbers in Ube3b cKO neurons, electrophysiological analyses 
of nerve cells devoid of Ube3b reveal increased mEPSCs frequency without changes in 
amplitude, indicative of increased numbers of functional synapses specified by Ube3b 
neurons (Figs. 32G-I). 
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Additionally, we report increased NMDAR to AMPAR ratio in Ube3b cKO neurons 
(Fig.32P). This alteration indicates either changes in the abundance of glutamate receptors 
on Ube3b cKO neurons, or altered composition of NMDARs facilitating increased NMDAR 
conductance. Neuronal NMDAR currents are positively correlated with the diameter of the 
spine head [336]. We therefore hypothesize, that enlarged spine heads in Ube3b-deficient 
neurons harbor increased number of NMDARs. 
Our data indicate that neuronal Ube3b deficiency alters spine number and morphology. 
Changes of physiology of individual neurons may in turn affect development and/or activity 
of neuronal networks.  
 
4.3.7. Ube3b loss in neurons leads to imbalance between excitatory/inhibitory 
input to hippocampal circuits 
 
To test, if altered morphology and electrophysiology of neurons deleterious of Ube3b lead 
to defects in neuronal circuitry, we recorded kainate-induced γ-oscillatory activity in CA3 
field of hippocampus. Almost all Ube3b cKO brain slices treated with 100 nM kainate 
display epileptiform activity as opposed to slices from control animals (Fig. 33C). This 
suggests an augmented susceptibility to kainate-induced excitatory/inhibitory imbalance in 
hippocampal network in Ube3b cKO mice. This hypothesis is in line with an observed trend 
towards increased power of γ-oscillations induced by 50 nM kainate (Fig. 33B and 33E). 
Interestingly, half of reported KOS patients with mutations in UBE3B are diagnosed with 
seizures, indicative of excitatory/inhibitory imbalance of neuronal networks. 
Alteration in excitatory/inhibitory balance in Ube3b cKO neurons may be due to several 
factors. Intact RRP size and Pvr in Ube3b cKO neurons (Figs. 32D, and 32E) exclude 
malfunction of presynaptic release machinery. Given that we observed not significant 
increase in amplitude of evoked EPSCs (Fig. 32A), and glutamate-induced responses (Fig. 
32K, and 32N) as well as significant increase in spine density (Fig. 31) in Ube3b cKO 
neurons, it is likely, that excitatory/inhibitory imbalance is attributable to augmented 
intrinsic excitability of Ube3b cKO neurons.  
Interestingly, spontaneous seizures in Ube3b cKO mice in the home cage were not noted. 
Like in the case of other mouse models of intellectual disability, e.g. Rett syndrome model, 
only application of kainate revealed increased susceptibility to seizures. Moreover, also in 
Rett syndrome mouse model, kainate treatment of brain slices revealed increased power of 
γ-oscillations in CA3 field of hippocampus [377]. 
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Disrupted activity of neuronal networks in Ube3b cKO observed as induced seizures, and a 
not statistically significant increase in power of γ-oscillations may represent a primary cause 
of mental incapacity [378-380]. 
 
4.3.8. Disrupted spatial memory and altered social interactions in Ube3b cKO 
mice 
 
We report that neuronal loss of Ube3b in mice disrupts spatial learning and memory and 
alters social interactions (Fig. 34). Interestingly, Ube3b cKO mice exhibit superior social 
memory as compared to control animals. 
Poor performance in the Morris water maze test reflecting cognitive impairments have been 
reported for mouse models of mental retardation syndromes, such as Down syndrome [381], 
X-linked mental retardation [382], or autism spectrum disorders [383]. Behavioral defects 
in neuron- and glia specific-Ube3b deficient mice indicate essential roles of Ube3b in 
neurons and glia to control learning, memory, and social behavior. 
Spatial memory impairment indicates malfunction of hippocampal CA1 region [299]. 
Ube3b-mediated changes of neuronal morphology concerning dendritic spines were 
described in the primary branches of CA1 pyramidal neurons. Our observations indicate a 
straightforward detrimental contribution of altered morphology of CA1 pyramidal nerve 
cells to circuits important for learning and memory. Possibly, morphological defects 
observed for pyramidal CA1 neurons reflect aberrant function of hippocampal circuitry. 
Interestingly, it has been reported that CA2 region of the hippocampus is essential for social 
memory and interaction in mice [384]. Ube3b cKO mice display a complex alterations in 
hippocampus-dependent behaviors. Presumptively, Ube3b cKO exerts detrimental effects 
on neuronal wiring in CA1 region implicated in spatial learning and improves neuronal 
function in CA2 subfield . 
Behavior of animals and humans is associated with specific activity of neuronal networks 
resulting in oscillatory patterns of activity. Hippocampal γ-oscillations in mice are triggered 
during exploratory behavior and navigation [385-387]. Moreover, γ-oscillatory activity is 
correlated with behavioral performance [388]. Susceptibility of to kainate-induced seizures 
and altered physiology of Ube3b-deficient neurons may reflect defectful neuronal networks 
resulting in profound behavioral alterations in Ube3b cKO mice. 
Interestingly, loss of Ube3b in neurons and glia leads to increased sociability, which mirrors 
the features of behavior of some patients with intellectual disability [389]. Mentally retarded 
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individuals are often characterized by ‘Distanzminderung’, which reflects eagerness for 
physical contact, and animated and happy demeanor in social interactions with foreign 
people [390].  
Reported Ube3b-mediated loss of spatial memory and improvement in social interactions 
seem to be a unique feature of KOS mouse models. Down syndrome mouse model, Ts65 
mice, display impairment in spatial learning, and no changes in sociability [381]. 
Furthermore, there are behavioral aspects of other mouse models of human diseases with 
intellectual disability syndromes, that were not reported for Ube3b cKO mice, such as 
increased aggression [391], or obsessive-compulsive-like behavior [392]. Interestingly, 
behavioral alterations entirely opposite to those we observe for Ube3b cKO were reported 
for neuroligin-3 R451C mutant mouse, which exhibits augmentation of spatial learning, and 
impaired social interactions, characteristic features for autism spectrum disorders [393]. 
KOS resultant from mutations in UBE3B represents an intellectual disability syndrome with 
pathology different from autism spectrum disorders. Our observations provide novel insights 
into the neuronal pathology of the intellectual disability. 
 
4.3.9. Protein targets of Ube3b 
 
During this study, we identified several putative substrates of Ube3b by yeast two-hybrid 
screening, and comparative mass spectrometry (Fig. 35).  
Among potential Ube3b substrates identified in yeast-two hybrid screening, G-protein 
coupled receptor kinase-interactor 1, Git1 regulates spine formation by Rac1-downstream 
effectors α-p21-activated kinases, PAKs. Active PAKs promote formation of dendritic 
protrusions, which correlates with number of excitatory synapses [394]. However, Ube3b-
mediated Git1 ubiquitylation, and if Git1 overexpression might be attributable to Ube3b-
mediated increase of spines should be validated in the future.  
Additionally, we report up-regulation of gamma isoform of protein phosphatase 3 catalytic 
subunit, Ppp3cc in SM3 fractions of Ube3b cKO brain. Ppp3cc is a part of large protein 
phosphatase complex, also known as calcineurin. Its role in neurons remains to be 
thoroughly studied, however it has been described in dendritic spines [395], where it 
localizes to F-actin, and regulates cytoskeleton stability [396]. Those features make Ppp3cc 
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